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FSP Section 20,000
Checklists and Illustrative Financial 
Statements for Life and Health 
Insurance Entities
.01 The checklists and illustrative financial statements in this section have been developed by the AICPA 
Accounting and Auditing Publications Team to serve as nonauthoritative practice aids for use by preparers 
and auditors of financial statements. They have not been reviewed, approved, disapproved, or otherwise 
acted on by any senior technical committee of the AICPA and do not represent official positions or pro­
nouncements of the AICPA. Readers should be aware of the following:
• The checklists and illustrative financial statements do not include all disclosures and presentation 
items promulgated; as a result, pronouncements deemed unlikely to be encountered in financial 
statements of life and health insurance companies are not included.
• The checklists and illustrative financial statements are tools and in no way represent official posi­
tions or pronouncements of the AICPA.
The checklists have been updated to include relevant reporting and disclosure guidance issued 
through September 30, 2008, including the following:
• Financial Accounting Standards Board (FASB) Statement of Financial Accounting Stan­
dards (SFAS) No. 163, Accounting for Financial Guarantee Insurance Contracts— an inter­
pretation of FASB Statement No. 60
• Revised SFAFs issued through September 30, 2008, including SFAS 141(R), Business 
Combinations
• FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes—an interpretation 
of FASB Statement No. 109
• FASB Technical Bulletin No. 01-1, Effective Date for Certain Financial Institutions of Certain 
Provisions of Statement 140 Related to the Isolation of Transferred Financial Assets
• FASB Emerging Issues Task Force consensuses adopted through the September 2008 
meeting
• FASB Staff Positions issued through September 30, 2008
• AICPA Statement on Auditing Standards No. 114, The Auditor's Communication With 
Those Charged With Governance (AICPA, Professional Standards, vol. 1, AU sec. 380)
• AICPA Statement of Position (SOP) 07-1, Clarification of the Scope of the Audit and Ac­
counting Guide Investment Companies and Accounting by Parent Companies and Equity 
Method Investors for Investments in Investment Companies (AICPA, Technical Practice Aids, 
ACC sec. 10,930)
• AICPA SOP 07-2, Attestation Engagements That Address Specified Compliance Control Objec­
tives and Related Controls at Entities That Provide Services to Investment Companies, Invest­
ment Advisers, or Other Service Providers (AICPA, Technical Practice Aids, AUD sec. 14,430)
(continued)
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• AICPA Practice Bulletin No. 15, Accounting by the Issuer of Surplus Notes (AICPA, Tech­
nical Practice Aids, PB sec. 12,150)
• Interpretation No. 3, "Financial Statements Audited in Accordance With International 
Standards on Auditing" of AU section 534, Reporting on Financial Statements Prepared for 
Use in Other Countries (AICPA, Professional Standards, vol. 1, AU sec. 9534 par. .09-.11)
• AICPA Statement on Standards for Accounting and Review Services (SSARS) No. 17, 
Omnibus Statement on Standards for Accounting and Review Services-2008 (AICPA, Profes­
sional Standards, vol. 2)
• Interpretation No. 30, "Considerations Related to Financial Statements Prepared in Ac­
cordance With International Financial Reporting Standards and Compilations and Re­
views Performed in Accordance With International Standards" of AR section 100, Com­
pilation and Review of Financial Statements (AICPA, Professional Standards, vol. 2, AR sec. 
9100 par. .130-.135)
• AICPA Statement on Standards for Attestation Engagements No. 14, SSAE Hierarchy 
(AICPA, Professional Standards, vol. 1, AT sec. 50)
• Interpretation No. 6, "Reporting on Attestation Engagements Performed in Accordance 
With Government Auditing Standards" of AT section 101, Attest Engagements (AICPA, 
Professional Standards, vol. 1, AT sec. 9101 par. .56-.58)
• Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 6, Eval­
uating Consistency of Financial Statements (AICPA, PCAOB Standards and Related Rules, 
Rules of the Board, "Standards")
• AICPA Audit and Accounting Guide Life and Health Insurance Entities (with conforming 
changes through March 1, 2008)
The checklists and illustrative financial statements should be modified, as appropriate, for sub­
sequent pronouncements. In determining the applicability of a pronouncement, its effective 
date should also be considered.
.02 A description of the insurance industry and a description of common accounting and reporting fea­
tures of stock life insurance companies are presented in the AICPA Audit and Accounting Guide Life and 
Health Insurance Entities (2008) (product no. 012638kk).
.03 The checklists and illustrative financial statements should be used by, or under the supervision of, 
persons having adequate technical training and proficiency in the application of generally accepted account­
ing principles, generally accepted auditing standards, PCAOB Auditing Standards, SSARs.
.04 Users of the checklists and illustrative financial statements are urged to refer directly to applicable 
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical 
Hotline at 1-877-242-7212.
Note: This publication was extracted from sections 20,000 through 20,600 of the AICPA Financial Statement 
Preparation Manual (FSP).
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Introduction
.01 The function of insurance is to pool the risks of many persons who are exposed to similar risks. For 
a payment known as a premium, insurance companies undertake to relieve the policyholder of all or part of 
a risk and to spread the total cost of similar risks among large groups of policyholders. One of the primary 
purposes of life insurance is to provide financial assistance to named beneficiaries at the time of the death 
of the insured. The long-term nature of the coverage involving the risk of death—a risk that increases with 
age—is the distinguishing characteristic that sets life insurance apart from other forms of insurance. Tradi­
tionally, life insurance entities provided life and health products to protect against the loss of financial sta­
bility resulting from premature death or illness, and provided annuity products to protect against the risk 
of outliving one's financial resources. The primary emphasis was on meeting the customer's insurance 
needs. The provisions of AICPA Audit and Accounting Guide Life and Health Insurance Entities (2008) (prod­
uct no. 012638kk) apply to all life and health insurance entities including stock, mutual, fraternal, and as­
sessment entities.
.02 The National Association of Insurance Commissioners (NAIC) codified statutory accounting prac­
tices for certain insurance enterprises, resulting in a revised Accounting Practices and Procedures Manual. The 
insurance laws and regulations of the states require insurance companies domiciled in the states to comply 
with the guidance provided in the NAIC Accounting Practices and Procedures Manual except as prescribed or 
permitted by state law.
.03 In December 2001, the AICPA issued Statement of Position (SOP) 01-5, Amendments to Specific AICPA 
Pronouncements for Changes Related to the NAIC Codification (AICPA, Technical Practice Aids, ACC sec. 10,840), 
which amends SOP 94-5, Disclosures of Certain Matters in the Financial Statements of Insurance Enterprises 
(AICPA, Technical Practice Aids, ACC sec. 10,630), as a result of the completion of the NAIC codification of 
statutory accounting practices for certain insurance enterprises.
.04 The amendments to SOP 94-5 included in SOP 01-5 require insurance enterprises to disclose, at the 
date each balance sheet is presented, a description of the prescribed or permitted statutory accounting prac­
tice and the related monetary effect on statutory surplus of using an accounting practice that differs from 
either state prescribed statutory accounting practices or NAIC statutory accounting practices.
.05 Those disclosures should be made if (a) state prescribed statutory accounting practices differ from 
NAIC statutory accounting practices or (b) permitted state statutory accounting practices differ from either 
state prescribed statutory accounting practices or NAIC statutory accounting practices, and the use of pre­
scribed or permitted statutory accounting practices (individually or in the aggregate) results in reported 
statutory surplus or risk-based capital that is significantly different from the statutory surplus or risk-based 
capital that would have been reported had NAIC statutory accounting practices been followed.
.06 Those disclosures should be applied by a U.S. insurance enterprise, a U.S. enterprise with a U.S. 
insurance subsidiary, or a foreign enterprise with a U.S. insurance subsidiary if the enterprise prepares U.S. 
generally accepted accounting principles (GAAP) financial statements. If a foreign insurance enterprise that 
does not have a U.S. insurance subsidiary prepares U.S. GAAP financial statements or is included in its 
parent's consolidated U.S. GAAP financial statements, the notes to the financial statements should disclose 
permitted regulatory accounting practices that significantly differ from the prescribed regulatory accounting 
practices of its respective regulatory authority and their monetary effects.
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.07 SOP 01-5 also includes the following auditing guidance that has been updated as a result of the 
completion of the NAIC codification: SOP 95-5, Auditor's Reporting on Statutory Financial Statements of Insur­
ance Enterprises (AICPA, Technical Practice Aids, AUD sec. 14,310); SOP 94-1, Inquiries of State Insurance Regu­
lators (AICPA, Technical Practice Aids, AUD sec. 14,290); and Interpretation No. 12, "Evaluation of the Appro­
priateness of Informative Disclosures in Insurance Enterprises' Financial Statements Prepared on a Statutory 
Basis," of AU section 623, Special Reports (AICPA, Professional Standards, vol. 1, AU sec. 9623 par. .60-.81). 
The included auditing guidance has been approved by the Auditing Standards Board.
FSP §20,100.07
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FSP Section 20,200 
Checklists—General
.01 AICPA disclosure checklists have been designed as practice aids to assist accountants in the prepa­
ration of financial statements and to assist auditors in their evaluation of the adequacy of disclosures in the 
financial statements they audit. Authoritative literature does not require the use of checklists, nor does it 
prescribe their format or content.
.02 Within these checklists is a number of questions or statements that are accompanied by references 
to the established sources of generally accepted accounting principles in which the disclosure requirements 
are found. These sources include Financial Accounting Standards Board (FASB) Statements of Financial Ac­
counting Standards, FASB Interpretations, FASB Staff Positions, Accounting Principles Board Opinions, Ac­
counting Research Bulletins, AICPA Audit and Accounting Guides, AICPA Statements of Position, and 
FASB Emerging Issues Task Force Consensuses. Checklists are designed to serve as convenient memory aids 
but should not be used as a substitute for direct reference to authoritative literature.
.03 The checklists provide spaces for checking off or initialing each question or point to indicate that it 
has been considered. Carefully review the topics listed and consider whether they represent potential disclo­
sure items for the reporting entity for which you are preparing or auditing financial statements. Users 
should check or initial
• Yes—If the disclosure is required and has been made appropriately.
• No—If the disclosure is required but has not been made.
• N/A (Not Applicable)—If the disclosure is not applicable to the entity.
.04 It is important that the effect of any "No" response be considered on the auditor's or accountant's 
report. For audited financial statements, a "No" response that is material to the financial statements may 
warrant a departure from an unqualified opinion as discussed in paragraphs .20-.64 of AU section 508, 
Reports on Audited Financial Statements (AICPA, Professional Standards, vol. 1). For reviewed or compiled fi­
nancial statements, a "No" response that is material to the financial statements may warrant a departure 
from a standard report as discussed in paragraphs .51-53 of AR section 100A, Compilation and Review of 
Financial Statements (AICPA, Professional Standards, vol. 2).*
.05 At the beginning of certain sections, a □ appears in the "N/A" column. If the entire section is 
deemed to be nonapplicable, place a check mark in the □ and proceed to the next section.
.06 Users may find it helpful to use the right margin for certain other remarks and comments as appro­
priate, including
a. for each disclosure for which a "Yes" is indicated, a notation explaining where the disclosure is 
* In February 2008, the Accounting and Review Services Committee, a senior technical committee of the AICPA, issued Statement on 
Standards for Accounting and Review Services (SSARS) No. 17, Omnibus Statement on Standards for Accounting and Review Services—2008 
(AICPA, Professional Standards, vol. 2). SSARS No. 17 is effective for compilations and reviews of financial statements for periods ending 
on or after December 15, 2008, with early application permitted.
Due to the issuance of SSARS No. 17, AR section 100, Compilation and Review of Financial Statements; AR section 9100, Accounting and 
Review Services Interpretations of Section 100; AR section 200, Reporting on Comparative Financial Statements; AR section 300, Compilation 
Reports on Financial Statements Included in Certain Prescribed Forms; AR section 9300, Accounting and Review Services Interpretations of Section 
300; and AR section 400, Communications Between Predecessor and Successor Accountants (as they existed prior to being amended by SSARS 
No. 17) have been moved to AR sections 100A, 9100A, 200A, AR section 300A, 9300A, and 400A, respectively, of Professional Standards 
until the effective date of SSARS No. 17.
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located in the financial statements and a cross-reference to the applicable working papers where the 
support to a disclosure may be found.
b. for items marked as "N/A," the reasons for which they do not apply in the circumstances of the 
particular report.
c. for each disclosure for which a "No" response is indicated, a notation explaining why the disclosure 
was not made (for example, because the item was not considered to be material to the financial 
statements).
.07 The use of these or any other checklists requires the exercise of individual professional judgment. 
These checklists are not substitutes for the original authoritative pronouncements. Users of these checklists 
and illustrative materials are urged to refer directly to applicable authoritative pronouncements when ap­
propriate. The checklists and illustrative materials may not include all disclosures and presentation items 
promulgated, nor do they represent minimum standards or requirements. Additionally, users of the check­
lists and illustrative materials are encouraged to tailor them as required to meet specific circumstances of 
each particular engagement.
FSP §20,200.07
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FSP Section 20,300
Financial Statements and Notes Checklist
.01 This checklist has been developed by the Accounting and Auditing Publications Team of the AICPA 
as a nonauthoritative practice aid for use by preparers and auditors of financial statements. This checklist 
includes disclosures commonly encountered in the financial statements of stock life insurance companies 
and reporting issues likely to be encountered by accountants who audit, compile, and review those types of 
financial statements. They do not include all disclosures required by generally accepted accounting princi­
ples (GAAP) or address all reporting situations that may arise in performing engagements in accordance 
with generally accepted auditing standards, Public Company Accounting Oversight Board standards, and 
Statements on Standards for Accounting and Review Services.
.02 Explanation of References:
AAG = AICPA Audit and Accounting Guide Life and Health Insurance Entities (with 
conforming changes as of March 1, 2008)
ACC = Reference to a section number in AICPA Technical Practice Aids, Statement of 
Position—Accounting
APB = Accounting Principles Board Opinion
ARB = Accounting Research Bulletin
AU = Reference to section number in AICPA Professional Standards (vol. 1)
EITF = Emerging Issues Task Force Consensus
FASB = Financial Accounting Standards Board
FASCON = FASB Concept Statement
FIN = FASB Interpretation Number
FSP = FASB Staff Position
PB = AICPA Practice Bulletin
PCAOB = Public Company Accounting Oversight Board
SFAS = FASB Statement of Financial Accounting Standards
SOP = AICPA Statement of Position
TB = Technical Bulletin issued by FASB staff
Checklist Questionnaire:
This checklist is organized into the sections listed below. Carefully review the topics listed and consider 
whether they represent potential disclosure items for the life and health insurance company.
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Place  by 
Applicable Sections
• Balance Sheet
A. General _________
B. Cash _________
C. Investment Securities _________
D. Investments Accounted for by the Equity Method _________
E. Impairment of a Loan _________
F. Accounts and Notes Receivable and Agents' Balances _________
G. Reinsurance Receivables _________
H. Lease Finance Receivables _________
I. Deferred Acquisition Costs _________
J. Property and Equipment _________
K. Lessee Leases _________
L. Intangible Assets and Goodwill _________
M. Separate Account Assets _________
N. Deposit Accounting _________
O. Policy Liabilities _________
P. Income Taxes _________
Q. Current Liabilities, Notes Payable, and Long-Term Debt _________
R. Other Liabilities _________
S. Shareholders' Equity _________
• Income Statement
A. Premium Revenue _________
B. Investment Income _________
C. Other Income _________
D. Benefits and Expenses _________
E. Income Taxes _________
F. Extraordinary Items, Unusual Items, Infrequent Items _________
G. Earnings Per Share _________
H. Comprehensive Income _________
I. Other _________
• Statement of Changes in Shareholders' Equity
• Statement of Cash Flows
• General
A. Titles and References _________
B. Disclosure of Accounting Policies _________
C. Comparative Financial Statements _________
D. Accounting Changes and Error Corrections _________
E. Risks and Uncertainties _________
F. Contingencies and Commitments _________
G. Environmental Remediation Liabilities _________
H. Related-Party Transactions and Economic Dependency _________
I. Employee Stock Ownership Plans _________
J. Employers' Disclosures for Defined Benefit Pension and Other
Postretirement Benefits _________
K. Consolidated Financial Statements _________
L. Financial Instruments _________
L1. Financial Instruments of Enterprises Subject to SFAS 161 _________
M. Foreign Currency _________
N. Impairment of Long-Lived Assets to Be Held and Used _________
FSP §20,300.03
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Place by 
Applicable Sections
O. Long-Lived Assets and Disposal Groups to Be Disposed Of
P. Accounting for Servicing Financial Assets
Q. Nonmonetary Transactions
R. Subsequent Events
S. Costs Associated With Exit or Disposal Activities
T. Business Combinations
U. Segment Information
V. Postemployment Benefits
W. Stock Compensation Plans
X. Asset Retirement Obligations
Y. Demutualizations and Formations of Mutual Insurance Holding 
Companies
Z. Guarantees
AA. Fair Value Measurements
Note: Reminder—A "No" answer is indicative of a potential GAAP depar­
ture. The reason for the "No" answer and the resolution of the matter should 
be documented in the working papers.
Yes No N/A
Balance Sheet
A. General
1. For classified balance sheets, are assets and liabilities segregated into 
current and noncurrent classifications, with totals presented for current 
assets and current liabilities?
[ARB 43 ch. 3A par. 2-8; SFAS 78 par. 5 and 13; SFAS 6 par. 15; FIN 8 
par. 3; TB 79-3 par. 2]
2. Are assets not expected to be realized during the current operating cycle 
classified as noncurrent?
[ARB 43 ch. 3A par. 5-6]
3. Are valuation allowances for assets shown as deductions from their 
related assets with appropriate disclosure?
[APB 12 par. 3]
B. Cash
1. Is separate disclosure made of restricted cash?
[ARB 43 ch. 3A par. 6]
2. Are restrictions on cash appropriately disclosed?
[SFAS 5 par. 18]
3. Is the policy for determining cash equivalents disclosed?
[SFAS 95 par. 10]
4. If the company has material bank overdrafts or material balance of 
undelivered checks as of the balance sheet date, are:
a. Bank overdrafts presented as a separate caption within current 
liabilities?
FSP §20,300.03
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Yes No N/A
b. Undelivered checks classified as accounts payable? ____  ____  ____
[Generally Accepted]
Practice Tip
Be sure that the amount of cash and cash equivalents displayed on the balance sheet equals the amount of 
cash and cash equivalents displayed on the statement of cash flows.
C. Investment Securities
1. Are there separate captions for each of the following investment cat­
egories:
a. Fixed-maturity securities? ____
b. Mortgage loans on real estate? ____
c. Investment real estate? ____
d. Policy loans? ____
e. Other long-term investments? ____
[AAG app. B]
2. Are mortgage loans reported at outstanding balances, net of the una­
mortized balances of loan origination, commitment, other fees and
costs, purchase premiums and discounts, and allowance for losses? ____
[SFAS 60 par. 47, as amended by SFAS 114; SFAS 91 par. 21]
3. Are changes in the allowance for uncollectible amounts relating to 
mortgage loans reported in income as prescribed in SFAS 114, Ac­
counting by Creditors for Impairment of a Loan—an amendment of FASB
Statements No. 5 and 15? ____
[SFAS 60 par. 47, as amended by SFAS 114]
4. Are real estate investments reported at cost less accumulated depre­
ciation? ____
[SFAS 60 par. 48, as amended by SFAS 121 and SFAS 144]
5. Are reductions in the carrying amounts of real estate investments re­
sulting from the application of SFAS 144, Accounting for the Impairment
or Disposal of Long-Lived Assets, included in realized gains and losses? ____
[SFAS 60 par. 48, as amended by SFAS 121 and SFAS 144]
6. Are the carrying amounts of investment securities on deposit with
regulatory authorities disclosed? ____
[AAG app. C par. 1]
7. Are debt and equity securities classified as (a) held-to-maturity, (b)
available-for-sale, or (c) trading? ____
[SFAS 115 par. 6]
FSP §20,300.03
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Yes No N/A
Note: In February 2007, FASB issued SFAS 159, The Fair Value Option for 
Financial Assets and Financial Liabilities—Including an amendment of FASB 
Statement No. 115, which is effective as of the beginning of an entity's first 
fiscal year that begins after November 15, 2007.
This statement applies to all entities, including not-for-profit organiza­
tions. Most of the provisions of this statement apply only to entities that 
elect the fair value option. However, the amendment to SFAS 115, Ac­
counting for Certain Investments in Debt and Equity Securities, applies to all 
entities with available-for-sale and trading securities. Some requirements 
apply differently to entities that do not report net income. This checklist 
has been updated to include the presentation and disclosure requirements 
of SFAS 159. Readers can refer to the full text of the statement on the FASB 
Web site at www.fasb.org.
See part A A, "Fair Value Measurements," for more information.
8. Does the enterprise reports its investments in available-for-sale secu­
rities and trading securities separately from similar assets that are 
subsequently measured using another measurement attribute on the 
face of the statement of financial position, does the entity either (a) 
present the aggregate of those fair value and non-fair-value amounts 
in the same line item and parenthetically disclose the amount of fair 
value included in the aggregate amount or (b) present two separate 
line items to display the fair value and non-fair-value carrying 
amounts?
[SFAS 115 par. 17, as amended by SFAS 135 and SFAS 159]
9. If an entity elects the fair value option for a held-to-maturity or avail­
able-for-sale security in conjunction with the adoption of SFAS 159, is 
the security then reported as a trading security under SFAS 115 but 
not subjected to the accounting rules normally associated with trans­
fers to the trading category?
[SFAS 159 par. 29]
10. In the statement of cash flows, are cash flows from purchases, sales, 
and maturities of trading securities classified based on the nature and 
purpose for which the securities were acquired?
[SFAS 115, par. 18]
11. If an enterprise presents a classified statement of financial position, 
are all individual held-to-maturity securities, individual available-for- 
sale securities, and individual trading securities reported as either 
current or noncurrent, as appropriate, under the provisions of ARB 43 
chapter 3A, "Working Capital—Current Assets and Current Liabili­
ties"?
[SFAS 115 par. 17, as amended by SFAS 135 and SFAS 159]
FSP §20,300.03
12 Life and Health Insurance Entities
Yes No N/A
Practice Tips
SFAS 115 does not apply to investments in equity securities that, absent the election of the fair value option 
in SFAS 159 would be required to be accounted for under the equity method, nor to investments in consol­
idated subsidiaries.
Electing the fair value option pursuant to SFAS 159 for an existing held-to-maturity security will not call 
into question the intent of the entity to hold other debt securities to maturity in the future.
Presentation of individual amounts for trading securities, held-to-maturity securities, and available-for-sale 
securities on the face of the balance sheet is not required as long as the information is provided in the notes 
to the financial statements.
12. For securities classified as available-for-sale, has the reporting entity 
made the following disclosures by major-security type as of each date 
for which a statement of financial position is presented:
a. Aggregate fair value?
b. Total gains for securities with net gains in accumulated other 
comprehensive income (OCI)?
c. Total losses for securities with net losses in accumulated OCI? 
[SFAS 115 par. 19, as amended by SFAS 133]
13. For securities classified as held-to-maturity, has the reporting entity 
made the following disclosures by major-security type as of each date 
for which a statement of financial position is presented:
a. Aggregate fair value?
b. Gross unrecognized holding gains or losses?
c. Net carrying amount?
d. Gross gains and losses in accumulated OCI for any derivatives 
that hedged the forecasted acquisition of the held-to-maturity 
securities?
[SFAS 115 par. 19, as amended by SFAS 133]
14. Are cash flows from purchases, sales, and maturities of available-for- 
sale securities and held-to-maturity securities classified as cash flows 
from investing activities and reported gross for each security classifi­
cation in the statement of cash flows?
[SFAS 115 par. 18]
15. Are cash flows from purchases, sales, and maturities of trading secu­
rities classified as cash flows from operating activities in the statement 
of cash flows?
[SFAS 115 par. 18]
16. For investments in debt securities classified as available-for-sale or 
held-to-maturity:
a. Is disclosure made about their contractual maturities as of the 
date of the latest balance sheet presented (maturity information 
may be combined in appropriate groupings)?
FSP §20,300.03
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Yes No N/A
b. If securities not due at a single date (such as mortgage-backed 
securities) are allocated over several maturity groupings, is the
basis for allocation disclosed? ____  ____  ____
[SFAS 115 par. 20, as amended by SFAS 133]
17. For each period for which an income statement is presented, are the 
following disclosed:
a. The proceeds from sales of available-for-sale securities and gross 
realized gains and losses that have been included in earnings as a
result of those sales? ____  ____  ____
b. The basis on which the cost of a security sold or the amount re­
classified out of accumulated OCI into earnings was determined 
(that is, specified identification, average cost, or other method
used)? ____  ____  ____
c. The gross gains and losses included in earnings from transfers of
securities from the available-for-sale category to the trading cate­
gory? ------- ------- ------
d. The amount of the net unrealized holding gain or loss on avail­
able-for-sale securities for the period that has been included in 
accumulated OCI and the amount of gains and losses reclassified
out of accumulated OCI into earnings for the period? ____  ____  ____
e. The portion of trading gains and losses for the period that relates
to trading securities still held at the reporting date? ____  ____  ____
[SFAS 115 par. 21, as amended by SFAS 133]
18. For any sales of or transfers from securities classified as held-to-ma­
turity, are the following disclosed for each period for which an earn­
ings statement is presented:
a. Net carrying amount of the sold or transferred security? ____  ____  ____
b. The net gain or loss in accumulated OCI for any derivative that
hedged the forecasted acquisition of the held-to-maturity secu­
rity? ____  ____  ____
c. Related realized or unrealized gain or loss? ____  ____  ____
d. The circumstances leading to the decision to sell or transfer the
security? ____  ____  ____
[SFAS 115 par. 22, as amended by SFAS 133; EITF 96-11]
19. For all investments in an unrealized loss position, including those that 
fall within the scope of EITF 99-20, "Recognition of Interest Income 
and Impairment on Purchased and Retained Beneficial Interests in Se­
curitized Financial Assets," for which other-than-temporary impair­
ments have not been recognized, does an investor disclose the follow­
ing in its annual financial statements:
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a. As of each date for which a statement of financial position is pre­
sented, quantitative information, aggregated by category of in­
vestment—each category of investment that the investor discloses 
in accordance with SFAS 115 and SFAS 124, Accounting for Certain 
Investments Held by Not-for-Profit Organizations (refer to paragraph 
4(b) in FSP FAS 115-1 and FAS 124-1, The Meaning of Other-Than- 
Temporary Impairment and Its Application to Certain Investments) and 
cost-method investments—in tabular form:
(1) The aggregate related fair value of investments with unreali­
zed losses?
(2) The aggregate amount of unrealized losses (that is, the 
amount by which cost exceeds fair value)?
Notes: The disclosures in question 19a(1)-(2) should be segregated by those 
investments that have been in a continuous unrealized loss position for 
less than 12 months and those that have been in a continuous unrealized 
loss position for 12 months or longer.
The reference point for determining how long an investment has been in 
a continuous unrealized loss position is the balance sheet date of the re­
porting period in which the impairment is identified. For entities that do 
not prepare interim financial information, the reference point would be the 
annual balance sheet date of the period during which the impairment was 
identified. The continuous unrealized loss position ceases upon either (a) 
the recognition of an other-than-temporary impairment or (b) the investor 
becoming aware of a recovery of fair value up to (or beyond) the cost of 
the investment during the period.
b. As of the date of the most recent statement of financial position, 
additional information (in narrative form) that provides sufficient 
information to allow financial statement users to understand the 
quantitative disclosures and the information that the investor con­
sidered (both positive and negative) in reaching the conclusion 
that the impairment(s) are not other than temporary? These dis­
closures could include: ____
(1) The nature of the investment(s)? ____
(2) The cause(s) of the impairment(s)? ____
(3) The number of investment positions that are in an unrealized
loss position? ____
(4) The severity and duration of the impairment(s)? ____
(5) Other evidence considered by the investor in reaching its con­
clusion that the investment is not other-than-temporarily im­
paired, including, for example, industry analyst reports, sec­
tor credit ratings, volatility of the security's fair value, and/
or any other information that the investor considers relevant? ____
[FSP FAS 115-1 and FAS 124-1 par. 17]
20. Are individually significant unrealized losses generally not aggre­
gated? ____
[FSP FAS 115-1 and FAS 124-1 par. 17]
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21. For cost-method investments, does an investor disclose the following 
additional information, if applicable, as of each date for which a state­
ment of financial position is presented in its annual financial state­
ments:
a. The aggregate carrying amount of all cost-method investments? ____  ____  ____
b. The aggregate carrying amount of cost-method investments that
the investor did not evaluate for impairment? ____  ____  ____
c. The fact that the fair value of a cost-method investment is not es­
timated if there are no identified events or changes in circum­
stances that may have a significant adverse effect on the fair value 
of the investment, and:
(1) The investor determined, in accordance with paragraphs 
14-15 of SFAS 107, Disclosures about Fair Value of Financial In­
struments, that it is not practicable to estimate the fair value of
the investment? ____  ____  ____
(2) The investor is exempt from estimating fair value under SFAS 
126, Exemption from Certain Required Disclosures about Financial 
Instruments for Certain Nonpublic Entities—an amendment to
FASB Statement No. 107? ____  ____  ____
[FSP FAS 115-1 and FAS 124-1 par. 18]
Note: FSP FAS 115-1 and FAS 124-1 includes a tabular example of the 
quantitative disclosures (see appendix A of the FSP) as referred to in the 
preceding question 19a.
22. For those entities that enter into options with no intrinsic value at 
acquisition in order to purchase securities accounted for under SFAS 
115, is disclosure made of the accounting policy for the premium paid 
(time value) to acquire the option that is classified as held-to-maturity
or available-for-sale disclosed? ____
[EITF 96-11]
23. Are adjustments to deferred acquisition costs (DAC) and other assets 
and liabilities as a result of including unrealized gains or losses as
part of shareholders equity in accordance with SFAS 115 disclosed? ____
[AAG app. C par. 4]
D. Investments Accounted for by the Equity Method
1. Are investments in common stock shown in the balance sheet of the 
investor as a single amount, and is the investor's share of earnings or 
losses of the investee shown in the income statement as a single
amount (except for extraordinary items or prior period adjustments)? -------
[APB 18 par. 19]
2. Are the following disclosures made for investments in common stock 
accounted for by the equity method:
a. The name of each investee and their percentage of ownership of
common stock? -------
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b. The accounting policies of the investor with respect to invest­
ments in common stock?
c. The difference between the amount at which an investment is car­
ried and the amount of underlying equity in net assets?
d. The accounting treatment of the difference described in c?
e. For investments in common stock for which a quoted market 
price is available, the aggregate value of each identified invest­
ment based on the quoted market price? (Note: This is not re­
quired for investments in common stock of subsidiaries.)
f. For investments in common stock, corporate joint ventures, or 
other investments which are in the aggregate material in relation 
to the financial position or results of operations of an investor, 
summarized information as to assets, liabilities, and results of op­
eration of the investees as appropriate?
g. Material effects of conversions of outstanding convertible securi­
ties, exercises, or contingent issuances?
[APB 18 par. 20]
3. If the reporting entity holds 20 percent or more of the voting stock of 
a significant investee corporation but does not account for the invest­
ment using the equity method, are the following disclosed:
a. The name of such investee?
b. The reasons why the equity method is not considered appropri­
ate?
[APB 18 par. 20, fn. 13]
4. If the reporting entity holds less than 20 percent of the voting stock of 
a significant investee corporation and accounts for the investment us­
ing the equity method, are the following disclosed:
a. The name of such investee?
b. The reasons why the equity method is considered appropriate? 
[APB 18 par. 20, fn. 13]
5. Upon loss of significant influence, has the investor recorded the pro­
portionate share of an investee's equity adjustments for OCI as offset 
against the carrying value of the investment at the time significant 
influence is lost?
[FSP APB 18-1 par. 4]
6. To the extent that the offset results in a carrying value of the invest­
ment that is less than zero has the investor (a) reduced the carrying 
value of the investment to zero and (b) recorded the remaining bal­
ance in income?
[FSP APB 18-1 par. 4]
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Note: FSP APB 18-1, Accounting by an Investor for Its Proportionate Share of 
Accumulated Other Comprehensive Income of an Investee Accounted for under 
the Equity Method in Accordance with APB Opinion No. 18 upon a Loss of Sig­
nificant Influence, does not provide guidance for entities that have histori­
cally not recorded their proportionate share of an investee's equity adjust­
ments for OCI. These entities should refer to paragraph 25 of SFAS 154, 
Accounting Changes and Error Corrections—a replacement of APB Opinion No. 
20 and FASB Statement No. 3, for the appropriate guidance. FSP APB 18-1 
also does not provide guidance on the measurement and recognition of a 
gain or loss on the sale of all or a portion of the underlying investment.
7. Does the life insurance entity disclose any contingent obligations or 
commitments for additional funding or guarantees of obligations of 
the investee?
[AAG 11.09]
8. Is the selected policy disclosed for determining the amount of equity 
method losses when previous losses have reduced the common stock 
investment account to zero?
[EITF 99-10]
9. If an equity method investor reports a change to (or the elimination 
of) a previously existing difference between the reporting period of 
an investor and the reporting period of an equity method investee in 
the investor's consolidated financial statements as described in EITF 
06-9, "Reporting a Change in (or the Elimination of) a Previously Ex­
isting Difference between the Fiscal Year-End of a Parent Company 
and That of a Consolidated Entity or between the Reporting Period of 
an Investor and That of an Equity Method Investee," has the change 
been reported as a change in accounting principle in accordance with 
the provisions of SFAS 154, excluding retrospective application if it is 
impracticable to do so?
[EITF 06-9 par. 4]
10. If the provisions of EITF 06-9 are applicable to the financial statements 
of an investor in an equity method investee, are the disclosures re­
quired by SFAS 154 made?
[EITF 06-9 par. 5]
11. If the organization has investments that would have been accounted 
for under the equity method if the organization had not chosen to 
apply the fair value option in SFAS 159 or in paragraph 16 of SFAS 
133, Accounting for Derivative Instruments and Hedging Activities, has it 
disclosed for each period for which a statement of financial position 
is presented the information required by paragraph 20 of APB 18, The 
Equity Method of Accounting for Investments in Common Stock, excluding 
the disclosures in paragraphs 20(a)(3), 20(b), and 20(e) of that APB? 
[SFAS 159 par. 18f]
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Practice Tip
The significance of an investment to the investor's financial position and results of operations should be 
considered in evaluating the extent of disclosures relating to the financial position and results of operations 
of an investee.
E. Impairment of a Loan
1. Is the allowance deducted from the related assets?
[APB 12 par. 3]
2. Is the following information disclosed, either in the body of the finan­
cial statements or in the accompanying notes for impaired loans:
a. As of the date of each balance sheet presented:
(1) Total recorded investment in the impaired loans at the end of 
each period and the amount of the recorded investment for 
which there is a related allowance for loan losses?
(2) The amount of the allowance?
(3) The amount of the recorded investment for which no allow­
ance for loan losses was recorded?
(4) The company's policy for recognizing interest on impaired 
loans, including how cash receipts are recorded?
b. For each period for which a statement of income is presented:
(1) Average recorded investments?
(2) Related amount of interest income recognized using the cash 
basis method of accounting during the time within the period 
the loans were impaired?
(3) If practicable, the amount of interest income recognized using 
the cash basis method of accounting during the time within 
the period the loans were impaired?
(4) The activity in the allowance for loan losses related to im­
paired loans including the following:
(i) Opening balance?
(ii) Additions charged to operations?
(iii) Direct write-down charged against the allowance?
(iv) Recovery of amounts previously charged off?
(v) Ending balance?
[SFAS 118 par. 6i]
3. In years after a restructuring, are loans that are restructured in a trou­
bled debt restructuring (as defined in SFAS 15, Accounting by Debtors 
and Creditors for Troubled Debt Restructurings) into two (or more) loan 
agreements considered separately when assessing the applicability of 
the disclosures described in the preceding question 2?
[EITF 96-22]
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4. If the reporting entity is a Securities and Exchange Commission (SEC) 
registrant, is adequate disclosure made of the impact of the multiple 
loan structures on impaired loan disclosures for loans restructured in
troubled debt restructurings? ____  ____  ____
[EITF 96-22]
F. Accounts and Notes Receivable and Agents' Balances
1. Are premiums due reported as assets? ____  ____  ____
[AAG table 3.1]
2. Are deferred premiums offset against liabilities for future policy ben­
efits? ____  ____  ____
[AAG table 3.1 and par. 7.19]
3. Are hypothecation or other pledging of receivables disclosed? ____  ____  ____
[SFAS 5 par. 18-19]
4. Are accounts and notes receivable from officers, employees, and affil­
iated entities shown separately with appropriate disclosures? ____  ____  ____
[ARB 43 ch. 1A par. 5]
5. If a note is noninterest bearing or has an inappropriate stated interest 
rate:
a. Is the discount or premium presented as a deduction from or ad­
dition to the face amount of the note? ____  ____  ____
b. Does the disclosure include the effective interest rate and face
amount of the note? ____  ____  ____
c. Is amortization of discount or premium reported as interest in the
income statement? ____  ____  ____
d. Are issue costs reported on the balance sheet as deferred charges?
[APB 21 par. 16] ____  ____  ____
6. Is the unamortized balance of loan origination, commitment, and 
other fees and costs and purchase premiums and discounts that is be­
ing recognized as an adjustment of yield reported as part of the loan
balance to which it relates? ____  ____  ____
[SFAS 91 par. 21]
Note: Regarding SOP 01-6, Accounting by Certain Entities (Including Entities 
With Trade Receivables) That Lend to or Finance the Activities of Others 
(AICPA, Technical Practice Aids, ACC sec. 10,850), questions 7-16 that fol­
low apply to organizations that (1) extend credit to customers (constitu­
ents) to encourage them to purchase products and services, (2) make mort­
gage loans, or (3) make secured or unsecured loans to constituents (for 
example, tenant loans). This checklist includes only the disclosure require­
ments for the more common activities within the scope of SOP 01-6. If the 
organization purchases or sells loans or servicing rights, forecloses on a 
loan, or engages in other more complex lending activities, the additional 
disclosure requirements of SOP 01-6, SFAS 140, Accounting for Transfers and 
Servicing of Financial Assets and Extinguishments of Liabilities—a replacement 
of FASB Statement No. 125, and SFAS 156, Accounting for Servicing of Finan­
cial Assets—an amendment of FASB Statement No. 140, not included herein 
also should be considered.
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7. Does the accounting policy note include the following:
a. The basis of accounting for loans, trade receivables, and lease fi­
nancings, including those classified as held for sale?
b. The method used in determining the lower of cost or fair value of 
nonmortgage loans held for sale (that is aggregate or individual 
asset basis)?
c. The method for recognizing interest income on loan and trade re­
ceivables, including the entity's policy for treatment of related 
fees and costs and the method of amortizing net deferred fees or 
costs?
d. The classification and method of accounting for interest-only 
strips, loans, other receivables, or retained interests in securitiza­
tions that can be contractually prepaid or otherwise settled in a 
way that the holder would not recover substantially all of its re­
corded investment?
e. A description of the accounting policies and methodology the en­
tity used to estimate its allowance for loan losses, allowance for 
doubtful accounts, any liability for off-balance sheet credit losses, 
and any related charges for loan, trade receivable or other credit 
losses, including a description of the factors that influenced man­
agement's judgment?
f. The policy for placing loans (and trade receivables if applicable) 
on nonaccrual status (or discontinuing accrual of interest) and re­
cording payments received on nonaccrual loans (and trade receiv­
ables if applicable), and the policy for resuming accrual of inter­
est?
g. The policy for charging off uncollectible loans and receivables?
h. The policy for determining past due or delinquency status (that 
is, whether that status is based on most recent payment or on con­
tractual terms)?
[SOP 01-6 par. 13a-c (ACC 10,850.13a-c]
8. Is the aggregate amount of gains or losses on sales of loans or trade 
receivables (including adjustments to record loans held for sale at the 
lower of cost or fair value) presented separately in the financial state­
ment or disclosed in the notes?
[SOP 01-6 par. 13d (ACC 10,850.13d)]
9. Loans or trade receivables may be presented on the balance sheet as 
aggregated amounts. However,
a. Are loans or trade receivables held for sale should be presented 
on the balance sheet in a separate balance sheet category?
b. Are major categories of loans or trade receivables should be pre­
sented separately either in the balance sheet or in the notes?
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c. Are the allowance for credit losses, the allowance for doubtful ac­
counts, and, as applicable, any unearned income, any unamorti­
zed premiums and discounts, and any net unamortized deferred
fees and costs, should be disclosed in the financial statements? ____  ___
[SOP 01-6 par. 13e (ACC 10,850.13e)]
10. Are foreclosed and repossessed assets classified as a separate balance 
sheet amount or included in other assets on the balance sheet with
separate disclosures in the notes? ____  ___
[SOP 01-6 par. 13f (ACC 10,850.13f)]
11. Are certain returned or repossessed assets, such as inventory, subse­
quently to be utilized by the entity in operations, not classified sepa­
rately? ____  ___
[SOP 01-6 par. 13f (ACC 10,850.13f )]
12. Is the valuation allowance for loans prior to foreclosure not carried 
over as a separate element of the cost basis in the foreclosed asset for
purposes of applying SFAS 144? ____  ___
[FSP FAS 144-1]
13. Is the recorded investment in loans (and trade receivables if applica­
ble) on nonaccrual status as of each balance sheet date disclosed in
the notes to the financial statements? ____  ___
[SOP 01-6 par. 13g (ACC 10,850.13g)]
14. Is the recorded investment in loans (and trade receivables if applica­
ble) past due ninety days or more and still accruing interest disclosed? ____  ___
[SOP 01-6 par. 13g (ACC 10,850.13g)]
15. Insurance subsidiaries may be required to deposit securities with state
regulatory authorities. If so, is the carrying amount of securities de­
posited disclosed? ____  ___
[SOP 01-6 par. 13h (ACC 10,850.13h)]
16. Is the carrying amount of loans, trade receivables, securities and fi­
nancial instruments that serve as collateral for borrowings disclosed
pursuant to paragraphs 18-19 of SFAS 5, Accounting for Contingencies? ____  ___
[SOP 01-6 par. 13i (ACC 10,850.13i)]
Notes: SOP 03-3, Accounting for Certain Loans or Debt Securities Acquired in 
a Transfer (AICPA, Technical Practice Aids, ACC sec. 10,880), addresses ac­
counting for differences between contractual cash flows and cash flows 
expected to be collected from an investor's initial investment in loans or 
debt securities (loans) acquired in a transfer if those differences are attrib­
utable, at least in part, to credit quality.
Readers may also refer to AICPA Technical Practice Aid Technical Ques­
tions and Answers (TIS) section 2130.09-.37 (AICPA, Technical Practice 
Aids) for additional nonauthoritative guidance pertaining to various topics 
on the application of SOP 03-3.
17. Do the notes to financial statements describe how prepayments are 
considered in the determination of contractual cash flows and cash 
flows expected to be collected?
[SOP 03-3 par. 14 (ACC 10,880.14)]
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18. Is information about loans meeting the scope criteria of paragraph 3 
of SOP 03-3 included in the disclosures required by paragraphs 
20(a)-20(b) of SFAS 114, if the condition in paragraph 16 of SFAS 115 
or paragraph 8(a) of SFAS 5 (as discussed in paragraphs 7(a)-8(a) of 
SOP 03-3) is met?
[SOP 03-3 par. 15 (ACC 10,880.15)]
19. In addition to disclosures required by other GAAP, for each balance 
sheet presented, does an investor disclose the following information 
about loans within the scope of SOP 03-3:
a. Separately for both those loans that are accounted for as debt se­
curities and those loans that are not accounted for as debt securi­
ties:
(1) The outstanding balance and related carrying amount at the 
beginning and end of the period?
(2) The amount of accretable yield at the beginning and end of 
the period, reconciled for additions, accretion, disposals of 
loans, and reclassifications to or from nonaccretable differ­
ence during the period?
(3) For loans acquired during the period, the contractually re­
quired payments receivable, cash flows expected to be col­
lected, and fair value at the acquisition date?
(4) For those loans within the scope of SOP 03-3 for which the 
income recognition model in SOP 03-3 is not applied in accor­
dance with paragraph 6, the carrying amount at the acquisi­
tion date for loans acquired during the period and the carry­
ing amount of all loans at the end of the period?
b. Further, for those loans that are not accounted for as debt securi­
ties, does an investor disclose:
(1) The amount of (a) any expense recognized pursuant to para­
graph 8(a) of SOP 03-3 and (b) any reductions of the allow­
ance recognized pursuant to paragraph 8(b)(1) of SOP 03-3 for 
each period for which an income statement is presented?
(2) The amount of the allowance for uncollectible accounts at the 
beginning and end of the period?
[SOP 03-3 par. 16 (ACC 10,880.16)]
G. Reinsurance Receivables
1. Are fronting arrangements treated as reinsurance arrangements for 
purposes of disclosures required by SFAS 60, Accounting and Reporting 
by Insurance Enterprises and SFAS 113, Accounting and Reporting for Re­
insurance of Short-Duration and Long-Duration Contracts?
[SFAS 113 par. 6, as amended by SFAS 120]
2. Are the following disclosed in relation to ceded insurance transac­
tions:
a. Nature of the transaction(s)?
b. Purpose of the transaction(s)?
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c. Effect of the transaction(s)? ____  ____  ____
d. The fact that the insurer is not relieved of its primary obligation
to the policyholder in a reinsurance transaction? ____  ____  ____
[SFAS 113 par. 27a]
3. Are the following disclosed for short-duration reinsurance contracts 
on both a written and an earned basis:
a. Premiums from direct business? ____  ____  ____
b. Reinsurance assumed? ____  ____  ____
c. Reinsurance ceded? ____  ____  ____
[SFAS 113 par. 27b]
4. Are the following disclosed for long-duration reinsurance contracts:
a. Premiums and amounts assessed against policyholders from di­
rect business? ____  ____  ____
b. Reinsurance assumed? ____  ____  ____
c. Reinsurance ceded? ____  ____  ____
d. Premiums and amounts earned? ____  ____  ____
[SFAS 113 par. 27b]
5. Are the methods used for income recognition on reinsurance contracts
disclosed? ____  ____  ____
[SFAS 113 par. 27c]
6. Are concentrations of credit risk associated with reinsurance receiva­
bles and prepaid reinsurance premiums disclosed for a ceding enter­
prise under the provisions of paragraph 15A of SFAS 107, as amended
by SFAS 133? ____  ____  ____
[SFAS 113 par. 28 as amended by SFAS 133]
7. Are the following items reported separately as assets for those com­
panies participating in ceding transactions:
a. Estimated reinsurance receivables arising from ceding transac­
tions? ____  ____  ____
b. Amounts paid to the reinsurer relating to the unexpired portion
of reinsured contracts (prepaid reinsurance premiums)? ____  ____  ____
[SFAS 113 par. 14]
8. Are amounts receivable and payable between the ceding company 
and an individual reinsurer offset only when a right of offset exists as 
defined in FIN 39, Offsetting of Amounts Related to Certain Contracts—an
interpretation of APB Opinion No. 10 and FASB Statement No. 105? ____  ____  ____
[SFAS 113 par. 15]
9. Are the amounts of earned premiums ceded and recoveries recog­
nized under reinsurance contracts reported in the statements of earn­
ings as separate line items or disclosed in the notes? ------- ------- ------
[SFAS 113 par. 16; AAG 12.30]
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H. Lease Finance Receivables
1. Do disclosures include:
a. Appropriate components of the net investment in the leases as of
the date of each balance sheet presented? ____
b. Future minimum lease payments to be received for each of the 
five succeeding fiscal years as of the date of the latest balance
sheet presented? ____
c. Total contingent rentals included in income for each period for
which a statement of income is presented? ____
[SFAS 13 par. 23a, as amended by SFAS 91]
2. Are leasing arrangements described? ____
[SFAS 13 par. 23, as amended by SFAS 91; SFAS 13 par. 29; SFAS 98
par. 17-18]
3. Are leveraged leases appropriately accounted for and reported? ____
[SFAS 13 par. 41-47, as amended by FSP FAS 13-2, SFAS 96, and SFAS
109]
I. Deferred Acquisition Costs
1. Are the following disclosed relating to deferred acquisition costs:
a. The nature of costs capitalized? ____
b. The method of amortizing these costs? ____
c. The amount of these costs amortized for the period? ____
[AAG app. C par. 7; SFAS 60 par. 60c]
d. The accounting policy applied to internal replacements, including 
whether or not the company has availed itself of the alternative 
application guidance in paragraphs 18-19 of SOP 05-1, Accounting 
by Insurance Enterprises for Deferred Acquisition Costs in Connection 
With Modification or Exchanges of Insurance Contracts (AICPA, Tech­
nical Practice Aids, ACC sec. 10,920 par. .18-.19), and if so, for
which kinds of internal replacement transactions? ____
[SOP 05-1 par. 28 (ACC 10,920.28)]
2. If the company considers anticipated investment income in determin­
ing if a premium deficiency relating to short-duration contracts exists
disclosed? ____
[SFAS 60 par. 60e]
3. If a public company acquires a life insurance entity accounted for as 
a purchase and the acquirer recognizes an asset for the present value 
of future profits (PVP), is the following disclosed:
a. A description of the company's accounting policy? ____
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b. An analysis of the PVP asset account for each year for which an 
income statement is presented, including the PVP balance at the 
beginning of the year, the amount of PVP additions during the 
year arising from acquisitions of insurance entities, the amount of 
interest accrued on the unamortized PVP balance during the year, 
the interest accrual rate, the amount of amortization during the 
year, the amount of any write-offs during the year attributable to 
impairment and how those write-offs were determined, and the
PVP balance at the end of the year? ____  ___
c. The estimated amount or percentage of the end of the year PVP
balance to be amortized during each of the next five years? ____  ___
[AAG app. C par. 8]
J. Property and Equipment
1. Is the carrying basis of property and equipment disclosed? ____  ____
[AAG app. B; APB 12 par. 5]
2. For depreciable assets, are the following disclosed:
a. Depreciation expense for each period for which an income state­
ment is presented? ____  ___
b. Balances of major classes of depreciable assets, by nature or func­
tion, at the balance sheet date? ____  ____
c. Accumulated depreciation, either by major classes of depreciable
assets or in total, at the balance sheet date? ____  ____
d. A general description of the method or methods used in comput­
ing depreciation for major classes of depreciable assets? ____  ____
[APB 12 par. 5]
3. Are pledged assets and material commitments for property expendi­
tures disclosed? ____  ____
[SFAS 5 par. 18-19]
4. For any accounting period in which interest costs are capitalized, is 
the total amount of interest cost incurred during the period, and the
amount thereof that is capitalized, disclosed? ____  ____
[SFAS 34 par. 21]
5. Is the amount of interest cost incurred and charged to expense during 
the period disclosed for an accounting period in which no interest cost
is capitalized? ____  ____
[SFAS 34 par. 21]
N/A
Note: Subsequent to the adoption of SFAS 143, Accounting for Asset Retire­
ment Obligations, the following consensus does not apply to obligations for 
asbestos removal that are within the scope of SFAS 143.
6. For an existing property with an asbestos problem, are the costs in­
curred to treat the problem, if charged to expense, not classified as an 
extraordinary item?
[EITF 89-13]
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K. Lessee Leases
1. Is the following information disclosed with respect to capital leases:
a. The gross amount of assets recorded under capital leases as of the 
date of each balance sheet presented by major classes according 
to nature or function (this information may be combined with the 
comparable information for owned assets)?
b. Future minimum lease payments as of the date of the latest bal­
ance sheet presented, in the aggregate and for each of the next 
five fiscal years, with separate deductions from the total for exec­
utory costs, including any profit thereon that is included in the 
minimum lease payments and for the amount of the imputed in­
terest necessary to reduce the net minimum lease payments to 
present value?
c. The total of minimum sublease rentals to be received in the future 
under noncancelable subleases as of the date of the latest balance 
sheet presented?
d. Total contingent rentals actually incurred for each period for 
which an income statement is presented?
[SFAS 13 par. 16, as amended by SFAS 29]
e. Separate identification of:
(1) Assets recorded under capital leases?
(2) Accumulated amortization of capital leases?
(3) Obligations under capital leases?
(4) Amount of amortization of capital lease assets or the fact that 
the amortization of capital lease assets is included in depreci­
ation expense?
[SFAS 13 par. 13]
2. Are the following disclosed for operating leases that have initial or 
remaining noncancelable lease terms in excess of one year:
a. Future minimum rental payments required, as of the date of the 
latest balance sheet presented, in the aggregate, and for each of 
the five succeeding fiscal years?
b. The total of minimum rentals to be received in the future under 
noncancelable subleases as of the date of the latest balance sheet 
presented?
[SFAS 13 par. 16]
3. For all operating leases, do disclosures include rental expense for each 
period for which an income statement is presented, with separate 
amounts for minimum rentals, contingent rentals, and sublease rent­
als (rental payments under leases with terms of a month or less that 
are not renewed need not be included)?
[SFAS 13 par. 16c]
4. Do disclosures include a general description of the lessee's leasing ar­
rangements including, but not limited to, the following:
a. The basis on which contingent rental payments are determined?
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b. The existence and terms of renewal or purchase options and es­
calation clauses? ____  ____  ____
c. Restrictions imposed by lease agreements, such as those concern­
ing dividends, additional debt, and further leasing? ____  ____  ____
[SFAS 13, par. 16]
5. Is the nature and extent of leasing transactions with related parties
disclosed? ____  ____  ____
[SFAS 13 par. 29]
6. If there is a modification of lease terms and the increase in lease pay­
ments is a termination penalty, is the accounting policy disclosed in
accordance with APB 22? ____  ____  ____
[EITF 95-17; APB 22 par. 12-14]
7. Do the financial statements of a seller-lessee include a description of 
the terms of the sale-leaseback transaction including future commit­
ments, obligations, provisions, or circumstances that require or result
in the seller-lessee's continuing involvement? ____  ____  ____
[SFAS 98 par. 17]
8. For the financial statement of a seller-lessee when a sale-leaseback 
transaction is accounted for using the deposit method or as a financ­
ing arrangement, are the following disclosures made:
a. The obligation for future minimum lease payments as of the date 
of the latest balance sheet presented in the aggregate and for each
of the five succeeding fiscal years? ____  ____  ____
b. The total of minimum sublease rentals, if any, to be received in 
the future under noncancelable subleases in the aggregate and for
each of the five succeeding fiscal years? ____  ____  ____
[SFAS 98 par. 18]
9. When rental costs incurred during and after a construction period are 
for the right to control the use of a leased asset during and after con­
struction of a lessee asset, are the rental costs included in income from
continuing operations? ____  ____  ____
[FSP FAS 13-1 par. 6]
L. Intangible Assets and Goodwill
Notes: In April 2008, FASB issued FSP FAS 142-3, Determination of the Use­
ful Life of Intangible Assets, to improve the consistency between the useful 
life of a recognized intangible asset under SFAS 142, Goodwill and Other 
Intangible Assets, and the period of expected cash flows used to measure 
the fair value of the asset under SFAS 141 (revised 2007), Business Combi­
nations, and other U.S. GAAP. This FSP applies to recognized intangible 
assets that are accounted for pursuant to SFAS 142 and applies regardless 
of the nature of the transaction that resulted in the recognition of the in­
tangible asset, that is, whether acquired in a business combination or oth­
erwise.
(continued)
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Among other significant provisions, FSP FAS 142-3 provides that, in deter­
mining the useful life of the intangible asset for amortization purposes, an 
entity shall consider the period of expected cash flows used to measure 
the fair value of the recognized intangible asset, adjusted for the entity- 
specific factors in paragraph 11 of SFAS 142. This FSP contains several 
disclosures requirements in addition to the required disclosures in para­
graphs 44-45 of SFAS 142, including information that enables users of fi­
nancial statements to assess the extent to which the expected future cash 
flows associated with the intangible asset are affected by the entity's intent 
or ability to renew or extend the arrangement.
FSP FAS 142-3 is effective for financial statements issued for fiscal years 
beginning after December 15, 2008, and interim periods within those fiscal 
years. Early adoption is prohibited. As such, this checklist has not been 
updated to include the disclosure requirements of FSP FAS 142-3. Readers 
can refer to the full text of the FSP on the FASB Web site at www.fasb.org.
1. At a minimum, are all intangible assets aggregated and presented as 
a separate line item in the statement of financial position? (This re­
quirement does not preclude presentation of individual intangible as­
sets or classes of intangible assets as separate line items.)
[SFAS 142 par. 42]
2. Are amortization expense and impairment losses for intangible assets 
presented in income statement line items within continuing opera­
tions as deemed appropriate for each entity?
[SFAS 142 par. 42]
3. Is the aggregate amount of goodwill presented as a separate line item 
in the statement of financial position?
[SFAS 142 par. 43]
4. Is the aggregate amount of goodwill impairment losses presented as 
a separate line item in the income statement before the subtotal income 
from continuing operations (or similar caption) unless a goodwill im­
pairment loss is associated with a discontinued operation?
[SFAS 142 par. 43]
5. Is a goodwill impairment loss associated with a discontinued opera­
tion included (on a net-of-tax basis) within the results of discontinued 
operations?
[SFAS 142 par. 43]
6. For intangible assets acquired either individually or with a group of 
assets, is the following information disclosed in the notes to the finan­
cial statements in the period of acquisition:
a. For intangible assets subject to amortization:
(1) The total amount assigned and the amount assigned to any 
major intangible asset class?
(2) The amount of any significant residual value, in total and by 
major intangible asset class?
(3) The weighted-average amortization period, in total and by 
major intangible asset class?
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b. For intangible assets not subject to amortization, the total amount 
assigned and the amount assigned to any major intangible asset
class? ____  ____  ____
c. The amount of research and development assets acquired and 
written off in the period and the line item in the income statement
in which the amounts written off are aggregated? ____  ____  ____
[SFAS 142 par. 44]
7. Has the following information been disclosed in the financial state­
ments or the notes to the financial statements for each period for 
which a statement of financial position is presented:
a. For intangible assets subject to amortization:
(1) The gross carrying amount and accumulated amortization, in
total and by major intangible asset class? ____  ____  ____
(2) The aggregate amortization expense for the period? ____  ____  ____
(3) The estimated aggregate amortization expense for each of the
five succeeding fiscal years? ____  ____  ____
b. For intangible assets not subject to amortization, the total carrying 
amount and the carrying amount for each major intangible asset
class? ____  ____  ____
c. The changes in the carrying amount of goodwill during the pe­
riod including:
(1) The aggregate amount of goodwill acquired? ____  ____  ____
(2) The aggregate amount of impairment losses recognized? ____  ____  ____
(3) The amount of goodwill included in the gain or loss on dis­
posal of all or a portion of a reporting unit? ____  ____  ____
[SFAS 142 par. 45]
8. If the entity reports segment information in accordance with SFAS
131, Disclosures about Segments of an Enterprise and Related Information, 
is the above information about goodwill provided in total and for 
each reportable segment and are any significant changes in the allo­
cation of goodwill by reportable segment disclosed? ____  ____  ____
[SFAS 142 par. 45]
9. If any portion of goodwill has not yet been allocated to a reporting 
unit at the date the financial statements are issued, is that unallocated
amount and the reasons for not allocating that amount disclosed? ____  ____  ____
[SFAS 142 par. 45]
10. For each impairment loss recognized related to an intangible asset, is 
the following information disclosed in the notes to the financial state­
ments that include the period in which the impairment loss is recog­
nized:
a. A description of the impaired intangible asset and the facts and
circumstances leading to the impairment? ------- ------- -------
b. The amount of the impairment loss and the method for determin­
ing fair value? ------- ------- -------
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c. The caption in the income statement in which the impairment loss
is aggregated? ____  ____  ____
d. If applicable, the segment in which the impaired intangible asset
is reported under SFAS 131? ____  ____  ____
[SFAS 142 par. 46]
11. For each goodwill impairment loss recognized, is the following infor­
mation disclosed in the notes to the financial statement that include 
the period in which the impairment loss is recognized:
a. A description of the facts and circumstances leading to the im­
pairment? ____  ____  ____
b. The amount of the impairment loss and the method of determin­
ing the fair value of the associated reporting unit (whether based 
on quoted market prices, prices of comparable businesses, a pres­
ent value or other valuation technique, or a combination thereof)? ____  ____  ____
c. If a recognized impairment loss is an estimate that has not yet 
been finalized (refer to SFAS 142, paragraph 22), that fact and the 
reasons therefore and, in subsequent periods, the nature and 
amount of any significant adjustments made to the initial estimate
of the impairment loss? ____  ____  ____
[SFAS 142 par. 47]
M. Separate Account Assets
1. Are separate account assets reported as summary totals in the finan­
cial statements? ____  ____  ____
[SFAS 60 par. 54]
2. Has the insurance company disclosed the following information re­
garding separate accounts:
a. The general nature of the contracts reporting in separate accounts,
including the extent and terms of minimum guarantees? ____  ____  ____
b. The basis of presentation for separate account assets and liabilities
and related separate account activity? ____  ____  ____
c. The aggregate fair value of assets, by major investment asset cat­
egory, supporting separate accounts with additional insurance 
benefits and minimum investment return guarantees as of each
date for which a statement of financial position is presented? ____  ____  ____
d. The amount of gains and losses recognized on assets transferred
to separate accounts for the periods presented? ____  ____  ____
[SOP 03-1 par. 38 (ACC 10,870.38); AAG app. C par. 5]
3. If the separate account arrangement meets all of the following condi­
tions, have the portion of separate account assets representing con­
tract holder funds been measured at fair value and reported in the 
insurance enterprise's financial statements as a summary total, with 
an equivalent summary total reported for related liabilities:
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a. The separate account is legally recognized. That is, the separate
account is established, approved, and regulated under special 
rules such as state insurance laws, federal securities laws, or sim­
ilar foreign laws? ____  ____  ____
b. The separate account assets supporting the contract liabilities are 
legally insulated from the general account liabilities of the insur­
ance enterprise (that is, the contract holder is not subject to in­
surer default risk to the extent of the assets held in the separate
account)? ____  ____  ____
c. The insurer must, as a result of contractual, statutory, or regula­
tory requirements, invest the contract holder's funds within the 
separate account as directed by the contract holder in designated 
investment alternatives or in accordance with specific investment
objectives or policies? ____  ____  ____
d. All investment performance, net of contract fees and assessments, 
must as a result of contractual, statutory, or regulatory require­
ments be passed through to the individual contract holder. Con­
tracts may specify conditions under which there may be a mini­
mum guarantee, but not a ceiling, because a ceiling would 
prohibit all investment performance from being passed through
to the contract holder? ____  ____  ____
For the portion of separate account arrangements meeting these cri­
teria, the related investment performance (including interest, divi­
dends, realized gains and losses, and changes in unrealized gains and 
losses) and the corresponding amounts credited to the contract holder 
should be offset within the same statement of operations line item 
netting to zero. Contract fees and assessments should be reported in 
accordance with SFAS 97, Accounting and Reporting by Insurance Enter­
prises for Certain Long-Duration Contracts and for Realized Gains and 
Losses from the Sale of Investments, paragraph 19. Any liabilities related 
to minimum guarantees and insurance benefit liabilities under the 
contracts in excess of the fair value of separate account assets repre­
senting contract holder funds should be recognized as general ac­
count liabilities.
[SOP 03-1 par. 11 (ACC 10,870.11)]
N. Deposit Accounting
1. Has a description of the contracts accounted for as deposits and the 
separate amounts of total deposit assets and total deposit liabilities
reported in the statement of financial position been disclosed? ____  ____  ____
[SOP 98-7 par. 18 (ACC 10,760.18); AAG app. C par. 25]
2. Has the following information regarding the changes in the recorded 
amount of the deposit arising from an insurance or reinsurance con­
tract that transfers only significant underwriting risk been disclosed:
a. The present values of initial expected recoveries that will be re­
imbursed under the insurance or reinsurance contracts that have
been recorded as an adjustment to incurred losses? ------- ------- ------
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b. Any adjustment of amounts initially recognized for expected re­
coveries? (The individual components of the adjustment [meaning 
interest accrual, the present value of additional expected recover­
ies, and the present value of reductions in expected recoveries] 
should be disclosed separately.)
c. The amortization expense attributable to the expiration of cover­
age provided under the contract?
[SOP 98-7 par. 19 (ACC 10,760.19); AAG app. C par. 25]
O. Policy Liabilities
1. Is the basis for estimating the liabilities for unpaid claims and claim 
adjustment expenses disclosed?
[SFAS 60 par. 60a; AAG app. C par. 10a]
2. Are the methods and assumptions used in estimating the liability for 
future policy benefits and the average rate of assumed investment 
yields in effect for the current year disclosed?
[SFAS 60 par. 60b; AAG app. C par. 13]
3. Is the carrying amount of liabilities for unpaid claims and claim ad­
justment expenses relating to short-duration contracts that are pre­
sented at present value in the financial statements and the range of 
interest rates used to discount those liabilities disclosed?
[SFAS 60 par. 60d; AAG app. C par. 10b; SOP 92-4 (AUD 14,230)]
4. For each fiscal year for which an income statement is presented, is the 
following information about the liability for unpaid claims and claim 
adjustment expenses disclosed:
a. The balance in the liability for unpaid claims and claim adjust­
ment expenses at the beginning and end of the period presented 
with, if net balances are presented, separate disclosure of the re­
lated amount of reinsurance recoverable?
b. Incurred claims and claim adjustment expenses with separate dis­
closure of the provision of insured events of the current period 
and for increases or decreases in the provision for insured events 
of prior fiscal years?
c. Payments of claims and claim adjustment expenses with separate 
disclosure of payments of claims and claim adjustment expenses 
attributable to insured events of the current fiscal year and to in­
sured events of the prior period?
[SOP 94-5 par. 11 (ACC 10,630.11), as amended by SOP 01-5 (ACC 
10,840); AAG app. C par. 11]
5. If changes in incurred claims and claim adjustment expenses recog­
nized in the income statement are attributable to insured events of 
prior periods, are the following disclosed in the financial statements:
a. The reasons for the change?
b. Whether additional premiums or return premiums have been ac­
crued as a result of the prior-period effects?
[SOP 94-5 par. 11 (ACC 10,630.11), as amended by SOP 01-5 (ACC 
10,840); AAG app. C par. 12]
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6. Whether that the company considers anticipated investment income
in determining if a premium deficiency relating to short-duration con­
tracts exists disclosed? ____  ____  ____
[SFAS 60 par. 60e; AAG app. C par. 10c]
7. For participating insurance, does disclosure include:
a. The relative percentage? ____  ____  ____
b. The method of accounting for policyholders' dividends? ____  ____  ____
c. The amount of dividends? ____  ____  ____
d. The amount of any additional income allocated to participating
policyholders? ____  ____  ____
[SFAS 60 par. 60g; AAG app. C par. 19]
Note: SOP 95-1, Accounting for Certain Insurance Activities of Mutual Life In­
surance Enterprises (AICPA, Technical Practice Aids, ACC sec. 10,650), ap­
plies to life insurance contracts that have both of the following character­
istics:1
1 SFAS 120, Accounting and Reporting by Mutual Life Insurance Enterprises and by Insurance Enterprises for Certain Long-Duration Participat­
ing Contracts—an amendment of FASB Statements 60, 97, and 113 and Interpretation No. 40, permits stock life insurance enterprises with 
participating life insurance contracts that meet the conditions listed above to account for those contracts in accordance with SOP 95-1, 
Accounting for Certain Insurance Activities of Mutual Life Insurance Enterprises (AICPA, Technical Practice Aids, ACC sec. 10,650).
[SFAS 120 par. 6]
• They are long-duration participating contracts that are expected to 
pay dividends to policyholders based on actual experience of the 
insurance enterprise.
• Annual policyholder dividends are paid in a manner that identifies 
divisible surplus and distributes that surplus in approximately the 
same proportion as the contracts are considered to have contributed 
to divisible surplus (commonly referred to in actuarial literature as 
the contribution principle).
8. Are premiums from participating insurance contracts reported as rev­
enue in the statement of income when due from policyholders?
[SOP 95-1 par. 12 (ACC 10,650.12)]
9. Are death and surrender benefits incurred reported as expense in the 
statement of income?
[SOP 95-1 par. 13 (ACC 10,650.13)]
10. Are annual policyholder dividends reported separately as an expense 
in the statement of income?
[SOP 95-1 par. 14 (ACC 10,650.14)]
11. Are the following disclosed in the financial statements with respect to 
participating contracts:
a. The methods and assumptions used in estimating the liability for 
future policy benefits?
b. The average rate of assumed investment yields used in estimating 
expected gross margins? 1
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c. The nature of acquisition costs capitalized, the method of amortiz­
ing those costs, and the amount of those costs amortized for the 
period?
[SOP 95-1 par. 24 (ACC 10,650.24); AAG app. C par. 20]
12. Has the entity disclosed a description of the liability valuation meth­
ods and assumptions used in estimating the liabilities for additional 
insurance benefits and minimum guarantees?
[SOP 03-1 par. 38 (ACC 10,870.38); AAG app. C par. 13]
13. Have the following been disclosed in relation to minimum guaran­
tees:
a. The separate account liability balances subject to various types of 
benefits (for example, guaranteed minimum death benefit, guar­
anteed minimum income benefit, guaranteed minimum accumu­
lation benefit)? Disclosures within these categories of benefits for 
the types of guarantees provided may also be appropriate (for ex­
ample, return of net deposits, return of net deposits accrued at a 
stated rate, return of highest anniversary value).
b. The amount of liability reported for additional insurance benefits, 
annuitization benefits and other minimum guarantees, by type of 
benefit, for the most recent balance sheet date and the incurred 
and paid amounts for all periods presented?
c. For contracts for which an additional liability is disclosed in ques­
tion 13b, net amount at risk and weighted average attained age 
of contract holders?
[SOP 03-1 par. 38 (ACC 10,870.38); AAG app. C par. 13]
P. Income Taxes
1. Are deferred tax assets and liabilities determined for each tax-paying 
component (an individual company or group of companies that is 
consolidated for tax purposes) in each tax jurisdiction presented sep­
arately?
[SFAS 109 par. 17]
2. Are the components of the net deferred tax liability or asset recog­
nized in the balance sheet disclosed as follows:
a. The total of all deferred tax liabilities?
b. The total of all deferred tax assets?
c. The total valuation allowance for deferred tax assets?
[SFAS 109 par. 43]
3. Is the net change during the year in the total valuation allowance dis­
closed?
[SFAS 109 par. 43]
4. Is the following information disclosed whenever a deferred tax liabil­
ity is not recognized because of the exceptions to comprehensive rec­
ognition of deferred taxes for any of the areas addressed by APB 23, 
Accounting for Income Taxes—Special Areas (as amended by SFAS 109, 
Accounting for Income Taxes):
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a. A description of the types of temporary differences for which a 
deferred tax liability is not recognized and the types of events that
would cause those temporary differences to become taxable? ____  ____  ____
b. The cumulative amount of each type of temporary differences? ____  ____  ____
c. The amount of the unrecognized deferred tax liability for tempo­
rary differences related to investments in foreign subsidiaries and 
foreign corporate joint ventures that are essentially permanent in 
duration if determination of that liability is practicable, or a state­
ment that determination is not practicable? ____  ____  ____
d. The amount of the deferred tax liability for temporary differences 
other than those in question 4c. (that is, undistributed domestic 
earnings and the policyholders' surplus of a life insurance enter­
prise) that is not recognized in accordance with the provisions of
paragraphs 31-32 of SFAS 109? ____  ____  ____
[SFAS 109 par. 44]
5. In a classified balance sheet:
a. Are deferred tax assets and deferred tax liabilities classified as 
current or noncurrent based on the classification of the related
asset or liability for financial reporting? ____  ____  ____
[SFAS 109 par. 41]
b. Are deferred tax assets or liabilities not related to an asset or lia­
bility for financial reporting (including those related to carry-for­
wards) classified according to the expected reversal date of the
temporary difference? ____  ____  ____
[SFAS 109 par. 41 and 288p]
c. Is the valuation allowance for a particular tax jurisdiction allo­
cated between current and noncurrent deferred tax assets for that
tax jurisdiction on a pro rata basis? ____  ____  ____
[SFAS 109 par. 41]
d. Are the following items offset and presented as a single amount 
for a particular taxpaying component and within a particular tax- 
paying jurisdiction:
(1) All current deferred tax liabilities and assets? ____  ____  ____
(2) All noncurrent deferred tax liabilities and assets? ____  ____  ____
[SFAS 109 par. 42]
6. Do the financial statements include disclosure of the portion of re­
tained earnings in excess of statutory unassigned surplus upon which
no income tax provisions have been made and the reasons therefore? ------- ------- ------
[AAG app. C par. 14]
7. If the reporting entity is a public enterprise:
a. Is the approximate tax-effect of each type of temporary difference 
and carryforward that gives rise to a significant portion of de­
ferred tax liabilities and deferred tax assets (before valuation al­
lowances) disclosed? ------- ------- ------
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b. If the reporting entity is not subject to income taxes because its 
income is taxed directly to its owners, is that fact and the net dif­
ferences between the tax bases and reported amounts of the enter­
prises' assets and liabilities disclosed? ____
[SFAS 109 par. 43]
8. If the reporting entity is a nonpublic enterprise, are the types of signifi­
cant temporary differences and carryforwards disclosed? ____
[SFAS 109 par. 43]
9. Are the following disclosures made:
a. Amounts and expiration dates of operating losses and tax carry­
forwards for tax purposes? ____
b. Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to 
reduce goodwill or other noncurrent intangible assets of an ac­
quired entity or directly to contributed capital? ____
[SFAS 109 par. 48]
Q. Current Liabilities, Notes Payable, and Long-Term Debt
1. For classified balance sheets, do current liabilities include:
a. Obligations for items that entered the operating cycle? ____
b. Collections received in advance of the performance of services? ____
c. Debts that arise from operations directly related to the operating
cycle? ____
d. Other liabilities whose regular and ordinary liquidation is likely
to occur within a relatively short time period? ____
e. Obligations that, by their terms, are due on demand or will be 
due within one year (or operating cycle, if longer) from the bal­
ance sheet date, even though liquidation may not be expected
within that period? ____
[ARB 43 ch. 3A par. 7-8; SFAS 78 par. 5]
2. Do current liabilities exclude short-term obligations that the provider 
intends to refinance on a long-term basis, provided the provider has
demonstrated the ability to consummate the long-term financing? ____
[SFAS 6 par. 8-15]
3. Is there adequate disclosure of interest rates, maturities, and other 
terms and conditions provided in loan agreements and bond inden­
tures (such as assets pledged as collateral, and covenants to reduce
debt and maintain working capital)? ____
[FASCON 5 par. 11; SFAS 5 par. 18]
4. Are the following disclosed for each of the five years following the 
date of the latest balance sheet presented:
a. The aggregate amount of payments for unconditional purchase 
obligations that meet the criteria of SFAS 47, Disclosure of Long- 
Term Obligations, and that are recognized on the purchaser's bal­
ance sheet? ____
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b. The combined aggregate amount of maturities and sinking fund
requirements for all long-term borrowings? ____  ____  ____
[SFAS 47 par. 10, as amended by SFAS 129]
Notes: In May 2008, FASB issued FSP APB 14-1, Accounting for Convertible 
Debt Instruments That May Be Settled in Cash upon Conversion (Including Par­
tial Cash Settlement), which requires an issuer to separately account for the 
liability and equity components of convertible debt instruments within its 
scope. Convertible debt instruments, including instruments within the 
scope of this FSP, consist of a liability component with a below-market 
interest coupon (the debt instrument) and an equity component (the con­
version option). Convertible debt instruments within the scope of this FSP 
are required to be separated into its liability and equity components, with 
each component accounted for pursuant to other U.S. GAAP applicable to 
that component.
This FSP applies to convertible debt instruments that, by their stated 
terms, may be settled in cash (or other assets) upon conversion, including 
partial cash settlement, unless the embedded conversion option is required 
to be separately accounted for as a derivative under SFAS 133. Other scope 
limitations apply. This FSP shall be effective for financial statements is­
sued for fiscal years beginning after December 15, 2008, and interim per­
iods within those fiscal years. Early adoption is not permitted. As such, 
this checklist has not been updated to include the presentation and disclo­
sure requirements of FSP APB 14-1. Readers can refer to the full text of the 
FSP on the FASB Web site at www.fasb.org.
5. Are conversion features appropriately accounted for and disclosed? ____
[APB 14 par. 12]
6. If a note is noninterest bearing or has an inappropriate stated interest 
rate:
a. Is the discount or premium presented as a deduction from or ad­
dition to the face amount of the note? ____
b. Is the effective interest rate and face amount of the note disclosed? ____
c. Is amortization of the discount or premium reported as interest
expense? -------
d. Are issue costs reported in the balance sheet as deferred charges? -------
[APB 21 par. 16]
7. If a short-term obligation is to be excluded from current liabilities in 
a classified balance sheet, do disclosures include:
a. A general description of the financing agreement? -------
b. The terms of any new obligation incurred or expected to be in­
curred, or equity securities issued or expected to be issued as a
result of the refinancing? -------
[SFAS 6 par. 15]
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8. Are long-term debt agreements subject to a subjective acceleration 
clause disclosed unless the likelihood of the acceleration of the due 
date is remote?
[TB 79-3]
9. For a troubled debt restructuring occurring during a period for which 
financial statements are presented, do disclosures include:
a. Description of the principal changes in terms, the major features 
of settlement, or both?
b. Aggregate gain on restructuring of payables?
c. Aggregate net gain or loss on transfers of assets recognized dur­
ing the period?
d. Per-share amount of the aggregate gain on restructuring of paya­
bles?
[SFAS 15 par. 25, as amended by SFAS 145]
10. For periods after a troubled debt restructuring, do disclosures include:
a. Extent to which amounts contingently payable are included in the 
carrying amount of restructured payables?
b. Total amounts that are contingently payable, if applicable, and 
conditions under which those amounts would become payable or 
forgiven?
[SFAS 15 par. 26]
11. If there is an early extinguishment of debt, is the difference between 
reacquisition price and net carrying amount identified as income in 
the period of extinguishment as gain or loss and identified as a sepa­
rate item?
[APB 26 par. 20]
12. Is the following disclosed if debt was considered to be extinguished 
by in-substance defeasance under the provisions of SFAS 76, Extin­
guishment of Debt—an amendment of APB Opinion No. 26, prior to the 
effective date of SFAS 125, Accounting for Transfers and Servicing of Fi­
nancial Assets and Extinguishments of Liabilities:
a. A general description of the transaction?
b. The amount of debt that is considered extinguished at the end of 
the period so long as that debt remains outstanding?
[SFAS 140 par. 17(b), as amended by SFAS 156]
13. If assets are set aside after January 1, 1997 solely for satisfying sched­
uled payments of a specific obligation, is disclosure made describing 
the nature of restrictions placed on those assets?
[SFAS 140 par. 17(c), as amended by SFAS 156]
14. Are long-term obligations that are or will be callable by the creditor, 
either because the debtor's violation of the debt agreement at the bal­
ance sheet date makes the obligation callable, or because the violation 
(if not cured within a specified grace period) will make the obligation 
callable, classified as current unless one of the following conditions is 
met:
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a. The creditor waives or subsequently loses the right to demand 
repayment for more than one year (or operating cycle, if longer)
from the balance sheet date? ____  ____  ____
b. The obligation contains a grace period within which the debtor
may cure the violation and it is probable that the violation will be 
cured within that period, thus preventing the obligation from be­
coming callable? ____  ____  ____
[SFAS 78 par. 5]
15. If an obligation under question 14b is included in long-term liabilities
(or in the case of an unclassified balance sheet is included as a long­
term liability in the disclosure of debt maturities), are the circum­
stances disclosed? ____  ____  ____
[SFAS 78 par. 5]
16. If a covenant on a long-term loan agreement is not met, and thus, the 
lender has the right to call the debt, and the lender waives that right 
for a period of greater than one year but retains the future covenant 
requirements, is the debt classified as noncurrent unless both of the 
following are met:
a. The covenant violation occurred at the balance sheet date or
would have occurred absent a loan modification? ____  ____  ____
b. It is probable the company will not be able to comply with the
covenant at a measurement date within the next 12 months? ____  ____  ____
[EITF 86-30]
17. Are borrowings outstanding under a revolving credit agreement that
includes both a subjective acceleration clause and a requirement to 
maintain a lock-box arrangement, whereby remittances from the bor­
rower's customers reduce the debt outstanding, classified as short­
term obligations? ____  ____  ____
[EITF 95-22]
18. In accordance with PB 15, Accounting by the Issuer of Surplus Notes, are 
surplus notes classified as debt in the financial statements of the is­
suer, and are existing disclosure requirements for debt instruments
complied with? ____  ____  ____
[AAG 14.15, app. C par. 15]
19. In accordance with PB 15, is the Insurance Commissioner's role and 
ability to approve or disapprove any interest or principal payments
disclosed? ____  ____  ____
[AAG 14.15, app. C par. 16]
20. If the reclassification to earnings of the amount in accumulated com­
prehensive income resulting from a cash flow hedge of debt is re­
quired under SFAS 133 when the debt is extinguished, is the reclassi­
fied amount not classified as extraordinary? ------- ------- ------
[EITF 00-9]
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R. Other Liabilities
1. Are liabilities appropriately accrued and reported for employees' 
compensation for future absences, including sabbatical leaves de­
scribed in EITF 06-2, "Accounting for Sabbatical Leave and Other 
Similar Benefits Pursuant to FASB Statement No. 43?"
[SFAS 43 par. 6; EITF 06-2 par. 5]
2. If the reporting entity has not accrued compensated absences (SFAS 
43) because the amount cannot be reasonably estimated, is that fact 
disclosed?
[SFAS 43 par. 6]
3. If an obligation for postemployment benefits is not accrued in accor­
dance with SFAS 5 or SFAS 43, Accounting for Compensated Absences, 
only because the amount cannot be reasonably estimated, is this fact 
of nonaccrual disclosed in the financial statements?
[SFAS 112 par. 7]
4. For insurance-related assessments:
a. If amounts relating to insurance-related assessments have been 
discounted pursuant to the provisions of SOP 97-3, Accounting by 
Insurance and Other Enterprises for Insurance-Related Assessments 
(AICPA, Technical Practice Aids, ACC sec. 10,710), has the entity 
disclosed in the financial statements the undiscounted amounts of 
the liability and any related asset for premium tax offsets or pol­
icy surcharges as well as the discount rate used?
b. If amounts have not been discounted, has the entity disclosed in 
the financial statements the amounts of the liability, any related 
asset for premium tax offsets or policy surcharges, the periods 
over which the assessments are expected to be paid, and the pe­
riod over which the recorded premium tax offsets or policy sur­
charges are expected to be realized?
[SOP 97-3 par. 27 (ACC 10,710.27); AAG app. C par. 26]
S. Shareholders' Equity
1. For each class of stock, do disclosures include the number of shares 
authorized, issued, and outstanding, and par or stated value per 
share?
[Generally Accepted]
2. Are classes of capital stock presented in order of priority in liquida­
tion?
[Generally Accepted]
3. Do the financial statements include a description, in summary form, 
sufficient to explain the pertinent rights and privileges of the various 
securities outstanding (for example, dividend and liquidation prefer­
ences, participation rights, call prices and dates, conversion or exer­
cise prices or rates and pertinent dates, sinking fund requirements, 
unusual voting rights, and significant terms of contracts to issue ad­
ditional shares)?
[SFAS 129 par. 4]
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4. Do disclosures include the number of shares issued upon conversion,
exercise, or satisfaction of required conditions during at least the most 
recent annual fiscal period and any subsequent interim period pre­
sented? ____  ___
[SFAS 129 par. 5]
5. For preferred stock or other senior stock that has a preference in in­
voluntary liquidation considerably in excess of par or stated value of 
the shares, is the liquidation preference disclosed in the equity section 
of the balance sheet in the aggregate, either parenthetically or "in 
short," rather than on a per share basis or in the notes to the financial
statements? ____  ___
[SFAS 129 par. 6]
6. Are the following disclosed on the face of the balance sheet or in the 
notes:
a. The aggregate or per share amounts at which preferred stock may
be called or is subject to redemption through sinking-fund oper­
ations or otherwise? ____  ___
b. The aggregate and per share amounts of arrearages in cumulative
preferred dividends? ____  ___
[SFAS 129 par. 7]
7. For redeemable stock, do disclosures include the amount of redemp­
tion requirements, separately by issue or combined, for all issues of 
capital stock that are redeemable at fixed or determinable prices on 
fixed or determinable dates in each of the five years following the
date of the latest balance sheet? ____  ___
[SFAS 129 par. 8]
8. Do disclosures for contingently convertible securities include the sig­
nificant quantitative and qualitative terms of the conversion features 
to enable users of the financial statements to understand the circum­
stances of the contingency and the potential impact of conversion, in­
cluding:
a. Events or changes in circumstances that would cause the contin­
gency to be met and any significant features necessary to under­
stand the conversion rights and the timing of those rights (for ex­
ample, the periods in which (1) the contingency might be met and
(2) the securities may be converted if the contingency is met)? ____  ___
b. The conversion price and the number of shares into which the
security is potentially convertible? ------- ------
c. Events or changes in circumstances, if any, that could adjust or 
change the contingency, conversion price, or number of shares,
including significant terms of those changes? ------- ------
d. The manner of settlement upon conversion and any alternative
settlement methods (for example, cash, shares, or a combination)? ------- -----
[FSP FAS 129-1 par. 3]
9. Do disclosures indicate whether the shares that would be issued if the 
contingently convertible securities were converted are included in the
calculation of diluted EPS, and the reasons why or why not? ------- ------
[FSP FAS 129-1 par. 4]
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10. Are appropriations of retained earnings for loss contingencies clearly
identified and included in shareholders' equity? ____
[SFAS 5 par. 15]
11. Are restrictions on payment of dividends disclosed? ____
[SFAS 5 par. 18-19]
12. After completion of a quasi-reorganization, is a new retained earnings
account established and dated with the date being disclosed in sub­
sequent financial statements until it is no longer deemed significant? ____
[ARB 43 ch. 7A par. 10; ARB 46]
13. Are the carrying basis, cost and number of shares of any treasury
stock held by the reporting entity disclosed? ____
[Generally Accepted]
14. If treasury stock is purchased for purposes other than retirement or if 
ultimate disposition has not yet been decided, is its cost:
a. Shown separately as a deduction from the total of capital stock,
additional paid-in capital, and retained earnings? ____
b. Accorded the accounting treatment appropriate for retired stock? ____
[APB 6 par. 12b, as amended by SFAS 135]
15. If state laws relating to acquisition of stock restrict the availability of
retained earnings for payment of dividends or other significant ef­
fects, is appropriate disclosure made? ____
[APB 6 par. 13]
16. If treasury shares are purchased at a stated price significantly in ex­
cess of current market price, is the allocation of amounts paid and the
accounting treatment for such amounts disclosed? ____
[TB 85-6 par. 1-3]
17. If the asset or liability that is recognized pursuant to SFAS 87, Employ­
ers' Accounting for Pensions, paragraph 35 results in a temporary dif­
ference, as defined in SFAS 109 is the deferred tax effects of any tem­
porary differences recognized in income tax expense or benefit for the 
year and allocated to various financial statement components, includ­
ing other comprehensive income, pursuant to paragraphs 35-39 of
SFAS 109? ____
[SFAS 87 par. 37, as amended by SFAS 158]
18. If statutory surplus is below the minimum required by law, is disclo­
sure of the relevant facts made? ____
[Generally Accepted]
19. Is the following information relating to stockholders' equity, statutory 
capital and surplus, and the effects of statutory accounting practices 
on the ability to pay dividends to stockholders disclosed:
a. The amount of statutory capital and surplus? ____
b. The amount of statutory capital and surplus necessary to satisfy
regulatory requirements (based on current operations) if signifi­
cant in relation to the statutory capital and surplus? ____
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c. The nature of statutory restrictions on the payment of dividends 
and the amount of retained earnings that is not available for the
payment of dividends to stockholders? ____  ____  ____
[SFAS 60 par. 60h; AAG app. C par. 17]
20. If the company receives a note rather than cash as a contribution to 
its equity, is the note classified as a reduction of stockholders' equity 
unless (in the very limited circumstance) there is substantial evidence
of ability and intent to pay within a reasonably short period of time? ____  ____  ____
[EITF 85-1]
Income Statement
A. Premium Revenue
1. Are premiums from universal life contracts no longer included in rev­
enue but recorded in the balance sheet policyholder accounts? ____  ____  ____
[SFAS 97 par. 59]
B. Investment Income
1. Are amounts of interest income, loan origination, commitment, am­
ortization amounts, and other fees and costs recognized as an adjust­
ment of yield reported as part of interest income? ____  ____  ____
[SFAS 91 par. 22]
2. Are realized gains and losses on all investments (except investments 
that are classified as trading securities and those that are accounted 
for as either hedges of net investments in foreign operations or cash 
flow hedges as described in SFAS 133) reported in the statement of
income as a component of other income, on a pretax basis? ____  ____  ____
[SFAS 97 par. 28, as amended by SFAS 115]
3. For all three categories of investments under SFAS 115, is interest and 
dividend income, including amortization of premium and discount,
included in earnings? ____  ____  ____
[AAG 11.12]
C. Other Income
1. Is amortization of other fees, such as commitment fees that are being 
amortized on a straight-line basis over the commitment period or in­
cluded in income when the commitment expires, reported as service
fee income? ------- ------- ------
[SFAS 91 par. 22]
D. Benefits and Expenses
1. Do disclosures for advertising costs include:
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a. The accounting policy selected from the two alternatives in para­
graph 26 of SOP 93-7, Reporting on Advertising Costs (AICPA, Tech­
nical Practice Aids, ACC sec. 10,590 par. .26), for reporting adver­
tising, indicating whether such costs are expensed as incurred or 
the first time the advertising takes place?
b. A description of the direct-response advertising reported as assets 
(if any), the accounting policy, and the amortization period?
c. The total amount charged to advertising expense for each income 
statement presented, with separate disclosure of amounts, if any, 
representing a write-down to net realizable value?
d. The total amount of advertising reported as assets in each balance 
sheet?
[SOP 93-7 par. 49 (ACC 10,590.49)]
2. Are payments to policyholders that represent a return of policyholder 
balances not reported as expenses in the statement of earnings?
[AAG 9.30; SFAS 97 par. 21]
3. Do amounts reported as expenses include benefit claims in excess of 
the related policyholder balances, expenses of contract administration, 
interest accrued to policyholders, and amortization of capitalized ac­
quisition costs?
[AAG 9.30]
4. Are depreciation and other related charges or credits related to real 
estate investments recorded as investment expense or operating ex­
pense depending on the balance sheet classification of the underlying 
assets?
[SFAS 60 par. 48]
E. Income Taxes
1. Are the types of significant temporary differences and carryforwards 
disclosed?
[SFAS 109 par. 43]
2. Are the following significant components of income tax expense at­
tributable to continuing operations for each year presented disclosed 
in the financial statements or notes thereto:
a. Current tax expense or benefit?
b. Deferred tax expense or benefit (exclusive of the effects of other 
components listed below)?
c. Investment tax credits?
d. Government grants (to the extent recognized as a reduction of 
income tax expense)?
e. The benefits of operating loss carryforwards?
f. Tax expense that results from allocating certain benefits, either di­
rectly to contributed capital or to reduce goodwill or other non- 
current intangible assets, of an acquired entity?
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g. Adjustments of a deferred tax liability or asset for enacted 
changes in tax laws or rates or a change in the tax status of the
reporting entity? ____  ____  ____
h. Adjustments of the beginning-of-the-year balance of a valuation 
allowance because of a change in circumstances that causes a 
change in judgment about the realizability of the related deferred
tax asset in future years? ____  ____  ____
[SFAS 109 par. 45a-h]
i. The amounts and expiration dates of operating loss and tax credit
carryforwards for tax purposes? ____  ____  ____
j. Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to 
reduce goodwill or other noncurrent intangible assets of an ac­
quired entity or directly to contributed capital? ____  ____  ____
[SFAS 109 par. 48]
3. Is the amount of income tax expense or benefit allocated to discontin­
ued operations, extraordinary items, items charged directly to share­
holders' equity, and prior period adjustments disclosed for each year
for which those items are presented? ____  ____  ____
[SFAS 109 par. 46]
4. If the company is a public enterprise, do the financial statements dis­
close a reconciliation using percentages or dollar amounts of (i) the 
reported amount of income tax expense attributable to continuing op­
erations for the year to (ii) the amount of income tax expense that 
would result from applying domestic federal statutory tax rates to
pretax income from continuing operations? ____  ____  ____
[SFAS 109 par. 47]
5. If the company is a public enterprise, are the estimated amount and
the nature of each significant reconciling item disclosed? ____  ____  ____
[SFAS 109 par. 47]
6. If the company is a nonpublic enterprise, is the nature of significant
reconciling items disclosed (a numerical reconciliation may be omit­
ted)? ____  ____  ____
[SFAS 109 par. 47]
7. If the company is a member of a group that files a consolidated tax 
return, are the following items disclosed in its separately issued finan­
cial statements:
a. The aggregate amount of current and deferred tax expense for 
each statement of income presented and the amount of any tax- 
related balances due to or from affiliates as of the date of each
statement of financial position presented? ------- ------- ------
b. The principal provisions of the method by which the consolidated
amount of current and deferred tax expense is allocated to mem­
bers of the group and the nature and effect of any changes in that 
method (and in determining related balances to or from affiliates) 
during the years for which the disclosures in question 7a are pre­
sented? ------- ------- ------
[SFAS 109 par. 49a-b]
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8. If an entity is involved in the sale or purchase of tax benefits through
tax leases, are the accounting policies or practices followed for those 
transactions disclosed in accordance with APB 22, Disclosure of Ac­
counting Polices? Do the disclosures include the following: ____
a. The method of accounting for those transactions? ____
b. The methods of recognizing revenue? ____
c. The method of allocating income tax benefits and asset costs to
current and future periods? ____
[TB 82-1 par. 4, as amended by SFAS 95]
9. If material and unusual or infrequent to the entity, are the nature and
financial effects of transactions involving the sale or purchase of tax 
benefits through tax leases disclosed on the face of the income state­
ment or, alternatively, in the notes to the financial statements in ac­
cordance with APB 30, Reporting the Results of Operations? ____
[TB 82-1 par. 6, as amended by SFAS 145]
10. Are disclosures included if significant contingencies exist with respect 
to the sale or purchase of tax benefits through tax leases in accordance
with SFAS 5? ____
[TB 82-1 par. 7, as amended by SFAS 96 and SFAS 109]
11. Are disclosures included for any change in the method of accounting 
for sales or purchases of tax benefits through tax leases that signifi­
cantly affects comparability if comparative financial statements are
presented in accordance with paragraph 2 of chapter 2A of ARB 43? ____
[TB 82-1 par. 7, as amended by SFAS 96 and SFAS 109]
Notes: FSP FIN 48-2, Effective Date of FASB Interpretation No. 48 for Certain 
Nonpublic Enterprises, amends paragraph 22 of FIN 48, Accounting for Un­
certainty in Income Taxes—an interpretation of FASB Statement No. 109, to 
defer the effective date of FIN 48 to fiscal years beginning after December 
15, 2007, for nonpublic enterprises as defined by paragraph 289 of SFAS 
109 including nonpublic not-for-profit organizations. Nonpublic enter­
prises subject to the provisions of FIN 48 that are consolidated with a pub­
lic enterprise or that have issued a full set of U.S. GAAP annual financial 
statements prior to the issuance of this FSP using the recognition, meas­
urement, and disclosure requirements of FIN 48 are not eligible for the 
deferral.
At the October 15, 2008, meeting, FASB decided to issue a proposed FSP 
to defer FIN 48 for all nonpublic entities until fiscal years beginning after 
December 15, 2008, The proposed FSP will include a request for comments 
on issues that private pass-through entities have encountered related to 
FIN 48. FASB expects to issue this proposed FSP in the first quarter of 
2009. FASB will then subsequently issue a separate proposed FSP that will 
provide guidance for pass-through entities and provide amendments to 
the existing disclosure requirements for nonpublic entities.
For those nonpublic entities to which the deferral provisions of FSP FIN 
48-2 apply, skip questions 12-15 that follow.
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12. Does an enterprise disclose its policy on classification of interest and 
penalties in accordance with paragraph 19 of FIN 48 in the footnotes
to the financial statements? ____  ____  ____
[FIN 48 par. 20]
13. Does an enterprise disclose the following at the end of each annual 
reporting period presented:
a. A tabular reconciliation of the total amounts of unrecognized tax 
benefits at the beginning and end of the period, which shall in­
clude at a minimum:
(1) The gross amounts of the increases and decreases in unrecog­
nized tax benefits as a result of tax positions taken during a
prior period? ____  ____  ____
(2) The gross amounts of increases and decreases in unrecogni­
zed tax benefits as a result of tax positions taken during the
current period? ____  ____  ____
(3) The amounts of decreases in the unrecognized tax benefits re­
lating to settlements with taxing authorities? ____  ____  ____
(4) Reductions to unrecognized tax benefits as a result of a lapse
of the applicable statute of limitations? ____  ____  ____
b. The total amount of unrecognized tax benefits that, if recognized,
would affect the effective tax rate? ____  ____  ____
c. The total amounts of interest and penalties recognized in the
statement of operations and the total amounts of interest and pen­
alties recognized in the statement of financial position? ____  ____  ____
d. For positions for which it is reasonably possible that the total 
amounts of unrecognized tax benefits will significantly increase 
or decrease within 12 months of the reporting date:
(1) The nature of the uncertainty? ____  ____  ____
(2) The nature of the event that could occur in the next 12 months
that would cause the change? ____  ____  ____
(3) An estimate of the range of the reasonably possible change or
a statement that an estimate of the range cannot be made? ____  ____  ____
e. A description of tax years that remain subject to examination by
major tax jurisdictions? ------- ------- ------
[FIN 48 par. 21]
14. If an enterprise presents a classified statement of financial position, 
does the entity classify a liability associated with an unrecognized tax 
benefit as a current liability (or the amount of a net operating loss 
carryforward or amount refundable is reduced) to the extent the en­
terprise anticipates payment (or receipt) of cash within one year or 
the operating cycle, if longer? Furthermore, has the liability for unre­
cognized tax benefits (or reduction in amounts refundable) not been
combined with deferred tax liabilities or assets? ------- ------- ------
[FIN 48 par. 17]
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15. Is a liability that has been recognized as a result of applying FIN 48, 
not classified as a deferred tax liability unless it arises from a taxable
temporary difference? ____
[FIN 48 par. 18]
F. Extraordinary Items, Unusual Items, Infrequent Items
1. Do extraordinary items meet both criteria of (1) unusual nature and
(2) infrequency of occurrence? ____
[APB 30 par. 20]
2. Are extraordinary items segregated and shown (including applicable 
income taxes) following income before extraordinary items and before
net income? ____
[APB 30 par. 11]
3. Are descriptive captions and amounts (including applicable income 
taxes) presented for individual extraordinary events or transactions,
preferably on the face of the income statement? ____
[APB 30 par. 11]
4. Do disclosures include descriptions of an extraordinary event or
transaction and the principal items entering into determination of ex­
traordinary gain or loss? ____
[APB 30 par. 11]
5. Are the income taxes applicable to extraordinary events disclosed on
the face of the statement of operations or in related notes? ____
[APB 30 par. 11]
6. Is each adjustment in the current period of an element of an extraor­
dinary item that was reported in a prior period separately disclosed 
as to year of origin, nature, and amount and classified separately in
the current period as an extraordinary item? ____
[SFAS 16 par. 16c]
7. Are material events or transactions that are either unusual in nature 
or of infrequent occurrence, but not both (and therefore not meeting 
criteria for extraordinary items):
a. Reported as a separate component of income from continuing op­
erations? ____
b. Accompanied by disclosure of the nature and financial effects of
each event? ____
[APB 30 par. 26]
8. Is the following information disclosed in the notes to the financial 
statements in the period(s) in which business interruption (BI) insur­
ance recoveries are recognized:
a. The nature of the event resulting in business interruption losses? ____
b. The aggregate amount of BI insurance recoveries recognized dur­
ing the period and the line item(s) in the statement of operations 
in which those recoveries are classified (including amounts re­
ported as an extraordinary item pursuant to APB 30)? ____
[EITF 01-13]
FSP §20,300.03
No N/A
Financial Statements and Notes Checklist 49
Yes No N/A
G. Earnings Per Share
Notes: SFAS 128, Earnings per Share, applies only to entities with publicly 
held common stock or potential common stock.
FASB issued SFAS 160, Noncontrolling Interests in Consolidated Financial 
Statements—an amendment of ARB No. 51, in March 2008, to establish ac­
counting and reporting standards for the noncontrolling interests in a sub­
sidiary and for the de-consolidation of a subsidiary, areas for which lim­
ited guidance previously existed. In addition to the overview of this 
statement provided in a note appearing earlier in this checklist, readers 
should be aware that SFAS 160 clarifies that, for purposes of computing 
EPS in consolidated financial statements (both basic and diluted), if one or 
more less-than-wholly-owned subsidiaries are included in the consoli­
dated group, income from continuing operations and net income shall ex­
clude the income attributable to the noncontrolling interest in subsidiaries.
SFAS 160 is effective for fiscal years, and interim periods within those fis­
cal years, beginning on or after December 15, 2008 (that is, January 1, 2009, 
for entities with calendar year-ends). Earlier adoption is prohibited. As 
such, this checklist has not been updated to include the presentation and 
disclosure requirements of SFAS 160. Readers can refer to the full text of 
the statement on the FASB Web site at www.fasb.org.
1. If the reporting entity has a simple capital structure (only common 
stock outstanding), are basic per share amounts for income from con­
tinuing operations and for net income presented on the face of the 
income statement for all periods for which an income statement or
summary of earnings is presented? ____
[SFAS 128 par. 36 and 38]
2. If the reporting entity has other than a simple capital structure, are 
basic and diluted per share amounts for income from continuing op­
erations and for net income presented on the face of the income state­
ment with equal prominence for all periods for which an income 
statement or summary of earnings is presented? (Note: If diluted EPS 
data are reported for at least one period, they should be reported for
all periods presented, even if they are the same amounts as basic EPS.) ____
[SFAS 128 par. 36 and 38]
3. If discontinued operations, extraordinary items, or the cumulative ef­
fect of accounting changes are reported in the period, are the basic 
and diluted per share amounts for those line items presented on the
face of the income statement or in the notes? -------
[SFAS 128 par. 37, as amended by SFAS 154]
4. If per share amounts not required to be presented by SFAS 128 are 
disclosed, are they disclosed only in the notes and do the disclosures
indicate whether the per share amounts are pretax or net of tax? -------
[SFAS 128 par. 37, as amended by SFAS 154]
5. Are the following disclosed for each period for which an income state­
ment is presented:
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a. A reconciliation of the numerators and denominators of the basic
and diluted per share computations for income from continuing 
operations? ____
b. The effect that has been given to preferred dividends in arriving 
at income available to common shareholders' in computing basic
EPS? ____
c. Securities (including those issuable pursuant to contingent stock 
agreements) that could potentially dilute basic EPS in the future 
that were not included in the computation of diluted EPS because
to do so would have been antidilutive for the period(s) presented? ____
[SFAS 128 par. 40]
6. For the latest period for which an income statement is presented, do 
disclosures include a description of any transaction that occurs after 
the end of the most recent period but before issuance of the financial 
statements that would have changed materially the number of com­
mon shares or potential common shares outstanding at the end of the
period if the transaction had occurred before the end of the period? ____
[SFAS 128 par. 41]
7. If the number of common shares outstanding increases as a result of 
a stock dividend or stock split or decreases as a result of a reverse 
stock split, the computations of basic and diluted EPS should be ad­
justed retroactively for all periods presented to reflect that change in 
capital structure. If per share computations reflect such changes in the
number of shares, is that fact disclosed? ____
[SFAS 128 par. 54]
8. If changes in common stock resulting from stock dividends, stock
splits, or reverse stock splits occur after the close of the period but 
before issuance of the financial statements, the per share computa­
tions for those and any prior-period financial statements presented 
should be based on the new number of shares. If per share computa­
tions reflect such changes in the number of shares, is that fact dis­
closed? ____
[SFAS 128 par. 54]
9. When prior earnings per share amounts have been restated in com­
pliance with an accounting standard requiring restatement, is the ef­
fect of the restatement, expressed in per share terms, disclosed in the
period of restatement? ____
[SFAS 128 par. 57]
10. Are prior period earnings per share amounts presented for compara­
tive purposes restated to conform to the consensus guidance in EITF 
03-6, "Participating Securities and the Two-Class Method under FASB
Statement No. 128", Earnings per Share? ____
[EITF 03-6]
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11. For contingently convertible instruments outstanding at the date of
adoption of EITF 04-8, "The Effect of Contingently Convertible Instru­
ments on Diluted Earnings per Share," and whose terms have not 
been modified since the date of issuance, are prior-period diluted 
earnings per share restated to conform to the guidance in the consen­
sus for comparative purposes? ____  ____  ____
[EITF 04-8]
12. For contingently convertible instruments outstanding at the date of 
adoption of EITF 04-8 and whose terms have been modified, are prior- 
period diluted earnings per share restated to conform to the guidance 
in the consensus for comparative purposes based on the modified
terms of the instrument at the date of adoption of EITF 04-8? ____  ____  ____
[EITF 04-8]
H. Comprehensive Income
Notes: FASB issued SFAS 160 in March 2008 to establish accounting and 
reporting standards for the noncontrolling interests in a subsidiary and for 
the deconsolidation of a subsidiary, areas for which limited guidance pre­
viously existed.
In addition to the overview of this statement provided in a note appearing 
earlier in this checklist, readers should be aware that SFAS 160 clarifies 
that, if an entity has an outstanding noncontrolling interest (minority in­
terest), amounts for both comprehensive income attributable to the parent 
and comprehensive income attributable to the noncontrolling interest in a 
less-than-wholly-owned subsidiary are reported on the face of the finan­
cial statement in which comprehensive income is presented in addition to 
presenting consolidated comprehensive income. Additionally, if an entity 
has an outstanding noncontrolling interest, the components of other com­
prehensive income attributable to the parent and noncontrolling interest 
in a less-than wholly-owned subsidiary are required to be disclosed as 
part of its equity reconciliation.
SFAS 160 is effective for fiscal years, and interim periods within those fis­
cal years, beginning on or after December 15, 2008 (that is, January 1, 2009, 
for entities with calendar year-ends). Earlier adoption is prohibited. As 
such, this checklist has not been updated to include the presentation and 
disclosure requirements of SFAS 160. Readers can refer to the full text of 
the statement on the FASB Web site at www.fasb.org.
1. Are all components of comprehensive income reported in the finan­
cial statements in the period in which they are recognized?
[SFAS 130 par. 14]
2. Is a total amount for comprehensive income displayed in the financial 
statement where the components of OCI are reported?
[SFAS 130 par. 14]
3. Is an amount for net income displayed and included as a component 
of comprehensive income?
[SFAS 130 par. 15 and 22]
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4. Are items included in OCI classified separately into foreign currency 
items, gains or losses associated with pension or other postretirement 
benefits, prior service costs or credits associated with pension or other 
postretirement benefits, transition assets or obligations associated 
with pension or other postretirement benefits, and unrealized gains 
and losses on certain investments in debt and equity securities?
[SFAS 130 par. 17, as amended by SFAS 158]
5. Are reclassification adjustments made that avoid double counting in 
comprehensive income of items that are displayed as part of net in­
come for a period that also had been displayed as part of OCI in that 
period or other periods presented on the face of the financial state­
ment in which comprehensive income is reported or disclosed in the 
notes?
[SFAS 130 par. 18, as amended by SFAS 158]
6. Are comprehensive income and its components displayed in a finan­
cial statement that is displayed with the same prominence as the other 
financial statements? (Note: SFAS 130, Reporting Comprehensive Income, 
encourages but does not require that the components of OCI and total 
comprehensive income be displayed below the total for net income in 
a statement that reports results of operations or in a separate state­
ment of comprehensive income that begins with net income.)
[SFAS 130 par. 22-23]
7. Are the components of OCI displayed either net of related tax effects, 
or before related tax effects with one amount shown for the aggregate 
tax effect related to the total of OCI items?
[SFAS 130 par. 24]
8. Is the amount of income tax expense or benefit allocated to each com­
ponent of OCI (including reclassification adjustments) displayed on 
the face of the statement in which those components are displayed or 
disclosed in the notes to the financial statements?
[SFAS 130 par. 25]
9. Is the total of OCI for a period transferred to a component of equity 
that is displayed separately from retained earnings and additional 
paid-in-capital in the balance sheet with a descriptive title such as ac­
cumulated other comprehensive income?
[SFAS 130 par. 26]
10. Are accumulated balances for each classification within accumulated 
OCI disclosed on the face of the balance sheet, in the statement of 
changes in shareholders' equity, or in the notes?
[SFAS 130 par. 26]
11. Has the enterprise reported a total for comprehensive income in con­
densed financial statements of interim periods?
[SFAS 130 par. 27, as amended by SFAS 135]
12. Has the entity displayed as a separate classification within OCI the 
net gain or loss on derivative instruments designated and qualifying 
as cash flow hedging instruments that are reported in comprehensive 
income pursuant to paragraphs 30 and 41 of SFAS 133?
[SFAS 133 par. 46]
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13. As part of the disclosures of accumulated OCI, pursuant to paragraph
26 of SFAS 130, has the entity separately disclosed the beginning and 
ending accumulated derivative gain or loss, the related net change 
associated with current period hedging transactions, and the net
amount of any reclassification into earnings? ____  ____  ____
[SFAS 133 par. 47]
1. Other
1. Are the following excluded from determination of net income or re­
sults of operations under all circumstances:
a. Adjustments or charges or credits resulting from transactions in
the company's own capital stock? ____  ____  ____
b. Transfers to and from accounts properly designated as appropri­
ated retained earnings? ____  ____  ____
c. Adjustments made pursuant to a quasi reorganization? ____  ____  ____
[APB 9 par. 28]
2. Is the amount of revenue and expense recognized from advertising
barter transactions disclosed for each income statement period pre­
sented? ____  ____  ____
[EITF 99-17]
3. If the entity engages in advertising barter transactions for which the
fair value is not determinable within the limits of EITF 99-17, "Ac­
counting for Advertising Barter Transactions," is information regard­
ing the volume and type of advertising surrendered and received 
(such as the number of equivalent pages, the number of minutes, or 
the overall percentage of advertising volume) disclosed for each in­
come statement period presented? ____  ____  ____
[EITF 99-17]
4. At a minimum, is a description of the nature and amounts of losses 
and costs recognized as a result of the September 11 events and the 
amount of related insurance recoveries (if any) recognized disclosed 
in the notes to the financial statements in all periods affected by the
September 11, 2001, attacks? ____  ____  ____
[EITF 01-10]
5. Are losses and costs incurred as a result of the September 11, 2001
attacks classified as part of income from continuing operations? ____  ____  ____
[EITF 01-10]
6. Does a vendor disclose the following in regard to revenue arrange­
ments with multiple deliverables:
a. Its accounting policy for recognition of revenue from multiple- 
deliverable arrangements (for example, whether deliverables are
separable into units of accounting)? ------- ------- ------
b. The description and natures of such arrangements, including per­
formance, cancellation, termination, or refund-type provisions? ------- ------- ------
[EITF 00-21]
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Yes No N/A
7. Is the income statement classification of the expense associated with a 
"free" product or service delivered at the time of sale of another prod­
uct or service classified as cost of sales? ____  ____  ____
[EITF 01-9]
Notes: EITF 06-3, "How Taxes Collected from Customers and Remitted to 
Governmental Authorities Should Be Presented in the Income Statement 
(That Is, Gross Versus Net Presentation)," provides guidance on the pre­
sentation of taxes in the income statement. The EITF reached a consensus 
that the presentation of taxes within the scope of the issue, either on either 
a gross basis (included in revenues and costs) or a net basis (excluded 
from revenues), is an accounting policy decision that should be disclosed 
pursuant to APB 22.
Included in the scope of this issue is any tax assessed by a governmental 
authority that is both imposed on and concurrent with a specific revenue- 
producing transaction between a seller and a customer, and may include, 
but is not limited to, sales, use, value added, and some excise taxes. The 
issue excludes tax schemes that are based on gross receipts and taxes that 
are imposed during the inventory procurement process.
The consensuses in EITF 06-3 should be applied to financial reports for 
interim and annual reporting periods beginning after December 15, 2006. 
This checklist has been updated to include the disclosure requirements of 
EITF 06-3. Readers can refer to the full text of the issue on the FASB Web 
site at www.fasb.org
8. Is the accounting policy decision regarding the presentation of taxes 
within the scope of EITF 06-3 either on a gross basis (included in rev­
enues and costs) or a net basis (excluded from revenues) disclosed 
pursuant to APB 22? (Note: An entity is not required to reevaluate its 
existing policies related to taxes assessed by a governmental authority 
as a result of this consensus.)
[EITF 06-3 par. 4]
9. For any such taxes that are reported on a gross basis, does the entity 
disclose the amounts of those taxes in interim and annual financial 
statements for each period for which an income statement is pre­
sented if those amounts are significant? (Note: The disclosure of those 
taxes can be done on an aggregate basis.)
[EITF 06-3 par. 4]
Notes: EITF 07-1, "Accounting for Collaborative Arrangements," estab­
lishes accounting and disclosure requirements for participants in a collab­
orative arrangement. The issue defines a collaborative arrangement as a 
contractual arrangement that involves a joint operating activity and two 
(or more) parties who are both (a) active participants in the activity and 
(b) exposed to significant risks and rewards dependent on the commercial 
success of the activity. The scope of this issue does not include arrange­
ments for which the accounting is specifically addressed within the scope 
of other authoritative accounting literature such as ARB 51, Consolidated
(continued) 
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Financial Statements, SFAS 94, Consolidation of All Majority-owned Subsidar­
ies—an amendment of ARB No. 51, with related amendments of APB Opinion 
No. 18 and ARB No. 43, Chapter 12, APB 18, and FIN 46(R), Consolidation of 
Variable Interest Entities—an interpretation of ARB No. 51, for example.
The issue requires a participant to a collaborative arrangement to make 
certain disclosures in the initial period (which may be an interim period). 
EITF 07-1 is effective for financial statements issued for fiscal years begin­
ning after December 15, 2008, and interim periods within those fiscal 
years. Furthermore, EITF 07-1 shall be applied retrospectively to all prior 
periods presented for all collaborative arrangements existing as of the ef­
fective date. This checklist has not been updated to include the disclosure 
requirements of EITF 07-1. Readers can refer to the full text of the issue on 
the FASB Web site at www.fasb.org.
Statement of Changes in Shareholders' Equity
1. Are changes in the separate accounts of shareholders' equity dis­
closed?
[APB 12 par. 10]
2. Are changes in the number of shares of equity securities disclosed?
[APB 12 par. 10]
3. If prior-period adjustments have been recorded during the current 
year, are their resulting effects (both gross and net of applicable 
income taxes and including the amounts of income tax applicable to 
the prior period adjustments) appropriately disclosed:
a. For single-period statements, does the disclosure indicate the ef­
fects of such restatement on the balance of retained earnings at 
the beginning of the period and on the net income of the imme­
diately preceding period?
b. If financial statements of more than one period are presented, 
does disclosure include the effects for each of the periods pre­
sented in the statements?
[APB 9 par. 26]
Practice Tip
Disclosure of restatements in annual reports issued subsequent to the first such post-revision disclosure 
would ordinarily not be required.
4. If the reporting entity is a publicly traded company and if interim 
financial data and disclosures are not separately reported for the 
fourth quarter, are accounting changes made during the fourth quar­
ter, disposals of components of an entity, extraordinary, unusual, or 
infrequently occurring items recognized in the fourth quarter, and the 
aggregate effect of year end adjustments that are material to the re­
sults of that quarter disclosed in a note to the financial statements? 
[APB 28 par. 31]
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Statement of Cash Flows
1. Is a statement of cash flows presented as a basic financial statement
(for each period for which a statement of income is presented) if fi­
nancial statements present both financial position and results of op­
erations? ____
[SFAS 95 par. 3, as amended by SFAS 102 and SFAS 117]
2. Does the statement of cash flows report net cash provided or used by
the operating, investing, and financing activities and the effect of 
those flows on cash and cash equivalents during the period in a man­
ner that reconciles beginning and ending cash and cash equivalents? ____
[SFAS 95 par. 26]
3. Is the policy for defining cash equivalent disclosed? ____
[SFAS 95 par. 10]
4. If applicable, is the effect of exchange rate changes on cash balances 
held in foreign currencies shown separately on statement of cash
flows? ____
[SFAS 95 par. 25]
5. Is the change in cash and cash equivalents shown? ____
[SFAS 95 par. 7 and 26]
6. Are noncash investing and financing activities, such as converting
debt to equity, either summarized in a separate schedule or in narra­
tive format? ____
[SFAS 95 par. 32]
Operating Activities
7. Are cash receipts and cash payments from operating activities shown
separately on the statement of cash flows? ____
[SFAS 95 par. 27-28, as amended by SFAS 123(R)]
8. If SFAS 159 has been adopted, are cash receipts and cash payments 
resulting from purchases and sales of securities classified as trading 
securities as discussed in SFAS 115, classified pursuant to SFAS 95 (as 
amended) based on the nature and purpose for which the securities
were acquired as operating cash flows? ____
[SFAS 102 par. 8, as amended by SFAS 115, SFAS 145, and SFAS 159]
9. If SFAS 159 has not been adopted, are cash receipts and cash pay­
ments resulting from purchases and sales of securities classified as 
trading securities as discussed in SFAS 115 classified as operating
cash flows? ____
[SFAS 102 par. 8, as amended by SFAS 115 and SFAS 145]
10. Are cash receipts and cash payments from purchases and sales of se­
curities and other assets acquired for resale and carried at market
value in a trading account classified as operating cash flows? ____
[SFAS 102 par. 8, as amended by SFAS 115]
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11. Are cash receipts and cash payments resulting from purchases, acqui­
sitions and sales of loans, if those loans are acquired specifically for 
resale and are carried at market value or the lower of cost or market,
classified as operating cash flows? ____  ___
12. Is cash payment made to settle an asset retirement obligation classi­
fied in the statement of cash flows as an operating activity? ____  ___
[EITF 02-6]
Direct Method of Reporting Net Cash Flow from
Operating Activities
13. If the direct method of reporting net cash flow from operating activi­
ties is used, do cash flows from operating activities separately report:
a. Cash receipts from customers?
b. Cash receipts from interest and dividends?
c. All other cash receipts that do not stem from transactions defined 
as investing or financing activities?
d. Cash payments to suppliers and employees, such as benefits paid 
to policyholders, surrender benefits, and dividends paid to poli­
cyholders?
e. Cash payments to governments for taxes, duties, fines, and other 
fees or penalties and the cash that would have been paid for 
income taxes if increases in the value of equity instruments issued 
under share-based payment arrangements that are not included 
in the cost of goods or services recognizable for financial report­
ing purposes also had not been deductible in determining taxable 
income (paragraph 19(e) of SFAS 95)?
f. Cash payments to lenders and other creditors for interest?
g. All other cash payments that do not stem from transactions de­
fined as investing or financing activities?
[SFAS 95 par. 22-23, as amended by SFAS 123(R)]
14. Is a separate schedule provided to reconcile net income to net cash 
flow from operating activities?
[SFAS 95 par. 30]
Indirect Method of Reporting Net Cash Flow from
Operating Activities
15. Is the net cash flow from operating activities reported indirectly by 
adjusting net income to reconcile it to net cash flow from operating 
activities?
16. Is the reconciliation of net income to net cash flows from operating 
activities reported, either within the statement of cash flows or pro­
vided in a separate schedule (the reconciliation should separately re­
port all major reconciling items pertaining to operating activities)? 
[SFAS 95 par. 28-29]
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17. Are the amounts of interest paid (net of amounts capitalized) and 
income taxes paid during the period(s) disclosed?
[SFAS 95 par. 29]
Investing Activities
18. Are cash receipts and cash payments from investing activities shown 
separately on statement of cash flows?
[SFAS 95 par. 31]
19. Are cash receipts and cash payments for the following transactions 
classified as cash flows from investing activities:
a. Receipts from collections or sales of loans?
b. Receipts from sales of property, plant, and equipment?
c. Loans to others?
d. Payments to acquire property, plant, and equipment?
e. Receipts from sales of equity instruments of other enterprises ex­
clusive of those carried in the trading account?
f. Receipts and payments from purchases, sales, and maturities of 
available for sale and held to maturity securities
g. Payments to acquire equity instruments of other enterprises, ex­
clusive of those carried in a trading account?
[SFAS 95 par. 16-17, as amended by SFAS 102, SFAS 145, SFAS 
159]
Financing Activities
20. Are cash receipts and cash payments from financing activities shown 
separately on the statement of cash flows?
[SFAS 95 par. 31]
21. Are cash receipts and cash payments for the following transactions 
classified as cash flows from financing activities:
a. Proceeds from issuing equity instruments?
b. Proceeds from issuing bonds, mortgages, and notes, and from 
other short- or long-term borrowing?
c. Repayment of amounts borrowed?
d. Dividend payments to stockholders?
e. Acquisition of treasury stock?
f. Other principal payments to creditors who have extended long­
term credit?
g. Debt issue costs?
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h. Proceeds received from derivative instruments and distributions 
to counterparties of derivative instruments that include financing
elements at inception? ____  ____  ____
[SFAS 95 par. 19-20, as amended by SFAS 117, SFAS 123(R), SFAS 
149; EITF 95-13]
i. Cash retained as a result of the tax deductibility of increases in
the value of equity instruments issued under share-based pay­
ment arrangements that are not included in the cost of goods or 
services that is recognizable for financial reporting purposes? For 
this purpose, excess tax benefits shall be determined on an indi­
vidual award (or a portion thereof) basis? ____  ____  ____
[SFAS 123(R) par. 68a; SFAS 95 par. 19(e), as amended by SFAS
117, SFAS 123(R), SFAS 149]
Practice Tip
Any change in policy for determining which items are treated as cash equivalents is a change in accounting 
principle.
22. If an other-than-insignificant financing element is present at incep­
tion, other than a financing element inherently included in an at-the- 
market derivative instrument with no prepayments (that is, the for­
ward points in an at-the-money forward contract), does the borrower 
report all cash inflows and outflows associated with that derivative 
instrument in a manner consistent with financing activities as de­
scribed in paragraphs 18-20 of SFAS 95?
[SFAS 133 par. 45A, as amended by SFAS 149 and SFAS 155]
General
A. Titles and References
1. For a full presentation in conformity with GAAP, are the following 
financial statements presented:
a. Balance sheet?
b. Statement of income (operations)?
c. Statement of retained earnings or changes in shareholders' eq­
uity?
d. Statement of cash flows?
e. Description of accounting policies?
f. Notes to the financial statements?
[Generally Accepted]
2. Are the financial statements suitably titled?
[Generally Accepted]
3. Does each statement include a general reference indicating that the 
notes are an integral part of the financial statement presentation? 
[Generally Accepted]
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B. Disclosure of Accounting Policies
1. Is a description of significant accounting policies of the reporting en­
tity presented as either a separate summary preceding the notes to the 
financial statements or as the initial note:
[APB 22 par. 15]
a. Principles of consolidation? ____
b. Basis of presentation? ____
c. Basis of investments? ------
d. Realized gains and losses? ------
e. Cash equivalents? ____
f. Recognition of premium revenues? ____
g. Deferred policy acquisition costs? ____
h. Property and equipment? ____
i. Insurance liabilities? ____
j. Participating policies? ____
k. Reinsurance? ____
l. Income taxes? ____
m. Foreign reinsurance? ____
[APB 22 par. 8; FIN 40 par. 5, as amended by SFAS 115 and SFAS 
135]
2. Do the summary or notes identify and describe all significant account­
ing principles followed by the reporting entity and the methods of 
applying those principles that materially affect the determination of
financial position, cash flows, and results of operations? ____
[APB 22 par. 12]
3. Do those principles and methods identified in question 2 include all 
instances in which there:
a. Is a selection from existing acceptable alternatives? ____
b. Are principles and methods peculiar to the industry in which the
reporting entity operates, even if such principles and methods are 
predominantly followed in that industry? ____
c. Are unusual or innovative applications of GAAP? ____
[APB 22 par. 12]
4. Is an explanation that the preparation of financial statements in con­
formity with GAAP requires the use of management's estimates in­
cluded? ____
[SOP 94-6 par. 11; FSP SOP 94-6-1 par. 10]
5. Does disclosure of significant accounting policies include appropriate 
reference to details presented elsewhere (in the statements and notes
thereto) so duplication of details is avoided? ____
[APB 22 par. 14]
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6. Is the company's accounting policy with respect to vendor's sales in­
centive arrangements disclosed? ____  ____  ____
[EITF 03-10]
7. Is the policy for requiring collateral or other security disclosed if the 
entity has entered into repurchase agreements or securities lending
transactions? ____  ____  ____
[SFAS 140 par. 17(a), as amended by SFAS 156]
8. If material, is the accounting policy used in recognizing amounts re­
lated to a modification of an operating lease (that does not change the
lease classification) disclosed? ____  ____  ____
[EITF 95-17]
9. Do mutual life insurance companies disclose the principles and meth­
ods used to account for marketable securities and insurance activities? ____  ____  ____
[FIN 40 par. 5, as amended by SFAS 115 and SFAS 135]
10. If (a) state prescribed statutory accounting practices differ from the 
National Association of Insurance Commissioners (NAIC) statutory 
accounting practices or (b) permitted state statutory accounting prac­
tices differ from either state prescribed statutory accounting practices 
or NAIC statutory accounting practices, is the following information 
about the use of prescribed or permitted statutory accounting prac­
tices (individually or in the aggregate) results in reported statutory 
surplus or risk-based capital that is significantly different from the 
statutory surplus or risk-based capital that would have been reported 
had NAIC statutory accounting practices been followed, disclosed:
a. If an insurance enterprise's risk-based capital would have trig­
gered a regulatory event had it not used a permitted practice, is
that fact disclosed in the financial statements? ____  ____  ____
b. A description of the prescribed or permitted statutory accounting
practice by insurance enterprises at the date each financial state­
ment is presented? ____  ____  ____
c. The related monetary effect on statutory surplus of using an ac­
counting practice that differs from either state prescribed statu­
tory accounting practices or NAIC statutory accounting practices 
by insurance enterprises at the date each financial statement is
presented?2 ____  ____  ____
2 Disclosures in this question should be applied by a U.S. insurance enterprise, a U.S. enterprise with a U.S. insurance subsidiary, or a 
foreign enterprise with a U.S. insurance subsidiary, if the enterprise prepares U.S. generally accepted accounting principles (GAAP) 
financial statements. If a foreign insurance enterprise that does not have a U.S. insurance subsidiary prepares U.S. GAAP financial 
statements or is included in its parent's consolidated U.S. GAAP financial statements, the notes to the financial statements should disclose 
permitted regulatory accounting practices that significantly differ from the prescribed regulatory accounting practices of its respective 
regulatory authority and their monetary effects.
[SOP 94-5 par. 9 (ACC 10,630.09), as amended by SOP 01-5 (ACC 
10,840)]
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11. Are managements' policies and methodologies for estimating a liabil­
ity for unpaid claims and claim adjustment expenses for difficult-to- 
estimate liabilities such as for claims for toxic waste cleanup, asbestos- 
related illnesses, or other environmental remediation exposures
disclosed? ------- ------- ------
[SOP 94-5 par. 12 (ACC 10,630.12), as amended by SOP 01-5 (ACC 
10,840)]
12. Do the notes to the accompanying insurance enterprise's statutory fi­
nancial statements contain a summary of significant accounting poli­
cies that discuss the following:
a. Statutory accounting practices? ------- ------- ------
b. Describe how this basis differs from GAAP? ------- ------- ------
[SOP 95-5 par. 20 (AUD 14,310.20), as amended by SOP 01-5]
13. For general-use statutory financial statements, are the effects of the 
differences between statutory accounting practices and GAAP, if
quantified, disclosed? ------- ------- ------
[SOP 95-5 par. 20 (AUD 14,310.20), as amended by SOP 01-5]
14. Has the insurance company disclosed its accounting policy for inter­
nal replacements, including whether or not the company has availed 
itself of the alternative application guidance in paragraphs 18-19 of 
SOP 05-1, and if so, for which types of internal replacement transac­
tions? ------- ------- ------
[SOP 05-1 par. 28 (ACC 10,920.28)]
15. Has the insurance company disclosed its accounting policy for sales 
inducements, including:
a. The nature of the costs deferred? ------- ------- ------
b. The method of amortizing those costs? ------- ------- ------
[SOP 03-1 par. 39 (ACC 10,870.39)]
16. For sales inducements, are the amount of costs deferred and amor­
tized for each of the periods presented and the unamortized balance
as of each balance sheet date disclosed? ____  ____  ____
[SOP 03-1 par. 39 (ACC 10,870.39)]
17. Has the insurance company disclosed its accounting policy for sepa­
rate accounts, including:
a. The general nature of the contracts reporting in separate accounts,
including the extent and terms of minimum guarantees? ____  ____  ____
b. The basis of presentation for separate account assets and liabilities
and related separate account activity? ____  ____  ____
[SOP 03-1 par. 38 (ACC 10,870.38)]
18. Has the insurance company included a description of the liability val­
uation methods and assumptions used in estimating the liabilities for
additional insurance benefits and minimum guarantees? ____  ____  ____
[SOP 03-1 par. 38 (ACC 10,870.38)]
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C. Comparative Financial Statements
1. If comparative statements are presented, are the notes and other dis­
closures included in the financial statements of the preceding year(s) 
repeated, or at least referred to, to the extent that they continue to be
of significance? ____  ____  ____
[ARB 43 ch. 2A par. 2]
2. If changes occurred in the manner of or basis for presenting corre­
sponding items for two or more periods, are appropriate explanations
of the changes disclosed? ____  ____  ____
[ARB 43 ch. 2A par. 3, as amended by APB 20 and SFAS 154]
D. Accounting Changes and Error Corrections3
3 For issuers, as prescribed by the rules of the Securities and Exchange Commission (SEC), see the SEC issued Staff Accounting Bulletin 
(SAB) 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (Codifica­
tion of Staff Accounting Bulletins, Topic 1—Financial Statements, Section N—Considering the Effects of Prior Year Misstatements when 
Quantifying Misstatements in Current Year Financial Statements).
Change in Accounting Principle
1. Is the following disclosed in the fiscal period in which a change in 
accounting principle is made:
a. The nature of and reason for the change in accounting principle, 
including an explanation of why the newly adopted accounting
principle is preferable? ____  ____  ____
b. The method of applying the change, and:
(1) A description of the prior-period information that has been
retrospectively adjusted, if any? ____  ____  ____
(2) The effect of the change on income from continuing opera­
tions, net income (or other appropriate captions of changes in 
the applicable net assets or performance indicator), any other 
affected financial statement line item, and any affected per 
share amounts for the current period and any prior periods 
retrospectively adjusted? Presentation of the effect on finan­
cial statement subtotals and totals other than income from 
continuing operations and net income (or other appropriate 
captions of changes in the applicable net assets or perfor­
mance indicator) is not required. ____  ____  ____
(3) The cumulative effect of the change on retained earnings or 
other components of equity or net assets in the statement of 
financial position as of the beginning of the earliest period
presented? ____  ____  ____
(4) If retrospective application to all prior periods (paragraph 7
of SFAS 154) is impracticable, disclosure of the reasons there­
fore, and a description of the alternative method used to re­
port the change (paragraphs 8-9 of SFAS 154)? ------- ------- ------
c. If indirect effects of a change in accounting principle are recog­
nized:
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(1) A description of the indirect effects of a change in accounting 
principle, including the amounts that have been recognized 
in the current period, and the related per share amounts, if 
applicable?
(2) Unless impracticable, the amount of the total recognized in­
direct effects of the accounting change and the related per 
share amounts, if applicable, that are attributable to each 
prior period presented?
[SFAS 154 par. 17]
Note: Financial statements of subsequent periods need not repeat the dis­
closures required by this paragraph.
[SFAS 154 par. 17]
2. If a change in accounting principle has no material effect in the period 
of change but is reasonably certain to have a material effect in later 
periods, are the disclosures required by question la provided when­
ever the financial statements of the period of change are presented? 
[SFAS 154 par. 17]
3. In the fiscal year in which a new accounting principle is adopted, does 
financial information reported for interim periods after the date of 
adoption include disclosure of the effect of the change on income 
from continuing operations, net income (or other appropriate captions 
of changes in the applicable net assets or performance indicator), and 
related per share amounts, if applicable, for those post-change interim 
periods?
[SFAS 154 par. 18]
4. If a public company that regularly reports interim information makes 
an accounting change during the fourth quarter of its fiscal year and 
does not report the data specified by paragraph 30 of APB 28, Interim 
Financial Reporting (as amended), in a separate fourth-quarter report or 
in its annual report, does the entity include disclosure of the effects of 
the accounting change on interim-period results, as required by para­
graph 17 of SFAS 154, in a note to the annual financial statements for 
the fiscal year in which the change is made?
[SFAS 154 par. 16]
5. If an entity chooses to apply the consensus in EITF 06-2 as a change 
in accounting principle through a cumulative-effect adjustment to re­
tained earnings, does the entity disclose the cumulative effect of the 
change on retained earnings or other components of equity or net as­
sets in the statement of financial position?
[EITF 06-2 par. 7]
6. If an entity chooses to apply the consensus in EITF 06-2 as a change 
in accounting principle through retrospective application to all prior 
periods, does the entity include the recognition of:
a. The cumulative effect of the change to the new accounting prin­
ciple on periods prior to those presented reflected in the carrying 
amounts of assets and liabilities as of the beginning of the first 
period presented?
FSP §20,300.03
Yes No N/A
Financial Statements and Notes Checklist
Yes No
b. The cumulative effect of the change on retained earnings or on
other components of equity or net assets in the statement of finan­
cial position? ____  ___
c. Adjustments to financial statements for each individual prior pe­
riod presented to reflect the period-specific effects of applying the
new accounting principle? ____  ___
[EITF 06-2 par. 8]
7. If an entity chooses to apply the consensus reached in this EITF 06-2 
as a change in accounting principle through retrospective application 
to all prior periods, are the following disclosed:
a. A description of the prior-period information that has been ret­
rospectively adjusted? ____  ____
b. The effect of the change on income from continuing operations, 
net income (or other appropriate captions of changes in the appli­
cable net assets or performance indicator), any other affected fi­
nancial statement line item, and any affected per share amounts
for any prior periods retrospectively adjusted? ____  ____
c. The cumulative effect of the change on retained earnings or on
other components of equity or net assets in the statement of finan­
cial position as of the beginning of the earliest period presented? ____  ____
[EITF 06-2 par. 9]
8. If the scope of EITF 06-9 applies, does the entity make the disclosures
required pursuant to SFAS 154? ____  ____
[EITF 06-9 par. 5]
N/A
Note: EITF 06-11, "Accounting for Income Tax Benefits of Dividends on 
Share-Based Payment Awards," should be applied prospectively to the in­
come tax benefits of dividends on equity-classified employee share-based 
payment awards that are declared in fiscal years beginning after Septem­
ber 15, 2007.
9. Does the entity disclose the nature of any change in their accounting 
policy for income tax benefits of dividends on share-based payment 
awards resulting from the adoption of EITF 06-11?
[EITF 06-11 par. 7]
Change in Accounting Estimate
10. Is the effect on income from continuing operations, net income (or 
other appropriate captions of changes in the applicable net assets or 
performance indicator), and any related per share amounts of the cur­
rent period disclosed for a change in estimate that affects several fu­
ture periods, such as a change in service lives of depreciable assets? 
Disclosure of those effects is not necessary for estimates made each 
period in the ordinary course of accounting for items such as uncol­
lectible accounts or inventory obsolescence; however, if the effect of a 
change in the estimate is material, is it disclosed?
[SFAS 154 par. 22]
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11. When an entity effects a change in estimate by changing an account­
ing principle, are the disclosures required by preceding questions 1-3
made? ____  ____  ____
[SFAS 154 par. 22]
12. If a change in estimate does not have a material effect in the period of 
change but is reasonably certain to have a material effect in later per­
iods, is a description of that change in estimate disclosed whenever
the financial statements of the period of change are presented? ____  ____  ____
[SFAS 154 par. 22]
Change in the Reporting Entity
13. When there has been a change in the reporting entity, do the financial 
statements of the period of the change describe the nature of the
change and the reason for it? ____  ____  ____
a. Is the effect of the change on income before extraordinary items, 
net income (or other appropriate captions of changes in the appli­
cable net assets or performance indicator), OCI, and any related
per share amounts disclosed for all periods presented? ____  ____  ____
[SFAS 154 par. 24]
Note: Financial statements of subsequent periods need not repeat the dis­
closures required by this paragraph.
[SFAS 154 par. 24]
14. If a change in reporting entity does not have a material effect in the 
period of change but is reasonably certain to have a material effect in 
later periods, is the nature of and reason for the change disclosed 
whenever the financial statements of the period of change are pre­
sented?
[SFAS 154 par. 24]
Note: Paragraphs 51-58 of SFAS 141 describe the manner of reporting and 
the disclosures required for a business combination.
[SFAS 154 par. 24]
Correction of an Error in Previously Issued Financial Statements
15. When financial statements are restated to correct an error, does the 
entity disclose that its previously issued financial statements have 
been restated, along with a description of the nature of the error? 
Does the entity also disclose the following:
a. The effect of the correction on each financial statement line item 
and any per share amounts affected for each prior period pre­
sented?
b. The cumulative effect of the change on retained earnings or other 
appropriate components of equity or net assets in the statement 
of financial position, as of the beginning of the earliest period pre­
sented?
[SFAS 154 par. 26]
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16. In addition, does the entity make the disclosures of prior-period ad­
justments and restatements required by paragraph 26 of APB 9, Re­
porting the Results of Operations? ____  ____  ____
a. The resulting effects (both gross and net of applicable income tax) 
on the net income of prior periods in both the annual report for 
the year in which the adjustments are made? And in interim re­
ports issued during that year subsequent to the date of recording
the adjustments (recommended but not required)? ____  ____  ____
b. For single period financial statements, the effects of such restate­
ment on the balance of retained earnings at the beginning of the 
period and on the net income of the immediately preceding
period? ____  ____  ____
c. When financial statements for more than one period are pre­
sented, the effects for each of the periods included in the state­
ments? Such disclosures should include the amounts of income
tax applicable to the prior period adjustments. ____  ____  ____
[APB 9 par. 26; SFAS 154 par. 26]
Notes: Financial statements of subsequent periods need not repeat the dis­
closures required by this paragraph. An entity that issues interim financial 
statements shall provide the required disclosures in the financial state­
ments of both the interim period of the change and the annual period of 
the change.
[SFAS 154 par. 26]
EITF 06-6, "Debtor's Accounting for a Modification or Exchange of Con­
vertible Debt Instruments," applies to modifications or exchanges of debt 
instruments occurring in interim or annual reporting periods beginning 
after board ratification (November 29, 2006). The scope of this issue in­
cludes modifications and exchanges of debt instruments that (a) either add 
or eliminate an embedded conversion option or (b) affect the fair value of 
an existing embedded conversion option. Earlier application of this issue 
is permitted for modifications or exchanges of debt instruments in periods 
for which financial statements have not yet been issued. Retrospective ap­
plication to previously issued financial statements is not permitted. The 
guidance in this issue supersedes EITF 05-7, "Accounting for Modifica­
tions to Conversion Options Embedded in Debt Instruments and Related 
Issues."
17. For debt instruments that were converted (or extinguished) in prior 
periods that fall within the scope of EITF 00-27, "Application of Issue 
No. 98-5 to Certain Convertible Instruments," but are still presented 
in the financial statements, has the entity retrospectively applied 
SFAS 154 and recorded SFAS 109 temporary differences as adjust­
ments to paid-in-capital?
[EITF 05-8 par. 5-6]
18. Does an issuer disclose the following information for the period in 
which an embedded conversion option previously accounted for as a 
derivative under SFAS 133 that no longer meets the separation criteria 
under that statement:
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a. A description of the principal changes causing the embedded con­
version option to no longer require bifurcation under SFAS 133?
b. The amount of the liability for the conversion option reclassified 
to stockholders' equity?
[EITF 06-7 par. 6]
Investments in Real Estate Ventures
19. When accounting for a controlling interest in a partnership and apply­
ing the guidance of FSP SOP 78-9-1, Interaction of AICPA Statement of 
Position 78-9 and EITF Issue No. 04-5, pertaining to Transition Method 
A of FSP SOP 78-9-1, does the entity disclose in the year of adoption 
the effect on the opening balance sheet of adopting the new account­
ing principle?
[FSP SOP 78-9-1 par. 8]
20. When accounting for a controlling interest in a partnership and apply­
ing the guidance of FSP SOP 78-9-1 pertaining to Transition Method 
B of FSP SOP 78-9-1, if the entity applies the guidance in FSP SOP 78- 
9-1 through retrospective application, does it apply the guidance in 
paragraphs 7-8 and 10 of SFAS 154, and the disclosures required by 
paragraph 17 of SFAS 154?
[FSP SOP 78-9-1 par. 10]
E. Risks and Uncertainties
Notes: The guidance in FSP SOP 94-6-1, Terms of Loan Products That May 
Give Rise to a Concentration of Credit Risk, addresses the adequacy of disclo­
sures for all lending products (including both secured and unsecured 
loans) and the effect of changes in market or economic conditions on the 
adequacy of those disclosures. An entity shall provide the disclosures re­
quired by SFAS 107 for products that are determined to represent a con­
centration of credit risk in accordance with the guidance in question 1 of 
the FSP for all periods presented.
[FSP SOP 94-6-1 par. 17]
Question 2 of the FSP references only existing effective literature; there­
fore, no effective date or transition guidance is required.
[FSP SOP 94-6-1 par. 18]
The type and extent of information provided shall be determined by 
whether the entity is the originator, holder, investor, guarantor, or servicer 
and also by the significance of the loan product(s) to the reporting entity. 
[FSP SOP 94-6-1 par. 9 question 2]
1. Is a description of the major products and services the entity sells or 
provides and the principal markets, including the location of those
markets, disclosed? ____
[SOP 94-6 par. 10 (ACC 10,640.10); FSP SOP 94-6-1 par. 10]
2. If the company operates in more than one business, are the relative 
importance of its operations in each business and the basis for the
determination (for example, assets, revenues, or earnings) disclosed? ____
[SOP 94-6 par. 10 (ACC 10,640.10); FSP SOP 94-6-1 par. 10]
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3. Is an explanation that the preparation of financial statements in con­
formity with GAAP requires the use of management's estimates in­
cluded in the financial statements? ____  ____  ____
[SOP 94-6 par. 11 (ACC 10,640.11); FSP SOP 94-6-1 par. 10]
4. Is the disclosure regarding an estimate made when known informa­
tion available prior to the issuance of the financial statements indi­
cates that both of the following criteria have been met:
a. It is at least reasonably possible that the estimate of the effect on 
the financial statements of a condition, situation, or set of circum­
stances that existed at the date of the financial statements will 
change in the near term due to one or more future confirming
events? ____  ____  ____
b. The effect of the change will be material? ____  ____  ____
[SOP 94-6 par. 13 (ACC 10,640.13); FSP SOP 94-6-1 par. 10]
5. Does the disclosure in question 4, indicate the nature of the uncer­
tainty and include an indication that it is reasonably possible that a
change in estimate will occur in the near term?4 ____  ____  ____
4 If risk reduction techniques are used to mitigate losses or the uncertainty that may result from certain events, these disclosures are 
encouraged but not required.
* See note in part F, "Contingencies and Commitments," for an important notice regarding a proposed SFAS titled Disclosure of Certain 
Loss Contingencies—an amendment of FASB Statements No. 5 and 141(R) that would replace the disclosure requirements in SFAS 5, Account­
ing for Contingencies. If finalized and issued as currently drafted, this statement would change the requirements of this question and 
would be effective for annual financial statements issued for fiscal years ending after December 15, 2008, and interim and annual periods 
in subsequent fiscal years. This checklist has not been updated to include the presentation and disclosure requirements of this proposed 
statement. Readers may continue to check the status of this proposed statement on the FASB Web site at www.fasb.org.
[SOP 94-6 par. 14 (ACC 10,640.14); FSP SOP 94-6-1 par. 10]
6. If the estimate in question 4 involves a loss contingency covered by
SFAS 5, do disclosures include an estimate of the possible loss or
range of loss, or state that such an estimate cannot be made?*  ____  ____  ____
[SOP 94-6 par. 13-14 (ACC 10,640.13-14); FSP SOP 94-6-1 par. 10-11]
7. Is disclosure of the concentrations described in paragraph 22 of SOP
94-6, Disclosure of Certain Significant Risks and Uncertainties (AICPA,
Technical Practice Aids, ACC sec. 10,640 par. .22), made if, based on 
information known to management before the financial statements 
are issued, all of the following criteria are met:
a. The concentration exists at the date of the financial statements? ____  ____  ____
b. The concentration makes the enterprise vulnerable to the risk of a
near-term severe impact? ____  ____  ____
c. It is at least reasonably possible that the events that could cause
the severe impact will occur in the near term? ____  ____  ____
[SOP 94-6 par. 21-22 (ACC 10,640.21-.22); FSP SOP 94-6-1 par.
10-11]
8. For those concentrations of labor subject to collective bargaining 
agreements and concentrations of operations located outside of the 
company's home country that meet the criteria of paragraph 21 of 
SOP 94-6, are the following disclosed:
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a. The percentage of labor force covered by a collective agreement
and the percentage of the labor force covered by a collective bar­
gaining agreement that will expire in one year? ____  ____  ____
b. The carrying amounts of net assets and the geographic areas in
which they are located for operations located outside the com­
pany's home country? ____  ____  ____
[SOP 94-6 par. 24 (ACC 10,640.24); FSP SOP 94-6-1 par. 10-11]
9. Have the optional disclosures in paragraphs 14-15 of SOP 94-6 been
considered? ____  ____  ____
[SOP 94-6 par. 14-15 (ACC 10,640.14-.15)]
10. Are major categories of loans, including unusual risk concentrations 
disclosed, such as:
a. Commercial, financial, and agricultural? ____  ____  ____
b. Real estate construction? ____  ____  ____
c. Real estate mortgage? ____  ____  ____
d. Installment loans to individuals? ____  ____  ____
e. Lease financing? ____  ____  ____
f. Foreign? ____  ____  ____
g. Loans in process? ____  ____  ____
h. Other? ____  ____  ____
[FSP SOP 94-6-1 par. 11]
11. Are major concentrations of loan products whose contractual features 
may increase credit risk disclosed, such as:
a. Negative amortization? ____  ____  ____
b. Loans with a high loan-to-value ratio? ____  ____  ____
c. Multiple loans on the same collateral that, when combined, result
in a high loan-to-value ratio? ____  ____  ____
d. Option adjustable rate mortgages or similar products that may ex­
pose the borrower to future increases in repayments? ____  ____  ____
e. An initial interest rate that is below the market interest rate for
the initial period of a loan term and that may increase signifi­
cantly when that period ends? ____  ____  ____
f. Interest only loans?
[FSP SOP 94-6-1 par. 2 and 7; SFAS 107 par. 15A, as amended by ____  ____  ____
SFAS 133]
12. Are foreign loans, foreign nonaccrual loans, and foreign operations, if
any of these foreign activities exceed a material percentage of activi­
ties, disclosed? ____  ____  ____
[FSP SOP 94-6-1 par. 7; SFAS 107 par. 15A, as amended by SFAS 133]
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F. Contingencies and Commitments (See also part Z, "Guarantees.")
Notes: In June 2008, FASB issued a proposed SFAS titled Disclosure of Cer­
tain Loss Contingencies—an amendment of FASB Statements No. 5 and 141(R), 
that would replace the disclosure requirements in SFAS 5 for loss contin­
gencies that are recognized as liabilities in a statement of financial position 
and for unrecognized loss contingencies that would be recognized as lia­
bilities if the criteria for recognition in paragraph 8 of SFAS 5 were met. 
Loss contingencies that are (or would be) recognized as asset impairments 
would continue to be disclosed in accordance with SFAS 5. This proposed 
statement would also amend SFAS 141(R) to require the disclosures in­
cluded in this statement for loss contingencies recognized in a business 
combination. This proposed statement would not change the recognition 
and measurement guidance for loss contingencies contained in SFAS 5 and 
in SFAS 141(R).
On September 24, 2008, FASB decided on a plan for redeliberations and 
directed the staff to prepare an alternative model that will attempt to ad­
dress the concerns that certain constituents raised about this proposed 
statement. This alternative model will be field tested along with the model 
in the exposure draft. The board also decided that any final statement on 
this topic will be effective no sooner than for fiscal years ending after De­
cember 15, 2009.
This checklist has not been updated to include the presentation and disclo­
sure requirements of this proposed statement. Readers may continue to 
check the status of this proposed statement on the FASB Web site at 
www.fasb.org.
1. Is disclosure made of the nature of estimated loss contingencies ac­
crued when (a) information available prior to issuance of the financial 
statements indicates that it is probable that an asset has been impaired 
or a liability incurred at the date of the financial statements and (b) 
the amount of loss can be reasonably estimated?
2. If necessary to keep the financial statements from being misleading, 
are the amounts of contingencies accrued as described in question 1 
disclosed?
[SFAS 5 par. 9]
3. For loss contingencies not accrued, do disclosures indicate:
a. Nature of the contingency?
b. Estimate of possible loss or range of loss, or a statement that such 
estimate cannot be made?
[SFAS 5 par. 10]
4. Are the nature and amount of guarantees disclosed (for example, 
guarantees of indebtedness of others, guarantees to repurchase receiv­
ables [or, in some cases, the related property] that have been sold or 
otherwise assigned) even though the possibility of loss may be re­
mote?
[SFAS 5 par. 12; FIN 45 par. 13; EITF 85-20]
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5. Are gain contingencies adequately disclosed with care to avoid any 
misleading implications about likelihood of realization?
[SFAS 5 par. 17]
6. Is there adequate disclosure of commitments, such as those for plant 
acquisition or an obligation to reduce debts, maintain working capital, 
or restrict dividends, for long term leases, for assets pledged as secu­
rity for loans, and unused letters of credit?
7. For long-term unconditional purchase obligations that are not re­
corded in the purchaser's balance sheet, are the following disclosed:
a. Nature and term of the obligations?
b. Amount of the fixed and determinable portion of the obligations 
as of the date of the latest balance sheet presented in the aggre­
gate and, if determinable, for each of the next five years?
c. Nature of any variable components of the obligation?
d. Amounts of purchases under the obligations for each year for 
which an income statement is presented?
[SFAS 5 par. 18-19, as amended by SFAS 111]
8. If the company as guarantor "lends" its creditworthiness to another 
party (borrower) for a fee, is the guarantee disclosed in a note, if ma­
terial?
[EITF 85-20]
9. If exposure to loss exists in excess of the amount accrued for a loss 
contingency, do disclosures include the excess amount or state that no 
estimate is possible?
[SFAS 5 par. 10]
10. Is disclosure made if a subsidiary entity has guaranteed parent com­
pany debt?
[SFAS 57 par. 1-2, as amended by SFAS 96 and SFAS 109]
11. When, after considering management's plans, the auditor concludes 
there is substantial doubt about the entity's ability to continue as a 
going concern for a reasonable period of time, is adequate disclosure 
of the situation made in the financial statements?
[AU 341.10]
12. Is a description of contingencies resulting from the September 11 
events that have not yet been recognized in the financial statements 
but that are reasonably expected to impact the entity's financial state­
ments in the near term disclosed in the notes to the financial state­
ments in all periods affected by the September 11, 2001 attacks?
[EITF 01-10]
Note: SFAS 5 states that it does not discourage disclosure of uninsured 
risks in appropriate circumstances. It is recommended that, though oper­
ational criteria have not been developed for such disclosures as stated in 
SFAS 5, they should be encouraged rather than simply not discouraged.
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13. For publicly held entities and entities with public accountability, such 
as governments, are circumstances disclosed in which (Encouraged, 
but not required):
a. They are exposed to risks of future material loss related to:
(1) Torts? ____  ____  ____
(2) Theft of, damage to, expropriation of, or destruction of assets? ____  ____  ____
(3) Business interruption? ____  ____  ____
(4) Errors or omissions? ____  ____  ____
(5) Injuries to employees? ____  ____  ____
(6) Acts of God? ____  ____  ____
b. Those risks have not been transferred to unrelated third parties
through insurance? (Encouraged, but not required.) ____  ____  ____
[EITF 03-8]
14. In considering those matters to be disclosed that relate to certain un­
insured risks of future material loss as described in EITF 03-8, "Ac­
counting for Claims-Made Insurance and Retroactive Insurance Con­
tracts by the Insured Entity," has the entity considered the following:
a. The actual and potential effects of losses from such risks on the 
entities historical or planned operations, including exposure to 
losses from claims, curtailment of research and development or 
manufacturing, or contraction or cessation of other activities, such
as discontinuance of a product line? ____  ____  ____
b. Comparison of current insurance coverage by major categories of 
risk to coverage in prior periods, without necessarily quantifying
such coverage or change in coverage? ____  ____  ____
c. Recent claims experience? ____  ____  ____
d. A description of the reporting entity's risk management pro­
grams? ____  ____  ____
[EITF 03-8]
Notes: In May 2008, the FASB issued SFAS 163, Accounting for Financial 
Guarantee Insurance Contracts—an interpretation of FASB Statement No. 60. 
The scope of SFAS 163 is limited to financial guarantee insurance and re­
insurance contracts issued by enterprises included in SFAS 60. This state­
ment does not apply to enterprises excluded from SFAS 60, to financial 
guarantee insurance contracts that are accounted for as derivative instru­
ments within the scope of SFAS 133 and to some insurance contracts that 
are similar to financial guarantee insurance contracts issued by insurance 
enterprises (such as mortgage guaranty insurance and credit insurance on 
trade receivables). The changes to current practice are around premium 
revenue, claim liabilities, and disclosure requirements. The provisions of 
SFAS 163 shall be applied on a contract-by-contract basis.
SFAS 163 is effective for financial statements issued for fiscal years begin­
ning after December 15, 2008, and all interim periods within those fiscal 
years, except for some disclosures about the insurance enterprise's risk-
(continued)
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management activities. This statement requires that disclosures about the 
risk-management activities of the insurance enterprise be effective for the 
first period (including interim periods) beginning after issuance of this 
statement. Except for those disclosures, earlier application is not permit­
ted.
The statement notes that an insurance enterprise shall disclose information 
that enables users of its financial statements to understand the factors af­
fecting the present and future recognition and measurement of financial 
guarantee insurance contracts. Given the immediate effectiveness of the 
disclosure requirements, this checklist has been updated to include the re­
quired disclosures in SFAS 163.
Readers are encouraged to review the full SFAS 163 statement before ap­
plying its guidance, which can be found on the FASB Web site at 
www.fasb.org.
15. In each annual period (and in an interim period if a significant change 
has occurred in that interim period), for financial guarantee insurance 
contracts where premiums are received as payments over the period 
of the contract, rather than at inception, has the insurance enterprise 
disclosed:
a. The premium receivable and the unearned premium revenue as 
of the date(s) of the statement of financial position and the line 
item in the statement of financial position where those amounts 
are reported (if not presented separately)?
b. The amount of accretion on the premium receivable and the line 
item in the statement of income where that amount is reported (if 
not presented separately)?
c. The weighted-average risk-free rate used to discount the premi­
ums expected to be collected and the weighted-average period of 
the premium receivable?
[SFAS 163 par. 30a]
16. In each annual period (and in an interim period if a significant change 
has occurred in that interim period) has the insurance enterprise dis­
closed a schedule of premiums expected to be collected related to the 
premium receivable which details the following:
a. The four quarters of the subsequent annual period and each of the 
next four annual periods?
b. The remaining periods aggregated in five-year increments?
[SFAS 163 par. 30b]
17. In each annual period (and in an interim period if a significant change 
has occurred in that interim period) has the insurance enterprise dis­
closed a rollforward of the premium receivable for the period, includ­
ing:
a. The beginning premium receivable?
b. Premium payments received?
c. New business written?
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d. Adjustments to the premium receivable, including at a minimum:
adjustments for changes in the period of a financial guarantee in­
surance contract and an explanation of why those adjustments oc­
curred, accretion of the premium receivable discount, and other 
adjustments with explanations provided for significant or recur­
ring adjustments? ------- ------- ------
e. The ending premium receivable? ____  ____  ____
[SFAS 163 par. 30c]
18. In each annual period (and in an interim period if a significant change 
has occurred in that interim period), for premium revenue recognition 
that has been accelerated, has the insurance enterprise disclosed the
amount and reasons for acceleration? ------- ------- ------
[SFAS 163 par. 30d]
19. In each annual period (and in an interim period if a significant change 
has occurred in that interim period) has the insurance enterprise dis­
closed a schedule of the future expected premium revenue as of the 
latest date of the statement of financial position detailing the follow­
ing:
a. The four quarters of the subsequent annual period and each of the
next four annual periods? ------- ------- ------
b. The remaining periods aggregated in five-year increments? ____  ____  ____
[SFAS 163 par. 30e]
20. In each annual period (and in an interim period if a significant change 
has occurred in that interim period) has the insurance enterprise dis­
closed the following for the claim liability:
a. The weighted-average risk-free rate used to discount the claim li­
ability? ------- ------- ------
b. The significant component(s) of the change in the claim liability
for the period (such as changes in the discount rate, the accretion 
of the discount on the claim liability, changes in the timing, 
changes in the likelihood of default), the amount relating to that 
component(s), and the line item in the statement of income where 
that amount or amounts are reported (unless separately dis­
closed)? ------- ------- ------
[SFAS 163 par. 30f]
21. In each annual period (and in an interim period if a significant change 
has occurred in that interim period) has the insurance enterprise dis­
closed a description of the insurance enterprise's risk-management ac­
tivities used to track and monitor deteriorating insured financial ob­
ligation, including the following:
a. A description of each grouping or category used to track and
monitor deteriorating insured financial obligations? ------- ------- ------
b. The insurance enterprise's policies for placing an insured financial
obligation in, and monitoring, each grouping or category? ------- ------- ------
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c. The insurance enterprise's policies for avoiding or mitigating 
claim liabilities, the related expense and liability reported during 
the period for those risk mitigation activities (not including rein­
surance), and a description of where that expense and that liabil­
ity are reported in the statement of income and the statement of
financial position, respectively? ____
[SFAS 163 par. 30g]
22. In each annual and interim period related to the claim liability, has 
the insurance enterprise disclosed a schedule of insured financial ob­
ligations at the end of each interim period detailing, at a minimum, 
the following for each category or grouping of these financial obliga­
tions:
a. Number of issued and outstanding financial guarantee insurance
contracts? ____
b. Remaining weighted-average contract period? ____
c. Insured contractual payments outstanding, segregating principal
and interest? ____
d. Gross claim liability? ____
e. Gross potential recoveries? ____
f. Discount, net (both claim liability and potential recoveries)? ____
g. Net claim liability? ____
h. Reinsurance recoverables? ____
i. Unearned premium revenue? ____
[SFAS 163 par. 31a]
G. Environmental Remediation Liabilities
Note: SOP 96-1, Environmental Remediation Liabilities (AICPA, Technical 
Practice Aids, ACC sec. 10,680), does not provide guidance on recognizing 
liabilities of insurance companies for unpaid claims.
1. Is there disclosure of the following accounting policies:
a. Whether accruals for environmental remediation liabilities are 
measured on a discounted basis?
b. The policy concerning the timing of recognition of recoveries? 
(Encouraged, but not required.)
[SOP 96-1 par. .152-.153 (ACC 10,680.152-.153)]
2. Do the financial statements disclose the event, situation, or set of cir­
cumstances that triggered recognition of loss contingencies that arose 
out of the reporting entity's environmental remediation-related obli­
gations? (Encouraged, but not required.)
[SOP 96-1 par. .153 (ACC 10,680.153)]
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Recognized Losses and Recoveries of Losses, and Reasonably Possible
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3. With respect to recorded accruals for environmental remediation loss 
contingencies and assets for third-party recoveries related to environ­
mental remediation obligations, are the following disclosed:
a. The nature of the accruals, if such disclosure is necessary for the 
financial statements not to be misleading, and, in situations where 
disclosure of the nature of the accruals is necessary, the total 
amount accrued for the remediation obligation, if such disclosure
is also necessary for the financial statements not to be misleading? ____  ___
b. If any portion of the accrued obligation is discounted, the undis­
counted amount of the obligation and the discount rate used in
the present-value determinations? ____  ___
c. If the criteria of SOP 94-6 (it is at least reasonably possible that an
estimate of the effect on the financial statements of a matter that 
existed at the balance sheet date will change in the near term and 
the effect of the change would be material to financial statements) 
are met with respect to the accrued obligation or to any recog­
nized asset for third-party recoveries, an indication that it is at 
least reasonably possible that a change in the estimate of the ob­
ligation or of the asset will occur in the near term? ____  ___
[SOP 96-1 par. .161 (ACC 10,680.161)]
4. With respect to reasonably possible loss contingencies, including rea­
sonably possible loss exposures in excess of the amount accrued, are 
the following disclosed:
a. The nature of the reasonably possible loss contingency, that is, a 
description of the reasonably possible remediation obligation, and 
an estimate of the possible loss exposure or the fact that such an
estimate cannot be made? ____  ___
b. If the criteria of SOP 94-6 are met with respect to estimated loss 
(or gain) contingencies, an indication that it is at least reasonably
possible that a change in the estimate will occur in the near term? ____  ____
c. The estimated time frame of disbursements for recorded amounts
if expenditures are expected to continue over the long term? (En­
couraged, but not required.) ____  ____
d. The estimated time frame for realization of recognized probable
recoveries, if realization is not expected in the near term? (En­
couraged, but not required.) ____  ____
e. If the criteria of SOP 94-6 are met with respect to the accrued ob­
ligation, to any recognized asset for third-party recoveries, or to 
reasonably possible loss exposures or disclosed gain contingen­
cies, the factors that cause the estimate to be sensitive to change?
(Encouraged, but not required.) ------ -----
f. If an estimate of the probable or reasonably possible loss or range
of loss cannot be made, the reasons why it cannot be made? (En­
couraged, but not required.) ------ -----
N/A
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g. If information about the reasonably possible loss or the recog­
nized and additional reasonably possible loss for an environmen­
tal remediation obligation related to an individual site is relevant 
to an understanding of the financial position, cash flows, or re­
sults of operations of the entity, the following with respect to the 
site: (Encouraged, but not required.)
(1) The total amount accrued for the site? ____
(2) The nature of any reasonably possible loss contingency or ad­
ditional loss, and an estimate of the possible loss or the fact 
that an estimate cannot be made and the reasons why it can­
not be made? ____
(3) Whether other potentially responsible parties are involved
and the entity's estimated share of the obligation? ____
(4) The status of regulatory proceedings? ____
(5) The estimated time frame for resolution of the contingency? ____
[SOP 96-1 par. .162-.163 (ACC 10,680.162-.163)]
Probable But Not Reasonably Estimable Losses
5. If the reporting entity's probable but not reasonably estimable envi­
ronmental remediation obligations may be material, are the nature of 
the probable contingency (that is, a description of the remediation ob­
ligation) and the fact that a reasonable estimate cannot currently be
made disclosed? ____
[SOP 96-1 par. .166 (ACC 10,680.166)]
6. Is the estimated time frame for resolution of the uncertainty as to the
amount of the loss disclosed? (Encouraged, but not required.) ____
[SOP 96-1 par. .166 (ACC 10,680.166)]
Environmental Remediation Costs Recognized Currently
7. Is the amount of environmental remediation costs recognized in the 
income statement disclosed in the following detail: (Encouraged, but 
not required.)
a. The amount recognized for environmental remediation loss con­
tingencies in each period? ____
b. The amount of any recovery from third parties that is credited to
environmental remediation costs in each period? ____
c. The income statement caption in which environmental remedia­
tion costs and credits are included? ____
[SOP 96-1 par. .170 (ACC 10,680.170)]
Other Matters
8. Do the financial statements include a contingency conclusion that ad­
dresses the estimated total unrecognized exposure to environmental
remediation and other loss contingencies? (Optional.) ____
[SOP 96-1 par. .171 (ACC 10,680.171)]
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9. Is there a description of the general applicability and impact of envi­
ronmental laws and regulations upon their business and how the ex­
istence of such laws and regulations may give rise to loss contingen­
cies for future environmental remediation? (Optional.) ____  ____  ____
[SOP 96-1 par. .172 (ACC 10,680.172)]
10. Are applicable disclosures about environmental obligations (and re­
coveries) related to the attacks of September 11 disclosed in the notes 
to the financial statements in all periods affected by the September 11,
200,1 attacks, pursuant to SOP 96-1? ____  ____  ____
[EITF 01-10]
H. Related-Party Transactions and Economic Dependency
1. For material related-party transactions, do disclosures include:
a. The nature of the relationship(s) involved (for example, parent,
subsidiary, and affiliate companies, officers, and stockholders)? ____  ____  ____
b. A description of the transactions, including transactions to which 
no amounts or nominal amounts were ascribed, for each of the 
periods for which an income statement is presented, and such 
other information deemed necessary to an understanding of the
effects of the transactions on the financial statements? ____  ____  ____
c. The dollar amounts of transactions for each of the periods for 
which an income statement is presented and the effects of any 
change in the method of establishing the terms from that used in
the preceding period? ____  ____  ____
d. Amounts due from or to related parties as of the date of each bal­
ance sheet presented and, if not otherwise apparent, the terms
and manner of settlement? ____  ____  ____
[SFAS 57 par. 2]
2. Is the nature of a controlled relationship disclosed, even though there
are no transactions between the enterprises, if the reporting company 
and one or more other enterprises are under common ownership or 
management control, and the existence of that control could result in 
operating results or financial position of the reporting company being 
significantly different from those that would have resulted if the com­
panies were autonomous? ____  ____  ____
[SFAS 57 par. 4]
I. Employee Stock Ownership Plans
1. If an employer sponsors an employee stock ownership plan (ESOP), 
do the employer's disclosures include:
a. A description of the plan, the basis for determining contributions, 
including the employee groups covered, and the nature and effect 
of significant matters affecting comparability of information for
all periods presented? ------- ------- ------
(1) For leveraged ESOPs and pension reversion ESOPs, does the 
description include the basis for releasing shares and how
dividends on allocated and unallocated shares are used? ------- ------- ------
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b. A description of the accounting policies followed for ESOP trans­
actions, including the method of measuring compensation, the 
classification of dividends on ESOP shares, and the treatment of
ESOP shares for EPS computations? ____  ____  ____
(1) If the entity has both old ESOP shares for which it does not 
adopt the guidance in SOP 93-6, Employers' Accounting for Em­
ployee Stock Ownership Plans (AICPA, Technical Practice Aids,
ACC sec. 10,580), and new ESOP shares for which the guid­
ance in SOP 93-6 is required, are the accounting policies for
both blocks of shares disclosed? ____  ____  ____
c. The amount of compensation cost recognized during the period? ____  ____  ____
d. The number of allocated shares, committed-to-be-released shares,
and suspense shares held by the ESOP at the balance sheet date? ____  ____  ____
(1) If the entity has both old ESOP shares for which it does not 
adopt the guidance in SOP 93-6 and new ESOP shares for 
which the guidance in SOP 93-6 is required, is the above dis­
closure made separately for both blocks of shares? ____  ____  ____
e. The fair value of unearned ESOP shares at the balance sheet date
for shares accounted for under SOP 93-6?5 ____  ____  ____
5 This disclosure need not be made for old ESOP shares for which the entity does not apply the guidance in SOP 93-6, Employers’ 
Accounting for Employee Stock Ownership Plans (AICPA, Technical Practice Aids, ACC sec. 10,580).
6 Employers may wish to disclose additional information about the obligation, particularly information about the timing of payments. 
[SOP 93-6 par. 95 (ACC 10,580.95)]
f. The existence and nature of any repurchase obligation, including
disclosure of the fair value of the shares allocated as of the bal­
ance sheet date, which are subject to a repurchase obligation?6 ____  ____  ____
[SOP 93-6 par. 53 (ACC 10,580.53)]
2. Are all the items listed in question 1 disclosed even if the employer 
with an ESOP does not adopt SOP 93-6 for shares held by the ESOP
on December 31, 1992? ____  ____  ____
[SOP 93-6 par. 55 (ACC 10,580.55)]
3. For leveraged ESOPs and for nonleveraged ESOPs where the assets 
from the pension plan are used by the ESOP to purchase shares, when 
the employer reports the issuance of shares or the sale of treasury 
shares to the ESOP, is the charge to unearned ESOP shares presented
as a separate item in the balance sheet as a contra-equity account? ____  ____  ____
[SOP 93-6 par. 13 and 46 (ACC 10,580.13 and .46)]
4. If the employer sponsors an ESOP with an indirect loan, is the outside
loan reported as a liability and the receivable from the ESOP not re­
ported on the employer's balance sheet? ____  ____  ____
[SOP 93-6 par. 26 (ACC 10,580.26)]
5. If the employer sponsors an ESOP with an employer loan, is the 
ESOP's note payable and the employer's note receivable from the
ESOP not reported in the employer's balance sheet? ____  ____  ____
[SOP 93-6 par. 27 (ACC 10,580.27)]
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6. If SOP 76-3, Accounting Practices for Certain Employee Stock Ownership 
Plans (AICPA, Technical Practice Aids, ACC sec. 10,130) is still being 
followed for ESOP shares purchased before December 31, 1992 and if 
the reporting entity has guaranteed the debt of an ESOP or made a 
commitment to make future contributions to the ESOP sufficient to 
meet debt service requirements, are the compensation element and 
the interest element of annual contributions reported separately, and 
are the interest rate and debt terms disclosed in the notes to the finan­
cial statements? ____  ____  ____
[SOP 76-3 par. 10 (ACC 10,130.10)]
J. Employers' Disclosures for Defined Benefit Pension and Other Post­
retirement Plans7
7 EITF 03-4, "Determining the Classification and Benefit Attribution Method for a 'Cash Balance' Pension Plan," states that a cash 
balance plan should be considered a defined benefit plan.
Note: In September 2006, FASB issued SFAS 158, Employers' Accounting for 
Defined Benefit Pension and Other Postretirement Plans—an amendment of 
FASB Statements No. 87, 88, 106, and 132(R). SFAS 158 requires, among 
other provisions, an employer to recognize the overfunded or under­
funded status of a defined benefit postretirement plan (other than a mul­
tiemployer plan) as an asset or liability in its statement of financial posi­
tion and to recognize changes in that funded status in the year in which 
the changes occur through comprehensive income. This statement also re­
quires an employer to measure the funded status of a plan as of the date 
of its year-end statement of financial position, with limited exceptions.
Effective Dates for Recognition and Related Disclosure Provisions
The required date of adoption of the recognition and disclosure provisions 
of SFAS 158 differs for an employer that is an issuer of publicly traded 
equity securities (as defined) and an employer that is not. Readers should 
refer to the complete statement for any of the conditions that need to be 
met for an employer to be deemed to have publicly traded equity securi­
ties.
An employer with publicly traded equity securities is required to initially 
recognize the funded status of a defined benefit postretirement plan (see 
paragraph 4 of SFAS 158) and to provide the required disclosures (see par­
agraph 7 of SFAS 158) as of the end of the fiscal year ending after Decem­
ber 15, 2006.
An employer without publicly traded equity securities is required to rec­
ognize the funded status of a defined benefit postretirement plan (see par­
agraphs 4 and 8 of SFAS 158) and to provide the required disclosures (see 
paragraphs 7 and 10 of SFAS 158) as of the end of the fiscal year ending 
after June 15, 2007.
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However, an employer without publicly traded equity securities is re­
quired to disclose additional information in the notes to financial state­
ments for a fiscal year ending after December 15, 2006, but before June 16, 
2007, unless it has applied the recognition provisions of the statement in 
preparing those financial statements. See the following question 2 for 
those additional disclosure requirements.
The requirement to measure plan assets and benefit obligations as of the 
date of the employer's fiscal year-end statement of financial position (see 
paragraphs 5-6, and 9 of SFAS 158) is effective for fiscal years ending after 
December 15, 2008. If in the last quarter of the preceding fiscal year an 
employer enters into a transaction that results in a settlement or experi­
ences an event that causes a curtailment of the plan, the related gain or 
loss pursuant to SFAS 88, Employers' Accounting for Settlements and Curtail­
ments of Defined Benefit Pension Plans and for Termination Benefits, or 106, 
Employers' Accounting for Postretirement Benefits Other Than Pensions, is re­
quired to be recognized in earnings or changes in unrestricted net assets 
of that quarter. The requirement in paragraphs 5(k) and 8(j) of SFAS 
132(R), Employers' Disclosures about Pensions and Other Postretirement Bene­
fits—an amendment of FASB Statements No. 87, 88, and 106, to disclose the 
measurement date is eliminated, effective in the year the employer initially 
adopts the measurement date provisions of this statement.
Earlier application of the recognition or measurement date provisions is 
encouraged; however, early application must be for all of an employer's 
benefit plans. Retrospective application of the statement is not permitted. 
This checklist has been updated to include the presentation and disclosure 
requirements of SFAS 158. Readers can refer to the full text of SFAS 158 at 
www.fasb.org.
1. Does a business entity that sponsors one or more benefit plans dis­
close the following information in the notes to its annual financial 
statements, separately for pension plans and other postretirement 
benefit plans:
a. For each annual statement of income presented, the amounts rec­
ognized in OCI, showing separately the net gain or loss and net 
prior service cost or credit. Those amounts shall be separated into 
amounts arising during the period and reclassification adjust­
ments of OCI as a result of being recognized as components of net 
periodic benefit cost for the period?
b. For each annual statement of income presented, the net transition 
asset or obligation recognized as a reclassification adjustment of 
OCI as a result of being recognized as a component of net peri­
odic benefit cost for the period?
c. For each annual statement of financial position presented, the 
amounts in accumulated OCI that have not yet been recognized 
as components of net periodic benefit cost, showing separately the 
net gain or loss, net prior service cost or credit, and net transition 
asset or obligation?
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d. The amounts in accumulated OCI expected to be recognized as 
components of net periodic benefit cost over the fiscal year that 
follows the most recent annual statement of financial position pre­
sented, showing separately the net gain or loss, net prior service
cost or credit, and net transition asset or obligation? ____  ___
e. The amount and timing of any plan assets expected to be returned 
to the business entity during the 12-month period, or operating 
cycle if longer, that follows the most recent annual statement of
financial position presented? ____  ___
[SFAS 158 par. 7]
2. Does an employer without publicly traded equity securities disclose 
the following information in the notes to the financial statements for 
a fiscal year ending after December 15, 2006, but before June 16, 2007, 
unless it has applied the recognition provisions of the statement in 
preparing those financial statements:
a. A brief description of the provisions of the statement? ____  ___
b. The date that adoption is required? ____  ___
c. The date the employer plans to adopt the recognition provisions
of the statement, if earlier? ____  ___
[SFAS 158 par. 14]
Disclosures Required in the Year of Application
3. In the year that the recognition provisions of SFAS 158 are initially 
applied, does the employer disclose, in the notes to the annual finan­
cial statements, the incremental effect of applying this statement on
individual line items in the year-end statement of financial position? ____  ___
[SFAS 158 par. 20]
4. In the year that the measurement date provisions of SFAS 158 are in­
itially applied, does a business entity disclose the separate adjust­
ments of retained earnings and accumulated OCI from applying the
statement? ____  ___
[SFAS 158 par. 21]
Note: The disclosures specified by paragraphs 17-18 of SFAS 154 are not 
required.
[SFAS 158 par. 22]
5. If an employer sponsors one or more defined benefit pension plans or 
one or more defined benefit postretirement plans, has the following 
information been provided separately for pension plans and other 
postretirement benefit plans:
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a. A reconciliation of beginning and ending balances of the benefit
obligation8 showing separately, if applicable, the effects during 
the period attributable to each of the following: service cost, inter­
est cost, contributions by plan participants, actuarial gains and 
losses, foreign currency exchange rate changes,9 benefits paid, 
plan amendments, business combinations, divestitures, curtail­
ments, settlements, and special termination benefits? ____  ____  ____
8 For defined benefit pension plans, the benefit obligation is the projected benefit obligation. For defined postretirement plans, the 
benefit obligation is the accumulated postretirement benefit obligation.
9 The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation 
whose functional currency is not the reporting currency pursuant to SFAS 52, Foreign Currency Translation.
10 Refer to footnote 9.
[SFAS 132(R) par. 5a, as amended by SFAS 158]
b. A reconciliation of beginning and ending balances of the fair
value of plan assets showing separately, if applicable, the effects 
during the period attributable to each of the following: actual re­
turn on plan assets, foreign currency exchange rate changes,10 
contributions by the employer, contributions by plan participants, 
benefits paid, business combinations, divestitures, and settle­
ments? ____  ____  ____
[SFAS 132(R) par. 5b, as amended by SFAS 158]
c. The funded status of the plans and the amounts recognized in the 
statement of financial position showing separately the assets and
current and noncurrent liabilities recognized? ____  ____  ____
[SFAS 132(R) par. 5c, as amended by SFAS 158]
d. Information about plan assets:
(1) For each major category of plan assets, which shall include, 
but is not limited to, equity securities, debt securities, real es­
tate, and all other assets, the percentage of the fair value of 
total plan assets held as of the measurement date used for
each statement of financial position presented? ____  ____  ____
(2) A narrative description of investment policies and strategies, 
including target allocation percentages or range of percent­
ages for each major category of plan assets presented on a 
weighted-average basis as of the measurement date(s) of the 
latest statement of financial position presented, if applicable, 
and other factors that are pertinent to an understanding of the 
policies or strategies such as investment goals, risk manage­
ment practices, permitted and prohibited investments includ­
ing the use of derivatives, diversification, and the relationship
between plan assets and benefit obligations? ____  ____  ____
(3) A narrative description of the basis used to determine the 
overall expected long-term rate-of-retum-on-assets assump­
tion, such as the general approach used, the extent to which 
the overall rate-of-retum-on-assets assumption was based on 
historical returns, the extent to which adjustments were made 
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined? ____  ____  ____
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(4) Disclosure of additional asset categories and additional infor­
mation about specific assets within a category is encouraged 
if that information is expected to be useful in understanding 
the risks associated with each asset category and the overall
expected long-term rate of return on assets? ____  ____  ____
[SFAS 132(R) par. 5d, as amended by SFAS 158]
e. For defined benefit pension plans, the accumulated benefit obli­
gation? ------- ------- ------
[SFAS 132(R) par. 5e, as amended by SFAS 158]
f. The benefits (as of the date of the latest statement of financial po­
sition presented) expected to be paid in each of the next five fiscal 
years, and in the aggregate for the five fiscal years thereafter? The 
expected benefits should be estimated based on the same assump­
tions used to measure the company's benefit obligation at the end 
of the year and should include benefits attributable to estimated
future employee service. ____  ____  ____
[SFAS 132(R) par. 5f, as amended by SFAS 158]
g. The employer's best estimate, as soon as it can reasonably be de­
termined, of contributions expected to be paid to the plan during 
the next fiscal year beginning after the date of the latest statement 
of financial position presented. Estimated contributions may be 
presented in the aggregate combining (1) contributions required 
by funding regulations or laws, (2) discretionary contributions,
and (3) noncash contributions? ____  ____  ____
[SFAS 132(R) par. 5g, as amended by SFAS 158]
h. The amount of net periodic benefit cost recognized, showing sep­
arately the service cost component, the interest cost component, 
the expected return on plan assets for the period, the gain or loss 
component, the prior service cost or credit component, the tran­
sition asset or obligation component, and the gain or loss recog­
nized due to settlements or curtailments? ____  ____  ____
[SFAS 132(R) par. 5h, as amended by SFAS 158]
i. Separately the net gain or loss and net prior service cost or credit 
recognized in OCI for the period pursuant to paragraphs 25 and 
29 of SFAS 87 and paragraphs 52 and 56 of SFAS 106, as 
amended, and reclassification adjustments of OCI for the period, 
as those amounts, including amortization of the net transition as­
set or obligation, are recognized as components of net periodic
benefit cost? ------- ------- ------
[SFAS 132(R) par. 5i, as amended by SFAS 158]
j. The amounts in accumulated OCI that have not yet been recog­
nized as components of net periodic benefit cost, showing sepa­
rately the net gain or loss, net prior service cost or credit, and net
transition asset or obligation? ------- ------- ------
[SFAS 132(R) par. 5ii, as amended by SFAS 158]
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k. On a weighted-average basis, the following assumptions used in 
the accounting for the plans: assumed discount rate, rates of com­
pensation increase (for pay-related plans), and expected long­
term rates of return on plan assets specifying, in a tabular format, 
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost? ____
[SFAS 132(R) par. 5j, as amended by SFAS 158]
l. The assumed health care cost trend rate(s) for the next year used 
to measure the expected cost of benefits covered by the plan 
(gross eligible charges) and a general description of the direction 
and pattern of change in the assumed trend rates thereafter, to­
gether with the ultimate trend rate(s) and when that rate is ex­
pected to be achieved? ____
[SFAS 132(R) par. 51, as amended by SFAS 158]
m. The effect of a one-percentage-point increase and the effect of a
one-percentage-point decrease in the assumed health care cost 
trend rates on (1) the aggregate of the service and interest cost 
components of net periodic postretirement health care benefit cost 
and (2) the accumulated postretirement benefit obligation for 
health care benefits? (For purposes of this disclosure, all other as­
sumptions shall be held constant, and the effects shall be meas­
ured based on the substantive plan that is the basis for the ac­
counting.) ____
[SFAS 132(R) par. 5m, as amended by SFAS 158]
n. If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate 
amount of future annual benefits of plan participants covered by 
insurance contracts issued by the employer or related parties, and 
any significant transactions between the employer or related par­
ties and the plan during the period? ____
[SFAS 132(R) par. 5n, as amended by SFAS 158]
o. If applicable, any alternative method used to amortize prior ser­
vice amounts or net gains and losses pursuant to paragraphs 26
and 33 of SFAS 87 or paragraphs 53 and 60 of SFAS 106? ____
[SFAS 132(R) par. 5o, as amended by SFAS 158]
p. If applicable, any substantive commitment such as past practice
or a history of regular benefit increases used as the basis for ac­
counting for the benefit obligation? ____
[SFAS 132(R) par. 5p, as amended by SFAS 158]
q. If applicable, the cost of providing special or contractual termi­
nation benefits recognized during the period and a description of
the nature of the event? ____
[SFAS 132(R) par. 5q, as amended by SFAS 158]
r. An explanation of any significant change in the benefit obligation
or plan assets not otherwise apparent in the other disclosures re­
quired by SFAS 132(R)? ____
[SFAS 132(R) par. 5r, as amended by SFAS 158]
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s. The amounts in accumulated OCI expected to be recognized as 
components of net periodic benefit cost over the fiscal year that 
follows the most recent annual statement of financial position pre­
sented, showing separately the net gain or loss, net prior service
cost or credit, and net transition asset or obligation? ____  ____  ____
[SFAS 132(R) par. 5s, as amended by SFAS 158]
t. The amount and timing of any plan assets expected to be returned 
to the employer during the 12-month period, or operating cycle if 
longer, that follows the most recent annual statement of financial
position presented? ____  ____  ____
[SFAS 132(R) par. 5t, as amended by SFAS 158]
6. Are amounts related to the employer's results of operations disclosed
for each period for which an income statement is presented? ____  ____  ____
[SFAS 132(R) par. 5, as amended by SFAS 158]
7. Are amounts related to the employer's statement of financial position
disclosed as of the date of each statement of financial position pre­
sented? ____  ____  ____
[SFAS 132(R) par. 5, as amended by SFAS 158]
Employers With Two or More Plans
8. Are the disclosures required by SFAS 132(R) aggregated for all of an 
employer's defined benefit pension plans and for all of an employer's 
other defined benefit postretirement plans unless disaggregating in 
groups is considered to provide useful information or is otherwise
required by paragraph 6-7 of SFAS 132(R)? ____  ____  ____
[SFAS 132(R) par. 6]
9. Are disclosures as of the date of each statement of financial position
presented? ____  ____  ____
[SFAS 132(R) par. 6, as amended by SFAS 158]
Note: Disclosures about pension plans with assets in excess of the accu­
mulated benefit obligation generally may be aggregated with disclosures 
about pension plans with accumulated benefit obligations in excess of as­
sets. The same aggregation is permitted for other postretirement benefit 
plans.
[SFAS 132(R) par. 6]
10. If aggregate disclosures are presented, does the employer disclose:
a. The aggregate benefit obligation and aggregate fair value of plan 
assets for plans with benefit obligations in excess of plan assets as 
of the measurement date of each statement of financial position 
presented?
b. The aggregate pension accumulated benefit obligation and aggre­
gate fair value of plan assets for pension plans with accumulated 
benefit obligations in excess of plan assets?
[SFAS 132(R) par. 6]
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11. If a U.S. reporting entity combines disclosures about pension plans or 
other postretirement benefit plans outside the United States with 
those for U.S. plans, are the benefit obligations of the plans outside 
the United States not significant relative to the total benefit obligation,
and do those plans not use significantly different assumptions? ____  ____  ____
[SFAS 132(R) par. 7]
Note: A foreign reporting entity that prepares financial statements in con­
formity with U.S. GAAP shall apply the preceding guidance to its domes­
tic and foreign plans.
Reduced Disclosure Requirements for Nonpublic Entities
Note: A nonpublic entity is not required to disclose the information re­
quired by paragraphs 5(a)-(c), 5(h), 5(m), and 5(o)-(r) of SFAS 132(R). See 
the preceding related disclosure questions.
12. For a nonpublic entity11 that sponsors one or more defined benefit 
pension plans or one or more other defined benefit postretirement 
plans, has the following information been disclosed, separately for 
pension plans and other postretirement benefit plans:
11 A nonpublic entity is any entity other than one (a) whose debt or equity securities trade in a public market either on a stock exchange 
(domestic or foreign) or in the over-the-counter market including securities quoted only locally or regionally, (b) that is a conduit bond 
obligor for conduit debt securities that are traded in a public market (a domestic or foreign stock exchange or an over-the-counter market, 
including local or regional markets), (c) that makes a filing with a regulatory agency in preparation for the sale of any class of debt or 
equity securities in a public market, or (d) that is controlled by an entity covered by (a), (b), or (c).
a. The benefit obligation, fair value of plan assets, and funded status 
of the plan?
[SFAS 132(R) par. 8a, as amended by SFAS 158]
b. Employer contributions, participant contributions, and benefits 
paid?
[SFAS 132(R) par. 8b, as amended by SFAS 158]
c. Information about plan assets:
(1) For each major category of plan assets which shall include, 
but is not limited to, equity securities, debt securities, real es­
tate, and all other assets, the percentage of the fair value of 
total plan assets held as of the measurement date used for 
each statement of financial position presented?
[SFAS 132(R) par. 8c(l), as amended by SFAS 158]
(2) A narrative description of investment policies and strategies, 
including target allocation percentages or range of percent­
ages for each major category of plan assets presented on a 
weighted-average basis as of the measurement date(s) of the 
latest statement of financial position presented, if applicable, 
and other factors that are pertinent to an understanding of the 
policies or strategies such as investment goals, risk manage­
ment practices, permitted and prohibited investments includ­
ing the use of derivatives, diversification, and the relationship 
between plan assets and benefit obligations?
[SFAS 132(R) par. 8c(2), as amended by SFAS 158] 11
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(3) A narrative description of the basis used to determine the 
overall expected long-term rate-of-return-on-assets assump­
tion, such as the general approach used, the extent to which 
the overall rate-of-return-on-assets assumption was based on 
historical returns, the extent to which adjustments were made 
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined? ____  ____  ____
[SFAS 132(R) par. 8c(3), as amended by SFAS 158]
Note: Disclosure of additional asset categories and additional information 
about specific assets within a category is encouraged if that information is 
expected to be useful in understanding the risks associated with each asset 
category and the overall expected long-term rate of return on assets. 
[SFAS 132(R) par. 8c(4), as amended by SFAS 158]
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d. For defined benefit pension plans, the accumulated benefit obli­
gation?
[SFAS 132(R) par. 8d, as amended by SFAS 158]
e. The benefits (as of the date of the latest statement of financial po­
sition presented) expected to be paid in each of the next five fiscal 
years, and in the aggregate for the five fiscal years thereafter? 
(The expected benefits should be estimated based on the same as­
sumptions used to measure the company's benefit obligation at 
the end of the year and should include benefits attributable to es­
timated future employee service.)
[SFAS 132(R) par. 8e, as amended by SFAS 158]
f. The employer's best estimate, as soon as it can reasonably be de­
termined, of contributions expected to be paid to the plan during 
the next fiscal year beginning after the date of the latest statement 
of financial position presented? (Estimated contributions may be 
presented in the aggregate combining (1) contributions required 
by funding regulations or laws, (2) discretionary contributions, 
and (3) noncash contributions.)
[SFAS 132(R) par. 8f, as amended by SFAS 158]
g. The amounts recognized in the statements of financial position, 
showing separately the postretirement benefit assets and current 
and noncurrent postretirement benefit liabilities?
[SFAS 132(R) par. 8g, as amended by SFAS 158]
h. Separately, the net gain or loss and net prior service cost or credit 
recognized in OCI for the period pursuant to paragraphs 25 and 
29 of SFAS 87 and paragraphs 52 and 56 of SFAS 106, as 
amended, and reclassification adjustments of OCI for the period, 
as those amounts, including amortization of the net transition as­
set or obligation, are recognized as components of net periodic 
benefit cost?
[SFAS 132(R) par. 8h, as amended by SFAS 158]
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i. The amounts in accumulated OCI that have not yet been recog­
nized as components of net periodic benefit cost, showing sepa­
rately the net gain or loss, net prior service cost or credit, and net
transition asset or obligation? ____  ___
[SFAS 132(R) par. 8hh, as amended by SFAS 158]
j. On a weighted-average basis, the following assumptions used in 
the accounting for the plans: assumed discount rates, rates of 
compensation increase (for pay-related plans), and expected long­
term rates of return on plan assets specifying, in a tabular format, 
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost? ____  ___
[SFAS 132(R) par. 8i, as amended by SFAS 158]
k. The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan 
(gross eligible charges) and a general description of the direction 
and pattern of change in the assumed trend rates thereafter, to­
gether with the ultimate trend rate(s) and when that rate is ex­
pected to be achieved? ____  ___
[SFAS 132(R) par. 8k, as amended by SFAS 158]
l. If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate 
amount of future annual benefits of plan participants covered by 
insurance contracts issued by the employer or related parties, and 
any significant transactions between the employer or related par­
ties and the plan during the period? ____  ___
[SFAS 132(R) par. 81, as amended by SFAS 158]
m. The nature and effect of significant non-routine events, such as
amendments, combinations, divestitures, curtailments, and settle­
ments? ____  ___
[SFAS 132(R) par. 8m, as amended by SFAS 158]
n. The amounts in accumulated OCI expected to be recognized as 
components of net periodic benefit cost over the fiscal year that 
follows the most recent annual statement of financial position pre­
sented, showing separately the net gain or loss, net prior service
cost or credit, and net transition asset or obligation? ____  ___
[SFAS 132(R) par. 8n, as amended by SFAS 158]
o. The amount and timing of any plan assets expected to be returned 
to the employer during the 12-month period, or operating cycle if 
longer, that follows the most recent annual statement of financial
position presented? ____  ___
[SFAS 132(R) par. 8o, as amended by SFAS 158]
13. Are amounts related to the employer's results of operations disclosed
for each period for which a statement of income is presented? ____  ___
[SFAS 132(R) par. 8]
14. Are amounts related to the employer's statement of financial position
disclosed as of the date of each statement of financial position pre­
sented? ____  ___
[SFAS 132(R) par. 8, as amended by SFAS 158]
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Disclosures in Interim Financial Reports
15. If the entity is publicly traded, does it disclose the following infor­
mation in its interim financial statements that include a statement of 
income:
a. The amount of net periodic benefit cost recognized for each pe­
riod for which a statement of income is presented, showing sepa­
rately the service cost component, the interest cost component, the 
expected return on plan assets for the period, the gain or loss 
component, the prior service cost or credit component, the tran­
sition asset or obligation component, and the gain or loss recog­
nized due to a settlement or curtailment? ____  ____  ____
b. The total amount of the employer's contributions paid, and ex­
pected to be paid, during the current fiscal year, if significantly 
different from amounts previously disclosed pursuant to para­
graph 5(g) of SFAS 132? (Estimated contributions may be pre­
sented in the aggregate combining (1) contributions required by 
funding regulations or laws, (2) discretionary contributions, and
(3) noncash contributions.) ____  ____  ____
[SFAS 132(R) par. 9, as amended by SFAS 158]
16. If the entity is nonpublic, does it disclose in interim periods, for which 
a complete set of financial statements is presented, the total amount 
of the employer's contributions paid, and expected to be paid, during 
the current fiscal year, if significantly different from amounts previ­
ously disclosed pursuant to paragraph 8(f) of SFAS 132? (Estimated 
contributions may be presented in the aggregate combining (a) contri­
butions required by funding regulations or laws, (b) discretionary
contributions, and (c) noncash contributions.) ____  ____  ____
[SFAS 132(R) par. 10]
Entities That Do Not Report Other Comprehensive Income
17. Did the entity comply with the following instructions: For employers 
that do not report OCI in accordance with SFAS 130, the references to 
the net gain or loss, net prior service cost or credit, and net transition 
asset or obligation recognized in OCI in paragraphs 5(i) and 8(h) of 
SFAS 132(R) shall instead be to such amounts recognized as changes 
in unrestricted net assets arising from a defined benefit plan but not
yet included in net periodic benefit cost? ____  ____  ____
[SFAS 132(R) par. 10A, as amended by SFAS 158]
18. Did the entity comply with the following instructions: For those em­
ployers, the references to reclassification adjustments of OCI in para­
graphs 5(i) and 8(h) of SFAS 132(R) shall instead be to reclassifications 
to net periodic benefit cost of amounts previously recognized as 
changes in unrestricted net assets arising from a defined benefit plan
but not included in net periodic benefit cost when they arose? ------- ------- ------
[SFAS 132(R) par. 10B, as amended by SFAS 158]
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19. Did the entity comply with the following instructions: For those em­
ployers, the references to the net gain or loss, net prior service cost or 
credit, and net transition asset or obligation recognized in accumu­
lated OCI in paragraphs 5(ii), 5(s), 8(hh), and 8(n) of SFAS 132(R) shall 
instead be to such amounts that have been recognized as changes in 
unrestricted net assets arising from a defined benefit plan but not yet
reclassified as components of net periodic benefit cost? ____
[SFAS 132(R) par. 10C, as amended by SFAS 158]
20. Did the entity comply with the following instructions: For those em­
ployers, the references to results of operations (including items of 
OCI) in paragraphs 5 and 8 of SFAS 132(R) shall instead be to changes 
in unrestricted net assets and the references to a statement of income
in those paragraphs shall instead be to a statement of activities? ____
[SFAS 132(R) par. 10D, as amended by SFAS 158]
Defined Contribution Plans
21. Does the employer disclose the amount of cost recognized for defined 
contribution pension plans and for other defined contribution postre­
tirement benefit plans for all periods presented separately from the
amount of cost recognized for defined benefit plans? ____
[SFAS 132(R) par. 11]
22. Do the disclosures include a description of the nature and effect of 
any significant changes during the period affecting comparability, 
such as a change in the rate of employer contributions, a business
combination, or a divestiture? ____
[SFAS 132(R) par. 11]
Multiemployer Plans
23. Has the employer disclosed the amount of contributions to multiem­
ployer plans for each annual period for which a statement of income
is presented? ____
[SFAS 132(R) par. 12]
24. If the employer chooses to disclose total contributions to multiem­
ployer plans without disaggregating the amounts attributable to pen­
sion plans and other postretirement benefit plans, do the disclosures 
include a description of the nature and effect of any changes affecting 
comparability, such as a change in the rate of employer contributions,
a business combination, or a divestiture? ____
[SFAS 132(R) par. 12]
25. In some situations, withdrawal from a multiemployer plan may result 
in an employer having an obligation to the plan for a portion of the 
unfunded benefit obligation of the pension plans and other postreti­
rement benefit plans. If withdrawal under circumstances that would 
give rise to an obligation is either probable or reasonably possible, 
have the provisions of SFAS 5 been applied in accordance with SFAS
87 paragraph 70? ____
[SFAS 132(R) par. 13]
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26. If it is either probable or reasonably possible that (a) an employer 
would withdraw from the plan under circumstances that would give 
rise to an obligation or (b) an employer's contribution to the fund 
would be increased during the remainder of the contract period to 
make up a shortfall in the funds necessary to maintain the negotiated 
level of benefit coverage (a "maintenance of benefits" clause), has the 
employer applied the provisions of SFAS 5 in accordance with SFAS
106 paragraph 83? ____  ____   ____
[SFAS 132(R) par. 13]† 
Other Matters
27. If the matters addressed in EITF 03-2, "Accounting for the Transfer to 
the Japanese Government of the Substitutional Portion of Employee 
Pension Fund Liabilities," apply, are the disclosure requirements of
that issue complied with? ____  ____  ____
[EITF 03-2]
28. If the matters addressed in EITF 06-4, "Accounting for Deferred Com­
pensation and Postretirement Benefit Aspects of Endorsement Split- 
Dollar Life Insurance Arrangements," relating to benefits that extend 
into postretirement periods apply, are the disclosure requirements of
that issue complied with? ____  ____ ______
[EITF 06-4]
29. If the matters addressed in EITF 06-10, "Accounting for Deferred 
Compensation and Postretirement Benefit Aspects of Collateral As­
signment Split-Dollar Life Insurance Arrangements," relating to ben­
efits that extend into postretirement periods apply, are the disclosure
requirements of that issue complied with? ____  ____  ____
[EITF 06-10]
30. Until an employer is able to determine whether benefits provided by 
its plan are actuarially equivalent, does it disclose the following in 
financial statements for interim or annual periods:
a. The existence of the act? ____  ____ _______
b. The fact that measures of the accumulated postretirement benefit 
obligation (APBO) or net periodic postretirement benefit cost do 
not reflect any amount associated with the subsidy because the 
employer is unable to conclude whether the benefits provided by 
the plan are actuarially equivalent to Medicare Part D under the
act? ____  ____  ___ —
[FSP FAS 106-2]
† See note in part F, "Contingencies and Commitments," for an important notice regarding a proposed FASB SFAS titled Disclosure of 
Certain Loss Contingencies—an amendment of FASB Statements No. 5 and 141(R) that would replace the disclosure requirements in SFAS 5. 
If finalized and issued as currently drafted, this statement would change the requirements of this question and would be effective for 
annual financial statements issued for fiscal years ending after December 15, 2008, and interim and annual periods in subsequent fiscal 
years. This checklist has not been updated to include the presentation and disclosure requirements of this proposed statement. Readers 
may continue to check the status of this proposed statement on the FASB Web site at www.fasb.org.
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31. In interim and annual financial statements for the first period in 
which an employer includes the effects of the subsidy in measuring 
the APBO and the first period in which an employer includes the ef­
fects of the subsidy in measuring net periodic postretirement benefit 
cost, does it disclose the following:
a. The reduction in the APBO for the subsidy related to benefits at­
tributed to past service?
b. The effect of the subsidy on the measurement of net periodic pos­
tretirement benefit cost for the current period? That effect in­
cludes (1) any amortization of the actuarial experience gain in a 
as a component of the net amortization called for by paragraph 
59 of SFAS 106, (2) the reduction in current period service cost 
due to the subsidy, and (3) the resulting reduction in interest cost 
on the APBO as a result of the subsidy.
c. Any other disclosures required by paragraph 5(r) of SFAS 132(R)? 
Paragraph 5(r) of SFAS 132(R) requires disclosure of "an expla­
nation of any significant change in the benefit obligation or plan 
assets not otherwise apparent in the other disclosures required by 
this Statement."
[FSP FAS 106-2]
32. For purposes of the disclosures required by paragraphs 5(a) and 5(f) 
of SFAS 132(R), does an employer disclose gross benefit payments 
(paid and expected, respectively), including prescription drug bene­
fits, and separately the gross amount of the subsidy receipts (received 
and expected, respectively)?
[FSP FAS 106-2]
K. Consolidated Financial Statements
Notes: In March 2008, FASB issued SFAS 160 to establish accounting and 
reporting standards for the noncontrolling interests in a subsidiary and for 
the deconsolidation of a subsidiary, areas for which limited guidance pre­
viously existed. SFAS 160 clarifies that a noncontrolling interest in a sub­
sidiary is an ownership interest in the consolidated entity that should be 
reported as equity in the consolidated financial statements. This statement 
amends authoritative accounting literature to change the term minority in­
terest to noncontrolling interest. SFAS 160 does not change the requirements 
in FIN 46 (revised December 2003).
This statement changes the way the consolidated income statement is pre­
sented. It requires consolidated net income to be reported at amounts that 
include the amounts attributable to both the parent and the noncontrolling 
interest. It also requires disclosure, on the face of the consolidated state­
ment of income, of the amounts of consolidated net income attributable to 
the parent and to the noncontrolling interest.
SFAS 160 establishes a single method of accounting for changes in a par­
ent's ownership interest in a subsidiary that do not result in deconsolida­
tion and clarifies that all of those transactions are equity transactions if the 
parent retains its controlling financial interest in the subsidiary.
(continued)
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This statement requires expanded disclosures in the consolidated financial 
statements that clearly identify and distinguish between the interests of 
the parent's owners and the interests of the noncontrolling owners of a 
subsidiary. Those expanded disclosures include a reconciliation of the be­
ginning and ending balances of the equity attributable to the parent and 
the noncontrolling owners and a schedule showing the effects of changes 
in a parent's ownership interest in a subsidiary on the equity attributable 
to the parent.
SFAS 160 is effective for fiscal years, and interim periods within those fis­
cal years, beginning on or after December 15, 2008 (that is, January 1, 2009, 
for entities with calendar year-ends). Earlier adoption is prohibited. As 
such, this checklist has not been updated to include the presentation and 
disclosure requirements of SFAS 160. Readers can refer to the full text of 
the statement on the FASB Web site at www.fasb.org.
1. If consolidated statements are presented, is the consolidation policy 
disclosed?
[ARB 51 par. 5; APB 22 par. 13]
2. Are the accounts of all majority-owned subsidiaries (except those for 
which control is likely to be temporary or does not rest with the ma­
jority owner) consolidated?
[SFAS 94 par. 13]
Practice Tip
Paragraph 1 of ARB No. 51 notes the presumption in GAAP that consolidated financial statements are more 
meaningful than parent company-only financial statements, but paragraph 24 of ARB No. 51 acknowledges 
that parent company financial statements may be needed in addition to consolidated financial statements. 
However, it does not suggest that parent company financial statements may be prepared in place of consol­
idated financial statements. TIS section 1400.32, "Parent-Only Financial Statements and Relationship to 
GAAP" (AICPA, Technical Practice Aids) clarifies that, even if a legal or regulatory agreement requires an 
entity to submit "restricted" or "special use" parent-only financial statements without related consolidated 
financial statements, the restricted or special use parent-only financial statements are not in accordance with 
GAAP.
3. If the financial reporting periods of any subsidiaries are different from 
that of the parent, are intervening events that materially affect finan­
cial position or results of operations disclosed?
[ARB 51 par. 4]
Note: EITF 06-9 clarifies that a parent company should report a change to 
(or the elimination of) a previously existing difference between the par­
ent's reporting period and the reporting period of a consolidated entity in 
the parent's consolidated financial statements as a change in accounting 
principle in accordance with the provisions of SFAS 154. This issue does 
not apply in situations in which a parent company or an investor changes 
its fiscal year-end. This issue is effective for changes occurring in interim
(continued)
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or annual reporting periods beginning after board ratification (November 
29, 2006). Readers can refer to the full text of EITF 06-9 on the FASB Web 
site at www.fasb.org.
4. If a parent company reports a change to (or the elimination of) a pre­
viously existing difference between the parent's reporting period and 
the reporting period of a consolidated entity in the parent's consoli­
dated financial statements as described in EITF 06-9, has the change 
been reported as a change in accounting principle in accordance with 
the provisions of SFAS 154, excluding retrospective application if it is
impracticable to do so? ____
[EITF 06-9 par. 4]
5. If the provisions of EITF 06-9 are applicable to the financial statements
of a parent company, are the disclosures required by SFAS 154 made? ____
[EITF 06-9 par. 5]
6. Are material intercompany transactions and accounts, and any in­
come or losses on assets that are eliminated disclosed (Encouraged,
but not required)? ____
[ARB 51 par. 6]
Consolidation of Variable Interest Entities
Notes: FIN 46(R) clarifies the application of ARB 51, Consolidated Financial 
Statements, and replaces the original FIN 46 issued in January 2003. This 
Interpretation provides guidance for identifying entities for which analysis 
of voting interests, and the holdings of those voting interests, is not effec­
tive in determining whether a controlling financial interest exists because 
the entity does not have adequate equity capital or the equity instruments 
do not have the normal characteristics of equity that provide its holders 
with a potential controlling financial interest. Those entities are called var­
iable interest entities.
This interpretation also provides guidance for determining whether an en­
terprise shall consolidate a variable interest entity. An enterprise that con­
solidates a variable interest entity is called the primary beneficiary of that 
variable interest entity. The guidance in this Interpretation identifies the 
primary beneficiary as a holder of variable interests in a variable interest 
entity that absorb or receive a majority of the entity's expected losses or 
expected residual returns.
FIN 46(R) contains scope exceptions that should be considered in deter­
mining whether its provisions apply to a particular entity.
Additionally, FSP FIN 46(R)-7, Application of FASB Interpretation No. 46(R) 
to Investment Companies, amends FIN 46(R) by clarifying that investments 
accounted for at fair value in accordance with the specialized accounting 
guidance in the AICPA Audit and Accounting Guide Investment Companies 
are not subject to consolidation according to the requirements of that in­
terpretation. Readers can refer to the full text of FIN 46(R) on the FASB 
Web site at www.fasb.org.
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7. Does the primary beneficiary of a variable interest entity disclose the 
following (unless the primary beneficiary also holds a majority voting 
interest):
a. The nature, purpose, size, and activities of the variable interest
entity? ____  ____  ____
b. The carrying amount and classification of consolidated assets that
are collateral for the variable interest entity's obligations? ____  ____  ____
c. Lack of recourse if creditors (or beneficial interest holders) of a
consolidated variable interest entity have no recourse to the gen­
eral credit of the primary beneficiary? ____  ____  ____
[FIN 46(R) par. 23]
8. Does an enterprise that holds a significant variable interest in a vari­
able interest entity but is not the primary beneficiary disclose:
a. The nature of its involvement with the variable interest entity and
when that involvement began? ____  ____  ____
b. The nature, purpose, size, and activities of the variable interest
entity? ____  ____  ____
c. The enterprise's maximum exposure to loss as a result of its in­
volvement with the variable interest entity? ____  ____  ____
[FIN 46(R) par. 24]
9. Does a reporting enterprise that is not the primary beneficiary but
holds a significant implicit variable interest in a variable interest en­
tity disclose the information in question 8? ____  ____  ____
[FSP FIN 46(R)-5 par. 6]
10. Are disclosures required by SFAS 140, about a variable interest entity
included in the same note to the financial statements as the informa­
tion required by FIN 46(R)? ____  ____  ____
[FIN 46(R) par. 25]
11. If an entity does not apply FIN 46(R) to one or more variable interest 
entities or potential variable interest entities because of the condition 
described in paragraph 4(g) of FIN 46(R), is the following information 
disclosed:
a. The number of entities to which this interpretation is not being 
applied and the reason why the information required to apply
this interpretation is not available? ------- ------- ------
b. The nature, purpose, size (if available), and activities of the en- 
tity(ies) and the nature of the enterprise's involvement with the
entity(ies)? ------- ------- ------
c. The reporting enterprise's maximum exposure to loss because of
its involvement with the entity(ies)? ------- ------- ------
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d. The amount of income, expense, purchases, sales, or other meas­
ure of activity between the reporting enterprise and the entity(ies) 
for all periods presented? (However, if it is not practicable to 
present that information for prior periods that are presented in 
the first set of financial statements for which this requirement ap­
plies, the information for those prior periods is not required.) 
[FIN 46(R) par. 26]
L. Financial Instruments
Note: For issuers, as prescribed by the rules of the SEC, the SEC issued 
SAB 109, Codification of Staff Accounting Bulletins, Topic 5—Miscellaneous 
Accounting, Section DD—Written Loan Commitments Recorded at Fair Value 
Through Earning, which replaces SAB 105, Application of Accounting Princi­
ples to Loan Commitments.
Derivative Instruments and Hedging Activities
Notes: In March 2008, FASB issued SFAS 161, Disclosures about Derivative 
Instruments and Hedging Activities—an amendment of FASB Statement No. 
133, to enhance the current disclosure framework in SFAS 133. This state­
ment has the same scope as SFAS 133 and, accordingly, applies to all en­
tities.
This statement changes the disclosure requirements for derivative instru­
ments and hedging activities. Entities are required to provide enhanced 
disclosures about (a) how and why an entity uses derivative instruments, 
(b) how derivative instruments and related hedged items are accounted for 
under SFAS 133 and its related interpretations, and (c) how derivative in­
struments and related hedged items affect an entity's financial position, 
financial performance, and cash flows.
SFAS 161 is effective for financial statements issued for fiscal years and 
interim periods beginning after November 15, 2008. Early application is 
encouraged. This statement encourages but does not require disclosures 
for earlier periods presented for comparative purposes at initial adoption. 
In years after initial adoption, it requires comparative disclosures only for 
periods subsequent to initial adoption. Readers can refer to the full text of 
SFAS 161 on the FASB Web site at www.fasb.org.
Organizations that have chosen to early adopt SFAS 161 or otherwise meet 
the effective date criteria of that statement should skip questions 1-7 of 
part L, "Financial Instruments," and complete part L1, "Financial Instru­
ments Subject to SFAS 161." Questions 8-37 of part L still apply. Organi­
zations that have not yet adopted SFAS 161 should complete part L and 
skip part L1.
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1. If an entity holds or issues derivative instruments (or nonderivative 
instruments that are designated and qualify as hedging instruments 
pursuant to paragraphs 37 and 42 of SFAS 133, as amended by SFAS 
138, Accounting for Certain Derivative Instruments and Certain Hedging 
Activities-an amendment of FASB Statement No. 133 and SFAS 159), has 
disclosure been made of its objectives for holding or issuing those in­
struments, the context needed to understand those objectives, and its
strategies for achieving those objectives? ____  ___
[SFAS 133 par. 44]
2. Does the description distinguish between derivative instruments (and
nonderivative instruments) designated as fair value hedging instru­
ments, derivative instruments designated as cash flow hedging instru­
ments, derivative instruments (and nonderivative instruments) des­
ignated as hedging instruments for hedges of the foreign currency 
exposure of a net investment in a foreign operation, and all other de­
rivatives? ____  ___
[SFAS 133 par. 44]
3. Does the description also indicate the entity's risk management policy 
for each of those types of hedges, including a description of the items
or transactions for which risks are hedged? ____  ___
[SFAS 133 par. 44]
4. For derivative instruments not designated as hedging instruments,
does the description indicate the purpose of the derivative activity? ____  ____
[SFAS 133 par. 44]
5. Qualitative disclosures about an entity's objectives and strategies for 
using derivative instruments may be more meaningful if such objec­
tives and strategies are described in the context of an entity's overall 
risk management profile. If appropriate, an entity is encouraged, but 
not required, to provide such additional qualitative disclosures. Have
such disclosures been made? ____  ____
[SFAS 133 par. 44]
6. Do the entity's disclosures for every reporting period for which a 
complete set of financial statements is presented also include the fol­
lowing:
Fair value hedges
a. For derivative instruments, as well as nonderivative instruments 
that may give rise to foreign currency transaction gains or losses 
under SFAS 52, Foreign Currency Translation, that have been des­
ignated and have qualified as fair value hedging instruments and 
for the related hedged items:
(1) The net gain or loss recognized in earnings during the report­
ing period representing (a) the amount of the hedges' ineffec­
tiveness and (b) the component of the derivative instruments' 
gain or loss, if any, excluded from the assessment of hedge 
effectiveness, and a description of where the net gain or loss 
is reported in the statement of income or other statement of 
financial performance? ------- ------
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(2) The amount of net gain or loss recognized in earnings when 
a hedged firm commitment no longer qualifies as a fair value 
hedge?
[SFAS 133 par. 45a]
Cash flow hedges
b. For derivative instruments that have been designated and have 
qualified as cash flow hedging instruments and for the related 
hedged transactions:
(1) The net gain or loss recognized in earnings during the report­
ing period representing (a) the amount of the hedges' ineffec­
tiveness and (b) the component of the derivative instruments' 
gain or loss, if any, excluded from the assessment of hedge 
effectiveness, and a description of where the net gain or loss 
is reported in the statement of income or other statement of 
financial performance?
(2) A description of the transactions or other events that will re­
sult in the reclassification into earnings of gains and losses 
that are reported in accumulated OCI, and the estimated net 
amount of the existing gains or losses at the reporting date 
that is expected to be reclassified into earnings within the next 
12 months?
(3) The maximum length of time over which the entity is hedging 
its exposure to the variability in future cash flows for fore­
casted transactions excluding those forecasted transactions re­
lated to the payment of variable interest on existing financial 
instruments?
(4) The amount of gains and losses reclassified into earnings as a 
result of the discontinuance of cash flow hedges because it is 
probable that the original forecasted transactions will not oc­
cur by the end of the originally specified time period (as doc­
umented at the inception of the hedging relationship) or 
within an additional two-month period of time thereafter? 
[SFAS 133 par. 45b, as amended by SFAS 138]
Hedges of the net investment in a foreign operation
c. For derivative instruments, as well as nonderivative instruments 
that may give rise to foreign currency transaction gains or losses 
under SFAS 52, that have been designated and have qualified as 
hedging instruments for hedges of the foreign currency exposure 
of a net investment in a foreign operation, the net amount of gains 
or losses included in the cumulative translation adjustment dur­
ing the reporting period?
[SFAS 133 par. 45c]
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7. The quantitative disclosures about derivative instruments may be 
more useful, and less likely to be perceived to be out of context or 
otherwise misunderstood, if similar information is disclosed about 
other financial instruments or nonfinancial assets and liabilities to 
which the derivative instruments are related by activity. Accordingly, 
in such situations, has the entity presented a more complete picture 
of its activities by disclosing that information? (Encouraged, but not
required.) ____  ____  ____
[SFAS 133 par. 45]
Certain Hybrid Financial Instruments
Notes: SFAS 155, Accounting for Certain Hybrid Financial Instruments—an 
amendment of FASB Statements No. 133 and 140, is effective for all financial 
instruments acquired, issued, or subject to a remeasurement (new basis) 
event occurring after the beginning of an entity's first fiscal year that be­
gins after September 15, 2006. The fair value election provided for in par­
agraph 4(c) of SFAS 155 may also be applied upon adoption of the state­
ment for hybrid financial instruments that had been bifurcated under 
paragraph 12 of SFAS 133 prior to the adoption of SFAS 155. At adoption, 
any difference between the total carrying amount of the individual com­
ponents of the existing bifurcated hybrid financial instrument and the fair 
value of the combined hybrid financial instrument shall be recognized as 
a cumulative-effect adjustment to beginning retained earnings. An entity 
shall separately disclose the gross gains and losses that make up the cu­
mulative-effect adjustment, determined on an instrument-by-instrument 
basis. Prior periods shall not be restated. SFAS 155 provides a fair value 
measurement election for certain hybrid financial instruments with em­
bedded derivatives that otherwise would require bifurcation. Hybrid fi­
nancial instruments that are elected to be accounted for in their entirety at 
fair value cannot be used as a hedge instrument in a SFAS 133 hedge.
In February 2007, FASB issued SFAS 159, which is effective for financial 
statements issued for fiscal years beginning after November 15, 2007.
This statement applies to all entities, including not-for-profit organiza­
tions. Most of the provisions of this statement apply only to entities that 
elect the fair value option. However, the amendment to SFAS 115, applies 
to all entities with available-for-sale and trading securities. Some require­
ments apply differently to entities that do not report net income.
See part AA, "Fair Value Measurements," for more information. Question 
10 applies only if SFAS 159 is applicable to the financial statements.
8. If the entity measures hybrid instruments (financial instruments con­
taining embedded derivatives) at fair value in accordance with the 
election in SFAS 155 or the practicability exception in SFAS 133, is the 
aggregate fair value of those instruments reported separately on the 
face of the statement of financial position from the aggregate carrying 
amounts of assets and liabilities measured using another measure­
ment attribute?
[SFAS 133 par. 44A, as amended by SFAS 155 and SFAS 159]
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9. Has the entity provided information that will allow users to under­
stand the effect of changes in the fair value of hybrid financial instru­
ments measured at fair value? ____  ____  ____
[SFAS 133 par. 44B, as amended by SFAS 155]
10. For those hybrid financial instruments measured at fair value under 
the election in SFAS 155 and under the practicability exception in par­
agraph 16 of SFAS 155, has the entity disclosed the information in
paragraphs 18-22 of SFAS 159? ____  ____  ____
[SFAS 133 par. 44A, as amended by SFAS 155]
Disclosures About Fair Value of Financial Instruments
11. Has the entity disclosed, either in the body of the financial statements 
or in the accompanying notes,12 the fair value of financial instruments 
(except for those excluded in paragraphs 8 and 13 of SFAS 107) for
12 If disclosed in more than a single note, one of the notes shall include a summary table. The summary table shall contain the fair value 
and related carrying amounts and cross-references to the location(s) of the remaining disclosures required by this statement as amended.
which it is practicable to estimate fair value? ____  ____  ____
[SFAS 107 par. 10, as amended by SFAS 119, SFAS 133, and SFAS 157]
12. Has the fair value disclosed in the notes been presented together with 
the related carrying amount in a form that makes it clear whether the 
fair value and carrying amount represent assets or liabilities and how 
the carrying amounts relate to what is reported in the statement of
financial position? ____  ____  ____
[SFAS 107 par. 10, as amended by SFAS 119, SFAS 133, and SFAS 157]
13. In disclosing the fair value of a financial instrument, has the entity 
taken care not to net that fair value with the fair value of other finan­
cial instruments—even if those financial instruments are of the same 
class or are otherwise considered to be related, for example, by a risk 
management strategy—except to the extent that the offsetting of car­
rying amounts in the statement of financial position is permitted un­
der the general principle in paragraphs 5-6 of FIN 39 or the excep­
tions for master netting arrangements in paragraph 10 of FIN 39 and 
for amounts related to certain repurchase and reverse repurchase 
agreements in paragraphs 3-4 of FIN 41, Offsetting of Amounts Related 
to Certain Repurchase and Reverse Repurchase Agreements—and interpre­
tation of APB Opinion No. 10 and a modification of FASB Interpretation
No. 39? ____  ____  ____
[SFAS 107 par. 13A]
14. If the organization has offset fair value amounts recognized for the 
right to reclaim cash collateral (a receivable) or the obligation to re­
turn cash collateral (a payable) against fair value amounts recognized 
for derivative instruments executed with the same counterparty un­
der the same master netting arrangement, have the disclosures in FSP
FIN 39-1, Amendment of FASB Interpretation No. 39, been made? ____  ____  ____
[FIN 39 par. 10B, as amended by FSP FIN 39-1]
15. If it is not practicable to estimate the fair value of a financial instru­
ment or a class of financial instruments, are the following disclosed:
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a. Information pertinent to estimating the fair value of that financial 
instrument or class of financial instruments, such as the carrying
amount, effective interest rate, and maturity? ____  ____  ____
b. The reasons why it is not practicable to estimate fair value? ____  ____  ____
[SFAS 107 par. 14]
Note: SFAS 126, as amended, makes the disclosures about fair values of 
financial instruments prescribed in SFAS 107 optional for reporting enti­
ties that
a. are nonpublic entities as defined in paragraph 3 of SFAS 126, as 
amended.
b. have total assets of less than $100 million on the date of the financial 
statements.
c. have no instrument that, in whole or in part, is accounted for as a 
derivative instrument under SFAS 133, other than commitments re­
lated to the origination of mortgage loans to be held for sale during 
the reporting period.
For purposes of SFAS 126, an entity is a public entity if
1. its debt or equity securities trade in a public market either on a stock 
exchange (domestic or foreign) or in the over-the-counter market, in­
cluding securities quoted only locally or regionally.
2. it is a conduit bond obligor for conduit debt securities that are traded 
in a public market (a domestic or foreign stock exchange or an over- 
the-counter market, including local or regional markets).
3. it makes a filing with a regulatory agency in preparation for the sale 
of any class of debt or equity securities in a public market.
4. it is controlled by an entity covered items 1, 2, or 3.
Disclosure About Concentrations of Credit Risk of All Financial 
Instruments
16. Except as indicated in paragraph 15b13 of SFAS 107, has the entity 
disclosed all significant concentrations of credit risk arising from all 
financial instruments (including derivative instruments accounted for 
under SFAS 133), whether from an individual counterparty or groups 
of counterparties? (Group concentrations of credit risk exist if a number 
of counterparties are engaged in similar activities and have similar 
economic characteristics that would cause their ability to meet con­
tractual obligations to be similarly affected by changes in economic or 
other conditions.)
13 SFAS 107, Disclosures about Fair Value of Financial Instruments, paragraph 15b provides that these disclosure requirements do not 
apply to the following financial instruments, whether written or held:
a. Financial instruments of a pension plan, including plan assets, when subject to the accounting and reporting requirements of 
SFAS 87, Employers' Accounting for Pensions (financial instruments of a pension plan, other than the obligations for pension 
benefits, when subject to the accounting and reporting requirements of SFAS 35, Accounting and Reporting by Defined Benefit 
Pension Plans, are subject to the reporting of paragraph 15a).
(continued)
[SFAS 107 par. 15a, as amended by SFAS 133]
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17. Has the entity made the following disclosures about each significant 
concentration:
a. Information about the (shared) activity, region, or economic char­
acteristic that identifies the concentration? ____  ____  ____
b. The maximum amount of loss due to credit risk that, based on the 
gross fair value of the financial instrument, the entity would incur 
if parties to the financial instruments that make up the concentra­
tion failed completely to perform according to the terms of the 
contracts and the collateral or other security, if any, for the
amount due proved to be of no value to the entity? ____  ____  ____
c. The entity's policy of requiring collateral or other security to sup­
port financial instruments subject to credit risk, information about 
the entity's access to that collateral or other security, and the na­
ture and a brief description of the collateral or other security sup­
porting those financial instruments? ____  ____  ____
d. The entity's policy of entering into master netting arrangements 
to mitigate the credit risk of financial instruments, information 
about the arrangements for which the entity is a party, and a brief 
description of the terms of those arrangements, including the ex­
tent to which they would reduce the entity's maximum amount
of loss due to credit risk? ____  ____  ____
[SFAS 107 par. 15a, as amended by SFAS 133]
18. Has the entity disclosed quantitative information14 about the market
b. The financial instruments described in paragraphs 8a, 8c, 8e, and 8f of SFAS 107, as amended by SFAS 112, Employers' Accounting 
for Postemployment Benefits—an amendment of FASB Statements No. 5 and 43, SFAS 123, Accounting for Stock-Based Compensation, 
and SFAS 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities—a replacement of SFAS 
125, except for reinsurance receivables and prepaid reinsurance premiums.
14 Appropriate ways of reporting the quantitative information encouraged will differ for different entities and will likely evolve over 
time as management approaches and measurement techniques evolve. Possibilities include disclosing (a) more details about current 
positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual income, 
of several possible changes in market prices, (c) a gap analysis of interest rate repricing or maturity dates, (d) the duration of the financial 
instruments, or (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period and the average 
value at risk during the year. This list is not exhaustive, and an entity is encouraged to develop other ways of reporting quantitative 
information.
risks of financial instruments that is consistent with the way it man­
ages or adjusts those risks? (Encouraged, but not required.) ____  ____  ____
[SFAS 107 par. 15c, as amended by SFAS 133]
19. Are gains and losses (realized and unrealized) on all derivative instru­
ments within the scope of SFAS 133 shown net when recognized in 
the income statement, whether or not settled physically, if the deriv­
ative instruments are held for trading purposes? ____  ____  ____
[EITF 02-3 par.16]
Note: SFAS 155 amended SFAS 133 in February 2006. SFAS 155 provides 
a fair value measurement election for certain hybrid financial instruments 
with embedded derivatives that otherwise would require bifurcation. Hy­
brid financial instruments that are elected to be accounted for in their en­
tirety at fair value cannot be used as a hedge instrument in a SFAS 133 
hedge.
[SFAS 155 app. B]
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20. Does the issuer of a registration payment arrangement disclose the 
following information about each registration payment arrangement 
or each group of similar arrangements:
a. The nature of the registration payment arrangement, including
the approximate term of the arrangement, the financial instru­
ments) subject to the arrangement, and the events or circum­
stances that would require the issuer to transfer consideration un­
der the arrangement? ____  ____  ____
b. Any settlement alternatives contained in the terms of the registra­
tion payment arrangement, including the party that controls the
settlement alternatives? ____  ____  ____
c. The maximum potential amount of consideration, undiscounted,
that the issuer could be required to transfer under the registration 
payment arrangement (including the maximum number of shares 
that may be required to be issued). If the terms of the arrange­
ment provide for no limitation to the maximum potential consid­
eration (including shares) to be transferred, is that fact disclosed? ____  ____  ____
d. The current carrying amount of the liability representing the is­
suer's obligations under the registration payment arrangement 
and the income statement classification of any gains or losses re­
sulting from changes in the carrying amount of that liability? ____  ____  ____
[FSP EITF 00-19-2 par. 12]
21. If derivative transactions are entered into in connection with the is­
suance of contingently convertible securities, do disclosures of the po­
tential impact of the contingently convertible securities include the 
terms of those derivative transactions (including the terms of settle­
ment), how those transactions relate to the contingently convertible
securities, and the number of shares underlying the derivatives? ____  ____  ____
[FSP 129-1 par. 5]
Disclosures About Certain Financial Instruments With Characteristics of
Both Liabilities and Equity
FSP §20,300.03
Notes: Depending upon whether an entity is a nonpublic entity, a public 
entity, or an SEC registrant, FSP FAS 150-3, Effective Date, Disclosures, and 
Transition for Mandatorily Redeemable Financial Instruments of Certain Non­
public Entities and Certain Mandatorily Redeemable Noncontrolling Interests un­
der FASB Statement No. 150, defers the effective date for applying the pro­
visions of SFAS 150, Accounting for Certain Financial Instruments with 
Characteristics of both Liabilities and Equity. Readers should read FSP 150-3 
to understand the various effective dates of SFAS 150. FSP 150-3 is avail­
able at the FASB Web site at www.fasb.org.
Early adoption of the provisions of SFAS 150 for instruments within the 
scope of the indefinite deferrals established by FSP 150-3 is precluded dur­
ing the deferral period.
During the deferral period, all public entities as well as nonpublic entities 
that are SEC registrants are required to follow the disclosure requirements 
in paragraphs 26-27 of SFAS 150 (questions 25-26 that follow) as well as 
disclosures required by other applicable guidance.
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22. For items within the scope of SFAS 150, are they presented as liabili­
ties (or assets in some circumstances), and are those items not pre­
sented between the liabilities section and the equity section of the 
statement of financial position?
[SFAS 150 par. 18]
23. If the entity has no equity instruments outstanding but has financial 
instruments in the form of shares, all of which are mandatorily re­
deemable financial instruments:
a. Are they classified as liabilities?
b. Are they described in the statement of financial position as 
"shares subject to mandatory redemption"?
c. Are payments to holders of such instruments and related accruals 
presented separately from payments to and interest due to other 
creditors in statements of cash flows and income?
[SFAS 150 par. 19 and 28]
24. Do the entities referred to in preceding question 23 above disclose the 
components of the liability that would otherwise be related to share­
holders' interest and OCI, if any, subject to the redemption feature 
(for example, par value and other paid-in amounts of mandatorily re­
deemable instruments should be disclosed separately from the 
amount of retained earnings or accumulated deficit)?
[SFAS 150 par. 28]
25. For issuers of financial instruments within the scope of SFAS 150:
a. Are the nature and terms of the financial instruments and the 
rights and obligations embodied in those instruments disclosed?
b. Does that disclosure include information about settlement alter­
natives, if any, in the contract and identify the entity that controls 
the settlement alternatives?
[SFAS 150 par. 26]
26. For all outstanding financial instruments within the scope of SFAS
150 and for each settlement alternative, do issuers disclose:
a. The amount that would be paid, or the number of shares that 
would be issued and their fair value, determined under the con­
ditions specified in the contract if the settlement were to occur at 
the reporting date?
b. How changes in the fair value of the issuer's equity shares would 
affect those settlement amounts (for example, "the issuer is obli­
gated to issue an additional x shares or pay an additional y dol­
lars in cash for each $1 decrease in the fair value of one share")?
c. The maximum amount that the issuer could be required to pay to 
redeem the instrument by physical settlement, if applicable?
d. The maximum number of shares that could be required to be is­
sued, if applicable?
e. That a contract does not limit the amount that the issuer could be 
required to pay or the number of shares that the issuer could be 
required to issue, if applicable?
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f. For a forward contract or an option indexed to the issuer's equity 
shares, the forward price or option strike price, the number of is­
suer's shares to which the contract is indexed, and the settlement
date or dates of the contract, as applicable? ____  ____  ____
[SFAS 150 par. 27]
27. Are unconditional mandatorily redeemable financial instruments clas­
sified as liabilities if those instruments are mandatorily redeemable on 
fixed dates unless the redemption is required to occur only upon the 
liquidation or termination of the reporting entity? (Note: A mandato­
rily redeemable financial instrument is conditional if the obligation 
depends upon the occurrence of an event not certain to occur. Death is
not uncertain of occurrence; thus, death is not a condition.) ____  ____  ____
[SFAS 150 par. 9-10 and A2]
28. Are financial instruments, other than an outstanding share, that, at
inception, (a) embodies an obligation to repurchase the issuer's equity 
shares, or is indexed to such an obligation, and (b) requires or may 
require the issuer to settle the obligation by transferring assets, clas­
sified as liabilities (or assets in some circumstances)? ____  ____  ____
[SFAS 150 par. 11]
29. Are financial instruments that embody an unconditional obligation, or
financial instruments other than an outstanding share that embodies 
a conditional obligation, that the issuer must or may settle by issuing 
a variable number of its equity shares, classified as liabilities (or assets 
in some circumstances) if, at inception, the monetary value of the ob­
ligation is based solely or predominantly on any one of the items in­
dicated in paragraph 12 of SFAS 150? ____  ____  ____
[SFAS 150 par. 12]
Related to the Adoption of SFAS 150
30. Is the cumulative transition adjustment and any subsequent adjust­
ment reported as an excess of liabilities over assets (a deficit) and 
changes thereto even though the mandatorily redeemable shares are
reported as a liability? ____  ____  ____
[FSP FAS 150-2]
31. Is the resulting change in the amount of the mandatorily redeemable 
shares, depending on the settlement terms, either measured at the 
present value of the amount to be paid at settlement or the amount of 
cash that would be paid under the conditions specified in the contract 
if settlement occurred at the reporting date recognized as interest cost
(change in redemption amount)? ------- ------- ------
[FSP FAS 150-2]
32. Although the disclosure requirements of SFAS 150 do not apply for
those mandatorily redeemable instruments of certain nonpublic com­
panies while application of the provisions of SFAS 150 to those instru­
ments is deferred, are the disclosure requirements in paragraph 4 of 
SFAS 129, Disclosure of Information about Capital Structure, in particular, 
information about the pertinent rights and privileges of the various 
securities outstanding, including mandatory redemption require­
ments, still disclosed? ------- ------- ------
[FSP FAS 150-3]
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33. Although the disclosure requirements of SFAS 150 do not apply for 
those mandatorily redeemable instruments of certain nonpublic com­
panies while application of the provisions of SFAS 150 to those instru­
ments is deferred, are the disclosure requirements in paragraph 8 of 
SFAS 129, which requires disclosure of the amount of redemption re­
quirements for all issues of stock that are redeemable at fixed or de­
terminable prices on fixed or determinable dates in each of the next
five years, still disclosed? ____  ____  ____
[FSP FAS150-3]
34. During the deferral period, if the entity is a public entity or a non­
public entity that is an SEC registrant, are the disclosure requirements 
in paragraphs 26-27 of SFAS 150 as well as disclosures required by
other applicable guidance complied with? ____  ____  ____
[FSP FAS 150-3]
35. Are the disclosures required by EITF 00-19, "Accounting for Deriva­
tive Financial Instruments Indexed to, and Potentially Settled in, a
Company's Own Stock," made? ____  ____  ____
[EITF 00-19]
36. Are the disclosures required by EITF 06-7, "Issuer's Accounting for a
Previously Bifurcated Conversion Option in a Convertible Debt In­
strument When the Conversion Option No Longer Meets the Bifurca­
tion Criteria in FASB Statement No. 133," made? ____  ____  ____
[EITF 06-7]
Notes: SFAS 155 amended SFAS 133 in February 2006. SFAS 155 provides 
a fair value measurement election for certain hybrid financial instruments 
with embedded derivatives that otherwise would require bifurcation. Hy­
brid financial instruments that are elected to be accounted for in their en­
tirety at fair value cannot be used as a hedge instrument in a SFAS 133 
hedge.
[SFAS 155 app. B]
In May 2008, FASB issued FSP APB 14-1, which requires an issuer to sep­
arately account for the liability and equity components of convertible debt 
instruments within its scope. Convertible debt instruments, including in­
struments within the scope of this FSP, consist of a liability component 
with a below-market interest coupon (the debt instrument) and an equity 
component (the conversion option). Convertible debt instruments within 
the scope of this FSP are required to be separated into its liability and 
equity components, with each component accounted for pursuant to other 
U.S. GAAP applicable to that component.
This FSP applies to convertible debt instruments that, by their stated 
terms, may be settled in cash (or other assets) upon conversion, including 
partial cash settlement, unless the embedded conversion option is required 
to be separately accounted for as a derivative under SFAS 133. Other scope 
limitations apply. This FSP shall be effective for financial statements is­
sued for fiscal years beginning after December 15, 2008, and interim per­
iods within those fiscal years. Early adoption is not permitted. As such, 
this checklist has not been updated to include the presentation and disclo­
sure requirements of FSP APB 14-1. Readers can refer to the full text of the 
FSP on the FASB Web site at www.fasb.org.
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37. For instruments that are within the scope of EITF 05-2, "Meaning of
'Conventional Convertible Debt Instrument' in Issue No. 00-19," are 
the applicable disclosures required by SFAS 129 included by the en­
tity? ____  ____  ____
[EITF 05-2 par. 10]
38. Weather derivative contracts within the scope of EITF 99-2, "Account­
ing for Weather Derivatives," therefore, are the existing GAAP disclo­
sures for financial instruments such as those required in SFAS 107
included? ____  ____  ____
[EITF 99-2]
L1. Financial Instruments of Enterprises Subject to SFAS 161
Derivative Instruments and Hedging Activities
1. Are derivative instruments that are within the scope of SFAS 133, in­
cluding certain derivative instruments embedded in other contracts, 
accounted for as assets or liabilities in the statement of financial posi­
tion and measured at their fair values? ____  ____  ____
[SFAS 133 par. 17]
2. Are gains and losses on derivative instruments or nonderivative fi­
nancial instruments that are designated and qualifying as hedges of a 
foreign currency exposure of a net investment in a foreign operation 
accounted for in the same manner as a translation adjustment to the 
extent they are effective as a hedge, that is, are they reported sepa­
rately in other comprehensive income in accordance with paragraph
13 of SFAS 52? ____  ____  ____
[SFAS 133 par. 42]
3. If an entity holds or issues derivative instruments (or nonderivative 
instruments that are designated and qualify as hedging instruments 
pursuant to paragraphs 37 and 42 of SFAS 133) have the following 
disclosures been made for every annual and interim reporting period 
for which a statement of financial position and statement of financial 
performance are presented:
a. Its objectives for holding or issuing those instruments? ____  ____  ____
b. The context needed to understand those objectives? ____  ____  ____
c. Its strategies for achieving those objectives? ------- ------- ------
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
4. Are the disclosures described in question 3 in the context of each in­
strument's primary underlying risk exposure (for example, interest 
rate, credit, foreign exchange rate, interest rate and foreign exchange
rate, or overall price? ------- ------- ------
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
5. Do the disclosures described in question 3 distinguish between instru­
ments used for risk management purposes and those used for other
purposes? ------- ------- ------
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6. For derivative instruments designated as hedging instruments under
SFAS 161, do the disclosures described in question 3 distinguish be­
tween instruments designated as (a) fair value hedging instruments,
(b) cash flow hedging instruments, and (c) hedges of foreign currency
exposure of net investments in foreign operations? ____
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
7. For derivative instruments not designated as hedging instruments un­
der SFAS 161, do the disclosures described in question 3 describe the
purpose of holding or issuing the derivatives? ____
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
8. Does the entity disclose (for every annual and interim reporting 
period for which a statement of financial position and statement of 
financial performance are presented) information that enables users 
of its financial statements to understand the volume of its derivative
activity? ____
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
9. Qualitative disclosures about an entity's objectives and strategies for 
using derivative instruments may be more meaningful if such objec­
tives and strategies are described in the context of an entity's overall 
risk exposures relating to interest rate risk, foreign currency exchange 
rate risk, commodity price risk, credit risk, and equity price risk. If 
appropriate, an entity is encouraged, but not required, to provide 
such additional qualitative disclosures. Have such disclosures been 
made (for every annual and interim reporting period for which a 
statement of financial position and statement of financial performance
are presented)? ____
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
10. For every annual and interim reporting period for which a statement 
of financial position and statement of financial performance are pre­
sented, does the entity disclose, in a tabular format, the location and 
fair value amounts of derivative instruments (or nonderivative instru­
ments it holds or issues that are designated and qualify as hedging 
instruments pursuant to paragraphs 37 and 42 of SFAS 133) reported
in the statement of financial position? ____
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
11. Do the disclosures described in question 10 provide the following:
a. The fair value on a gross basis (even if the derivative instruments 
qualify for net presentation in the statement of financial position
in accordance with FIN 39)? ____
b. Separate asset and liability values segregated between derivatives
that are designated and qualifying as hedging instruments under 
SFAS 161 and those that are not, and within those two broad cat­
egories, by type of derivative contract (for example, interest rate 
contracts, foreign exchange contracts, equity contracts, commod­
ity contracts, credit contracts, and so forth)? ____
c. The line item(s) in the statement of financial position in which the
fair value amounts for the above categories of derivative instru­
ments are included? ____
[SFAS 133 par. 44Ca, as added by SFAS 161 par. 3]
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12. For every annual and interim reporting period for which a statement 
of financial position and statement of financial performance are pre­
sented, does the entity disclose the location and amounts of the gains 
and losses for derivative instruments (or nonderivative instruments it 
holds or issues that are designated and qualify as hedging instru­
ments pursuant to paragraphs 37 and 42 of SFAS 133) reported in the 
statement of financial performance (or when applicable, the statement 
of financial position; for example, gains and losses initially recognized
in OCI? ____  ____  ____
[SFAS 133 par. 44Cb, added by SFAS 161 par. 3]
13. Do the disclosures described in question 12 provide separate presen­
tation of the following, in tabular format (with the exception of ques­
tion 13a for which a tabular or nontabular format is appropriate):
a. The gains and losses on derivative instruments designated and 
qualifying as hedging instruments in fair value hedges and re­
lated hedged items designated and qualifying in fair value
hedges? ____  ____  ____
b. The effective portion of gains and losses on derivative instru­
ments designated and qualifying in cash flow hedges and net in­
vestment hedges that was recognized in OCI during the current
period? ____  ____  ____
c. The effective portion of gains and losses on derivative instru­
ments designated and qualifying in cash flow hedges and net in­
vestment hedges recorded in accumulated other comprehensive 
income during the term of the hedging relationship and reclassi­
fied into earnings during the current period? ____  ____  ____
d. The portion of gains and losses on derivative instruments desig­
nated and qualifying in cash flow hedges and net investment 
hedges representing (a) the amount of the hedges' ineffectiveness 
and (b) the amount, if any, excluded from the assessment of hedge
effectiveness? ____  ____  ____
e. The gains and losses for derivative instruments not designated or
qualifying as hedging instruments under SFAS 161? ____  ____  ____
[SFAS 133 par. 44Cb, added by SFAS 161 par. 3]
14. Do the disclosures described in question 12 present information sep­
arately by type of derivative contract (for example, interest rate con­
tracts, foreign exchange contracts, equity contracts, commodity con­
tracts, credit contracts, and so forth)? ____  ____  ____
[SFAS 133 par. 44Cb, as added by SFAS 161 par. 3]
15. Do the disclosures described in question 12 identify the line item(s) in 
the statement of financial performance in which the gains and losses
for the categories of derivative instruments are included? ------- ------- ------
[SFAS 133 par. 44Cb and SFAS 133 par. 205F, as added by SFAS 161 
par. 3]
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16. If an entity's policy is to include derivative instruments that are not 
designated or qualifying as hedging instruments under SFAS 161 in 
its trading activities, and the entity elects to exclude those derivative 
instruments from the disclosures described in question 12, has the en­
tity disclosed the following information:
a. The gains and losses on its trading activities (including both de­
rivative and nonderivative instruments) recognized in the state­
ment of financial performance, separately by major types of items 
(such as fixed income/interest rates, foreign exchange, equity, 
commodity, and credit)?
b. The line items in the statement of financial performance in which 
trading activities gains and losses are included?
c. A description of the nature of its trading activities and related 
risks, and how the entity manages those risks?
[SFAS 133 par. 44Cc, added by SFAS 161 par. 3]
17. For every annual and interim reporting period for which a statement 
of financial position and statement of financial performance are pre­
sented, does the entity disclose the following information about deriv­
ative instruments it holds or issues (or nonderivative instruments it 
holds or issues that are designated and qualify as hedging instru­
ments pursuant to paragraphs 37 and 42 of SFAS 133) that have 
credit-risk-related contingent features and that are in a net liability 
position at the end of the reporting period:
a. The existence and nature of credit-risk-related contingent features 
and the circumstances in which the features could be triggered in 
derivative instruments that are in a net liability position at the 
end of the reporting period?
b. The aggregate fair value amounts of derivative instruments that 
contain credit-risk-related contingent features that are in a net li­
ability position at the end of the reporting period?
c. The aggregate fair value of assets that are already posted as col­
lateral at the end of the reporting period and (1) the aggregate fair 
value of additional assets that would be required to be posted as 
collateral or (2) the aggregate fair value of assets needed to settle 
the instrument immediately, if the credit-risk-related contingent 
features were triggered at the end of the reporting period?
[SFAS 133 par. 44D, added by SFAS 161 par. 3]
Fair Value Hedges
18. For every annual and interim reporting period for which a statement 
of financial position and statement of financial performance are pre­
sented, does the entity disclose the following for derivative instru­
ments, as well as nonderivative instruments that may give rise to for­
eign currency transaction gains or losses under SFAS 52, that have 
been designated and have qualified as fair value hedging instruments 
and for the related hedged items:
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Yes No N/A
a. The net gain or loss recognized in earnings during the reporting 
period representing (a) the amount of the hedges' ineffectiveness 
and (b) the component of the derivative instruments' gain or loss,
if any, excluded from the assessment of hedge effectiveness? ____  ____  ____
b. The amount of net gain or loss recognized in earnings when a 
hedged firm commitment no longer qualifies as a fair value
hedge? ____  ____  ____
[SFAS 133 par. 45a, as amended by SFAS 161 par. 3]
Cash Flow Hedges
19. For every annual and interim reporting period for which a statement 
of financial position and statement of financial performance are pre­
sented, does the entity disclose the following for derivative instru­
ments that have been designated and have qualified as cash flow 
hedging instruments and for the related hedged transactions:
a. A description of the transactions or other events that will result 
in the reclassification into earnings of gains and losses that are 
reported in accumulated other comprehensive income, and the es­
timated net amount of the existing gains or losses at the reporting 
date that is expected to be reclassified into earnings within the
next 12 months? ____  ____  ____
b. The maximum length of time over which the entity is hedging its 
exposure to the variability in future cash flows for forecasted 
transactions excluding those forecasted transactions related to the
payment of variable interest on existing financial instruments? ____  ____  ____
c. The amount of gains and losses reclassified into earnings as a re­
sult of the discontinuance of cash flow hedges because it is prob­
able that the original forecasted transactions will not occur by the 
end of the originally specified time period or within the addi­
tional period of time discussed in paragraph 33? ____  ____  ____
[SFAS 133 par. 45b, as amended by SFAS 161 par. 3]
20. If the disclosures related to derivative instruments (or nonderivative 
instruments that are designated and qualify as hedging instruments 
pursuant to paragraphs 37 and 42) are presented in more than a single 
footnote, does each derivative note cross-reference the other notes in
which derivative-related information is disclosed? ------- ------- ------
[SFAS 133 par. 44E, added by SFAS 161 par. 3]
21. The quantitative disclosures about derivative instruments may be 
more useful, and less likely to be perceived to be out of context or 
otherwise misunderstood, if similar information is disclosed about 
other financial instruments or nonfinancial assets and liabilities to 
which the derivative instruments are related by activity. Accordingly, 
in such situations, an entity is encouraged, but not required, to pres­
ent a more complete picture of its activities by disclosing that infor­
mation? Have such disclosures been made (for every annual and in­
terim reporting period for which a statement of financial position and
statement of financial performance are presented)? ------- ------- ------
[SFAS 133 par. 45]
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M. Foreign Currency
1. Is the aggregate transaction gain or loss included in net income for 
the period disclosed? (Note: For this disclosure and only for reporting 
periods prior to the effective date of SFAS 161 derivative instruments
are subject to the requirements of paragraph 45 of SFAS 133.) ____  ____  ____
[SFAS 52 par. 30, as amended by SFAS 133]
2. Is an analysis of changes during the period in the accumulated 
amount of translation adjustments reported in equity, included, and 
does it disclose:
a. Beginning and ending amounts of cumulative translation adjust­
ments? ____  ____  ____
b. The aggregate adjustment for the period resulting from transla­
tion adjustments and gains and losses from certain hedges and 
intercompany balances? (Note: Paragraph 45c of SFAS 133 speci­
fies additional disclosures for instruments designated as hedges 
of the foreign currency exposure of a net investment in a foreign
operation. See part L, "Financial Instruments.") ____  ____  ____
c. The amount of income taxes for the period allocated to translation
adjustments? ____  ____  ____
d. The amounts transferred from cumulative translation adjustments
and included in the determination of net income for the period as 
a result of the sale or complete or substantially complete liquida­
tion of an investment in a foreign entity? ____  ____  ____
[SFAS 52 par. 31, as amended by SFAS 133 and SFAS 135]
3. Are rate changes occurring after the date of the financial statements
and the effects on unsettled balances related to foreign currency trans­
lations disclosed, if significant? ____  ____  ____
[SFAS 52 par. 32]
4. Are any foreign earnings reported in addition to amounts received in
the U.S. disclosed, if significant? ____  ____  ____
[ARB 43 ch. 12 par. 5]
5. If the reporting entity entered into a foreign currency swap contract
to replace foreign currency debt with reporting currency debt, and the 
contract is not executed with the same counterparty under a master 
netting arrangement, is the contract accounted for separately and not 
netted against the foreign currency debt (because they are two sepa­
rate legal transactions and do not have the legal right of setoff)? ____  ____  ____
[EITF 86-25; FIN 39; FSP FIN 39-1 par. 4]
6. Is the entire change in the fair value of foreign-currency-denominated
available-for-sale debt securities reported in shareholders' equity? ____  ____  ____
[EITF 96-15]
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7. Are foreign currency transaction gains and losses on a forward 
exchange contract that is designated as, and is effective as, a hedge of 
the foreign-currency-denominated available-for-sale debt security also 
reported in the SFAS 115 component of shareholders' equity (to offset 
the portion of the market value change of a foreign-currency-denom­
inated available-for-sale debt security attributable to foreign exchange
rates)? ____  ____  ____
[EITF 96-15]
N. Impairment of Long-Lived Assets to Be Held and Used
1. Is an impairment loss recognized for a long-lived asset (asset group) 
to be held and used included in income from continuing operations
before income taxes in the income statement of a business enterprise? ____  ____  ____
[SFAS 144 par. 25]
2. Is the following information disclosed in the notes to the financial 
statements that include the period in which an impairment loss is rec­
ognized:
a. A description of the impaired long-lived asset (asset group) and
the facts and circumstances leading to the impairment? ____  ____  ____
b. If not separately presented on the face of the statement, the 
amount of the impairment loss and the caption in the income
statement that includes the loss? ____  ____  ____
c. The method or methods for determining fair value (whether
based on a quoted market price, prices for similar assets, or an­
other valuation technique)? ____  ____  ____
d. If applicable, the segment in which the impaired long-lived asset
(asset group) is reported under SFAS 131, Disclosures about Seg­
ments of an Enterprise and Related Information? ____  ____  ____
[SFAS 144 par. 26]
3. If the occurrence of a significant event or circumstance at any time 
during the assessment period results in an expectation that the criteria 
in paragraph 42 of EITF 03-13, "Applying the Conditions in Para­
graph 42 of FASB Statement No. 144 in Determining Whether to Re­
port Discontinued Operations," will be met by the end of the assess­
ment period, is the component's operations presented as discontinued
operations? ------- ------- ------
[EITF 03-13 par. 13]
4. Is the following information disclosed in the notes to the financial 
statements for each discontinued operation that generates continuing 
cash flows:
a. The nature of the activities that give rise to continuing cash flows? ------- ------- ------
b. The period of time continuing cash flows are expected to be gen­
erated? ------- ------- ------
c. The principal factors used to conclude that the expected continu­
ing cash flows are not direct cash flows of the disposed compo­
nent? ------- ------- ------
[EITF 03-13 par. 17]
FSP §20,300.03
116 Life and Health Insurance Entities
5. Additionally, for each discontinued operation in which the ongoing
entity will engage in a "continuation of activities" with the disposed 
component after its disposal and for which the amounts presented in 
continuing operations after the disposal transaction include a contin­
uation of revenues and expenses that were intercompany transactions 
(eliminated in consolidated financial statements) before the disposal 
transaction, are the intercompany amounts before the disposal trans­
action disclosed for all periods presented? -------
[EITF 03-13 par. 17]
6. Are the types of continuing involvement, if any, that the entity will 
have after the disposal transaction disclosed? Also, is that information 
disclosed in the period in which operations are initially classified as
discontinued? -------
[EITF 03-13 par. 17]
O. Long-Lived Assets and Disposal Groups to Be Disposed Of
Reporting Discontinued Operations
1. Are the results of operations of a component of an entity (as that phrase 
is defined in SFAS 144) that either has been disposed of or is classified 
as held for sale reported in discontinued operations in accordance 
with paragraph 43 of SFAS 144 (questions 2-5 that follow) if both of 
the following conditions are met:
a. The operations and cash flows of the component have been (or 
will be) eliminated from the ongoing operations of the entity as a
result of the disposal transaction? and ____
b. The entity will not have any significant continuing involvement
in the operations of the component after the disposal transaction? -------
[SFAS 144 par. 42]
2. In a period in which a component of an entity either has been dis­
posed of or is classified as held for sale, does the income statement 
for current and prior periods report the results of operations of the 
component, including any gain or loss recognized in accordance with
paragraph 37 of SFAS 144, in discontinued operations? -------
[SFAS 144 par. 43, as amended by SFAS 154]
3. Are the results of operations of a component classified as held for sale
reported in discontinued operations in the period(s) in which they oc­
cur? —
[SFAS 144 par. 43, as amended by SFAS 154]
4. Are the results of discontinued operations, less applicable income 
taxes (benefit), reported as a separate component of income before ex­
traordinary items and the cumulative effect of accounting changes (if
applicable)? -------
[SFAS 144 par. 43, as amended by SFAS 154]
5. Is the gain or loss recognized on the disposal disclosed either on the
face of the income statement or in the notes to the financial state­
ments? —
[SFAS 144 par. 43, as amended by SFAS 154]
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6. Are adjustments to amounts previously reported in discontinued op­
erations that are directly related to the disposal of a component of an 
entity in a prior period classified separately in the current period in
discontinued operations? ____  ____  ____
[SFAS 144 par. 44]
7. Are the nature and amount of such adjustments (as discussed in ques­
tion 6) disclosed? ____  ____  ____
[SFAS 144 par. 44]
Reporting Disposal Gains or Losses in Continuing Operations
8. Is a gain or loss, that is recognized on the sale of a long-lived asset 
(disposal group) that is not a component of an entity, included in in­
come from continuing operations before income taxes in the income
statement? ____  ____  ____
[SFAS 144 par. 45, as amended by SFAS 145]
9. If a subtotal such as "income from operations" is presented, does it
include the amounts of those gains or losses considered in question 8? ____  ____  ____
[SFAS 144 par. 45, as amended by SFAS 145]
Reporting a Long-Lived Asset or Disposal Group Sold or Classified as
Held for Sale
10. If the criteria of paragraph 30 of SFAS 144 are met (and thus a long- 
lived asset is classified as held for sale) after the balance sheet date 
but before issuance of the financial statements, does the long-lived 
asset continue to be classified as held and used in those financial state­
ments when issued and is the information required by paragraph 
47(a) of SFAS 144 (question 15a) disclosed in the notes to the financial
statements? ____  ____  ____
[SFAS 144 par. 33]
11. Is a long-lived asset that is classified as held for sale presented sepa­
rately in the statement of financial position? ____  ____  ____
[SFAS 144 par. 46]
12. Are the assets and liabilities of a disposal group that is classified as 
held for sale presented separately in the asset and liability sections,
respectively, of the statement of financial position? ____  ____  ____
[SFAS 144 par. 46]
13. Are those assets and liabilities considered in question 12, not offset
and presented as a single amount? ------- ------- ------
[SFAS 144 par. 46]
14. Are the major classes of assets and liabilities that are classified as held
for sale separately disclosed either on the face of the statement of fi­
nancial position or in the notes to financial statements? ------- ------- ------
[SFAS 144 par. 46]
15. Is the following information disclosed in the notes to the financial 
statements that cover the period in which a long-lived asset (disposal 
group) either has been sold or is classified as held for sale:
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a. A description of the facts and circumstances leading to the ex­
pected disposal, the expected manner and timing of that disposal, 
and, if not separately presented on the face of the statement, the 
carrying amount(s) of the major classes of assets and liabilities in­
cluded as part of a disposal group? ------
b. The gain or loss recognized in accordance with paragraph 37 of 
SFAS 144 and if not separately presented on the face of the in­
come statement, the caption in the income statement that includes
that gain or loss? ------
c. If applicable, amounts of revenue and pretax profit or loss re­
ported in discontinued operations? -----
d. If applicable, the segment in which the long-lived asset (disposal
group) is reported under SFAS 131? ------
[SFAS 144 par. 47]
16. If either paragraph 38 or 40 of SFAS 144 applies, is a description of 
the facts and circumstances leading to the decision to change the plan 
to sell the long-lived asset (disposal group) and its effect on the results 
of operations for the period and any prior periods presented disclosed 
in the notes to the financial statements that include the period of that
decision? -----
[SFAS 144 par. 48]
17. If a long-lived asset is to be disposed of other than by sale, does it
continue to be classified as held and used until it is disposed of? ___
[SFAS 144 par. 27, as amended by SFAS 153]
P. Accounting for Servicing Financial Assets
Collateral
1. Is the policy for requiring collateral or other security disclosed if the 
reporting entity has entered into repurchase agreements or securities
lending transactions? ___
[SFAS 140 par. 17a(1)]
2. If the entity has pledged any of its assets as collateral that are not 
reclassified and separately reported in the statement of financial po­
sition pursuant to paragraph 15a of SFAS 140, is the carrying amount 
and classification of those assets as of the date of the latest statement
of financial position presented? ___
[SFAS 140 par. 17a(2)]
3. If the entity has accepted collateral that it is permitted by contract or 
custom to sell or repledge, is the fair value, as of the date of each 
statement of financial position presented, of that collateral and of the
portion of that collateral that it has sold or repledged disclosed? ___
[SFAS 140 par. 17a(3)]
4. If debt was considered to be extinguished by in-substance defeasance 
under the provisions of SFAS 76 prior to the effective date of SFAS 
125, do the disclosures include a general description of the transaction 
and the amount of debt that is considered extinguished at the end of
the period so long as that debt remains outstanding? ___
[SFAS 140 par. 17b]
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5. If assets are set aside after the effective date of SFAS 125 solely for 
satisfying scheduled payments of a specific obligation, do the disclo­
sures include a description of the nature of restrictions placed on
those assets? ____  ____  ____
[SFAS 140 par. 17c]
6. If it is not practicable to estimate the fair value of certain assets ob­
tained or liabilities incurred in transfers of financial assets during the 
period, are those items and the reasons why it is not practicable to
estimate fair value described in the notes to the financial statements? ____  ____  ____
[SFAS 140 par. 17d, as amended by SFAS 156]
Servicing Assets and Servicing Liabilities
7. For all servicing assets and servicing liabilities, are the following dis­
closures made:
a. Management's basis for determining its classes of servicing assets 
and servicing liabilities per SFAS 140 paragraph 13A, as
amended? ____  ____  ____
b. A description of the risks inherent in servicing assets and servic­
ing liabilities and, if applicable, the instruments used to mitigate 
the income statement effect of changes in fair value of the servic­
ing assets and servicing liabilities? (Disclosure of quantitative in­
formation about the instruments used to manage the risks inher­
ent in servicing assets and servicing liabilities, including the fair 
value of those instruments at the beginning and end of the period,
is encouraged but not required.) ____  ____  ____
c. The amount of contractually specified servicing fees (as defined 
in the glossary of SFAS 156), late fees, and ancillary fees earned 
for each period for which results of operations are presented, in­
cluding a description of where each amount is reported in the
statement of income? ____  ____  ____
[SFAS 140 par. 17e, as amended by SFAS 156]
8. For servicing assets and servicing liabilities measured at fair value, 
are the following disclosures made:
a. For each class of servicing assets and servicing liabilities, the ac­
tivity in the balance of servicing assets and the activity in the bal­
ance of servicing liabilities (including a description of where 
changes in fair value are reported in the statement of income for 
each period for which results of operations are presented), includ­
ing, but not limited to, the following:
(1) The beginning and ending balances? ____  ____  ____
(2) Additions (through purchases of servicing assets, assump­
tions of servicing obligations, and servicing obligations that
result from transfers of financial assets)? ------- ------- ------
(3) Disposals? ------- ------- ------
(4) Changes in the fair value during the period resulting from
changes in valuation inputs or assumptions used in the valu­
ation model? ------- ------- ------
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(5) Changes in the fair value during the period resulting from 
other changes in fair value and a description of those 
changes?
(6) Other changes that affect the balance and a description of 
those changes?
b. A description of the valuation techniques or other methods used 
to estimate the fair value of servicing assets and servicing liabili­
ties? If a valuation model is used, the description shall include the 
methodology and model validation procedures, as well as quan­
titative and qualitative information about the assumptions used 
in the valuation model (for example, discount rates and prepay­
ment speeds)? (An entity that provides quantitative information 
about the instruments used to manage the risks inherent in the 
servicing assets and servicing liabilities, as encouraged by para­
graph 17(e)(2), is also encouraged, but not required, to disclose a 
description of the valuation techniques, as well as quantitative 
and qualitative information about the assumptions used to esti­
mate the fair value of those instruments.)
[SFAS 140 par. 17f, as amended by SFAS 156]
9. For servicing assets and servicing liabilities subsequently amortized 
in proportion to and over the period of estimated net servicing in­
come or loss and assessed for impairment or increased obligation:
a. For each class of servicing assets and servicing liabilities, the ac­
tivity in the balance of servicing assets and the activity in the bal­
ance of servicing liabilities (including a description of where 
changes in the carrying amount are reported in the statement of 
income for each period for which results of operations are pre­
sented), including, but not limited to, the following:
(1) The beginning and ending balances?
(2) Additions (through purchases of servicing assets, assumption 
of servicing obligations, and servicing obligations that result 
from transfers of financial assets)?
(3) Disposals?
(4) Amortization?
(5) Application of valuation allowance to adjust carrying value of 
servicing assets?
(6) Other-than-temporary impairments?
(7) Other changes that affect the balance and a description of 
those changes?
b. For each class of servicing assets and servicing liabilities, the fair 
value of recognized servicing assets and servicing liabilities at the 
beginning and end of the period if it is practicable to estimate the 
value?
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c. A description of the valuation techniques or other methods used 
to estimate fair value of the servicing assets and servicing liabili­
ties? If a valuation model is used, the description shall include the 
methodology and model validation procedures, as well as quan­
titative and qualitative information about the assumptions used 
in the valuation model (for example, discount rates and prepay­
ment speeds)? (An entity that provides quantitative information 
about the instrument used to manage the risks inherent in the 
servicing assets and servicing liabilities, as encouraged by para­
graph 17(e)(2), is also encouraged, but not required, to disclose a 
description of the valuation techniques as well as quantitative and 
qualitative information about the assumptions used to estimate
the fair value of those instruments.) ____  ___
d. The risk characteristics of the underlying financial assets used to 
stratify recognized servicing assets for purposes of measuring im­
pairment in accordance with paragraph 63 of SFAS 140, as
amended? ____  ___
e. The activity by class in any valuation allowance for impairment
of recognized servicing assets—including beginning and ending 
balances, aggregate additions charged and recoveries credited to 
operations, and aggregate write-downs charged against the al­
lowance—for each period for which results of operations are pre­
sented? ____  ___
[SFAS 140 par. 17g, as amended by SFAS 156]
Securitized Financial Assets Accounted for as a Sale
10. If the entity has securitized financial assets during any period pre­
sented and accounts for that transfer as a sale, are the following items 
disclosed for each major asset type (for example, mortgage loans, 
credit card receivables, and automobile loans):
a. Its accounting policies for initially measuring the interests that 
continue to be held by the transferor, if any, and servicing assets 
or servicing liabilities, if any, including the methodology 
(whether quoted market price, prices based on sales of similar as­
sets and liabilities, or prices based on valuation techniques) used 
in determining their fair value (per paragraphs 68-70 of SFAS 140,
as amended by SFAS 156)? ____  ____
b. The characteristics of securitizations (a description of the trans­
feror's continuing involvement with the transferred assets, includ­
ing, but not limited to, servicing, recourse, and restrictions on in­
terests that continue to be held by the transferor) and the gain or
loss from sale of financial assets in securitizations? ------- ------
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c. The key assumptions15 used in measuring the fair value of interest
15 If an entity has made multiple securitizations of the same major asset type during a period, it may disclose the range of assumptions.
16 Excluding securitized assets than an entity continues to service but with which it has no other continuing involvement.
that continue to be held by the transferor and servicing assets or 
servicing liabilities, if any, at the time of securitization (including, 
at a minimum, quantitative information about discount rates, ex­
pected prepayments including the expected weighted-average life 
of prepayable financial assets, and anticipated credit losses, if ap­
plicable)? ------- ------- -------
d. Cash flows between the securitization special purpose entity and 
the transferor, unless reported separately elsewhere in the finan­
cial statements or notes (including proceeds from new securitiza­
tions, proceeds from collections reinvested in revolving-period se­
curitizations, purchases of delinquent or foreclosed loans, 
servicing fees, and cash flows received on interests that continue
to be held by the transferor)? ------- ------- -------
[SFAS 140 par. 17h, as amended by SFAS 156 and SFAS 157]
Interests in Financial Assets That Continue to be Held by the Transferor
11. If the entity has interests that continue to be held by the transferor in 
financial assets that it has securitized or servicing assets or servicing 
liabilities relating to assets that it has securitized, at the date of the 
latest statement of financial position presented, are the following 
items disclosed for each major asset type (for example, mortgage 
loans, credit card receivables, and automobile loans):
a. Its accounting policies for subsequently measuring those interests, 
including the methodology (whether quoted market price, prices 
based on sales of similar assets and liabilities, or prices based on
valuation techniques) used in determining their fair value? ------- ------- -------
b. The key assumptions used in subsequently measuring the fair 
value of those interests (including, at a minimum, quantitative in­
formation about discount rates, expected prepayments including 
the expected weighted-average life of prepayable financial assets, 
and anticipated credit losses, including expected static pool
losses, if applicable)? ____  ____  ____
c. A sensitivity analysis or stress test showing the hypothetical effect 
on the fair value of those interests (including any servicing assets 
or servicing liabilities) of two or more unfavorable variations 
from the expected levels for each key assumption that is reported 
under b. above independently from any change in another key 
assumption, and a description of the objectives, methodology,
and limitations of the sensitivity analysis or stress test? ____  ____  ____
d. For the securitized assets and any other financial assets that it 
manages together with them:16
(1) The total principal amount outstanding, the portion that has 
been derecognized, and the portion that continues to be rec­
ognized in each category reported in the statement of finan­
cial position, at the end of the period? ____  ____  ____
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(2) Delinquencies at the end of the period? ____  ___
(3) Credit losses, net of recoveries, during the period? ____  ___
[SFAS 140 par. 17h, as amended by SFAS 157]
Note: Disclosure of average balances during the period is encouraged, but 
not required.
Q. Nonmonetary Transactions
1. Do disclosures for nonmonetary transactions during the period in­
clude:
a. Nature of the transactions?
b. Basis of accounting for the assets transferred?
c. Gains or losses recognized on the transfers?
[APB 29 par. 28]
2. Is the amount of gross operating revenue recognized as a result of 
nonmonetary transactions addressed by EITF 00-8, "Accounting by a 
Grantee for an Equity Instrument to Be Received in Conjunction with 
Providing Goods or Services," disclosed in each period's financial 
statements?
[EITF 00-8]
R. Subsequent Events
1. Are subsequent events that provide evidence about conditions that 
did not exist at the balance sheet date, but arose subsequent to that 
date, adequately disclosed to keep the financial statements from being 
misleading?
[SFAS 5 par. 11; AU 560.05-.07, .09, and 561.01-.09]
Note: Consider the appropriateness of dual-dating the auditor's report if a 
subsequent event is disclosed in the financial statements.
[AU 530.05]
S. Costs Associated With Exit or Disposal Activities
1. Is the following information disclosed in notes to the financial state­
ments that include the period in which an exit or disposal activity is 
initiated and any subsequent period until the activity is completed:
a. A description of the exit or disposal activity, including the facts 
and circumstances leading to the expected activity and the ex­
pected completion date?
b. For each major type of cost associated with the activity (for ex­
ample, one-time termination benefits, contract termination costs, 
and other associated costs):
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(1) The total amount expected to be incurred in connection with 
the activity, the amount incurred in the period, and the cu­
mulative amount incurred to date?
(2) A reconciliation of the beginning and ending liability balances 
showing separately the changes during the period attributa­
ble to costs incurred and charged to expense, costs paid or 
otherwise settled, and any adjustment to the liability with an 
explanation of the reason(s) therefore?
c. The line item(s) in the income statement in which the costs in b 
above are aggregated?
d. For each reportable segment:
(1) The total amount of costs expected to be incurred in connec­
tion with the activity?
(2) The amount incurred in the period?
(3) The cumulative amount incurred to date, net of any adjust­
ments to the liability with an explanation of the reason(s) 
therefore?
e. If a liability for a cost associated with the activity is not recog­
nized because fair value cannot be reasonably estimated, that fact 
and the reasons therefore?
[SFAS 146 par. 20]
2. Are costs associated with an exit or disposal activity that does not 
involve a discontinued operation included in income from continuing 
operations before income taxes, for example, in a subtotal such as 
"income from operations"?
[SFAS 146 par. 18]
3. Are costs associated with an exit or disposal activity that involves a 
discontinued operation included in the results of discontinued opera­
tion?
[SFAS 146 par. 18]
4. If an event or circumstance occurs that discharges or removes an en­
tity's responsibility to settle a liability for a cost associated with an 
exit or disposal activity recognized in a prior period, is the liability 
reversed?
[SFAS 146 par. 19]
5. Are the related costs reversed through the same line item(s) in the 
income statement used when those costs were recognized initially? 
[SFAS 146 par. 19]
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T. Business Combinations*
* See note in part F, "Contingencies and Commitments," for an important notice regarding a proposed SFAS titled Disclosure of Certain 
Loss Contingencies—an amendment of FASB Statements No. 5 and 141(R) that would replace the disclosure requirements in SFAS 5. If 
finalized and issued as currently drafted, this statement would change the requirements of this question and would be effective for 
annual financial statements issued for fiscal years ending after December 15, 2008, and interim and annual periods in subsequent fiscal 
years. This checklist has not been updated to include the presentation and disclosure requirements of this proposed statement. Readers 
may continue to check the status of this proposed statement on the FASB Web site at www.fasb.org.
Notes: In December 2007, FASB issued SFAS 141(R) to improve the rele­
vance, representational faithfulness, and comparability of the information 
that a reporting entity provides in its financial reports about a business 
combination and its effects. SFAS 141(R) supersedes SFAS 141, Business 
Combinations, but retains the fundamental requirements in SFAS 141 that 
the acquisition method of accounting (formerly called the purchase 
method in SFAS 141) be used for all business combinations and that an 
acquirer be identified for each business combination.
Among many other significant amendments to existing pronouncements 
precipitated by SFAS 141(R), this statement redefines goodwill in SFAS 
142 to mean an asset representing the future economic benefits arising 
from other assets acquired in a business combination that are not individ­
ually identified and separately recognized.
SFAS 141(R) applies to all transactions or other events in which an entity 
(the acquirer) obtains control of one or more businesses (the acquiree), in­
cluding those sometimes referred to as true mergers or mergers of equals and 
combinations achieved without the transfer of consideration, for example, 
by contract alone or through the lapse of minority veto rights. This state­
ment applies to all business entities, including mutual entities that previ­
ously used the pooling-of-interests method of accounting for some busi­
ness combinations. It does not apply to
a. the formation of a joint venture.
b. the acquisition of an asset or a group of assets that does not consti­
tute a business.
c. a combination between entities or businesses under common con­
trol.
d. a combination between not-for-profit organizations or the acquisi­
tion of a for-profit business by a not-for-profit organization.
This statement applies prospectively to business combinations for which 
the acquisition date is on or after the beginning of the first annual report­
ing period beginning on or after December 15, 2008. An entity may not 
apply it before that date. As such, this checklist has not been updated to 
include the requirements of SFAS 141(R).
In March 2008, FASB issued SFAS 160 to establish accounting and report­
ing standards for the noncontrolling interests in a subsidiary and for the 
deconsolidation of a subsidiary, areas for which limited guidance previ­
ously existed.
(continued)
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In addition to the overview of this statement provided in a note appearing 
earlier in this checklist, readers should be aware that SFAS 160 requires 
acquisitions of noncontrolling interests to be accounted for as equity trans­
actions. Thus, no goodwill or other intangible assets would be recognized 
on acquisitions of noncontrolling interests after the effective date of that 
statement.
SFAS 160 is effective for fiscal years, and interim periods within those fis­
cal years, beginning on or after December 15, 2008 (that is, January 1,2009, 
for entities with calendar year-ends). Earlier adoption is prohibited. As 
such, this checklist has not been updated to include the presentation and 
disclosure requirements of SFAS 160. The effective date of this statement 
is the same as that of SFAS 141(R).
Readers can refer to the full text of both of the aforementioned SFASs at 
www.fasb.org.
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1. Do the notes to the financial statements of a combined entity disclose 
the following information in the period in which a material business 
combination is completed:
a. The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired? ____
b. The primary reasons for the acquisition, including a description
of the factors that contributed to a purchase price that results in 
recognition of goodwill? ____
c. The period for which the results of operations of the acquired en­
tity are included in the income statement of the combined entity? ____
d. The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred 
shares, or partnership interests) issued or issuable, the value as­
signed to those interests, and the basis for determining that value? ____
e. A condensed balance sheet disclosing the amount assigned to
each major asset and liability caption of the acquired entity at the 
acquisition date? ____
f. Contingent payments, options, or commitments specified in the 
acquisition agreement and the accounting treatment that will be 
followed should any such contingency occur? ____
g. The amount of purchased research and development assets ac­
quired and written off in the period (refer to paragraph 42 of 
SFAS 141) and the line item in the income statement in which the 
amounts written off are aggregated? ____
h. For any purchase price allocation that has not been finalized, that
fact and the reasons therefore? ____
i. In subsequent periods, the nature and amount of any material ad­
justment made to the initial allocation of the purchase price? ____
[SFAS 141 par. 51]
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2. Is the following information disclosed in the notes to the financial 
statements in the period in which a material business combination is 
completed if the amounts assigned to goodwill or to other intangible 
assets acquired are significant in relation to the total cost of the ac­
quired entity:
a. For intangible assets subject to amortization in accordance with 
SFAS 142:
(1) The total amount assigned and the amount assigned to a ma­
jor intangible asset class? ____  ____  ____
(2) The amount of any significant residual value, in total and by
major intangible asset class? ____  ____  ____
(3) The weighted-average amortization period, in total and by
major intangible asset class? ____  ____  ____
b. For intangible assets not subject to amortization in accordance
with SFAS 142, the total amount assigned and the amount as­
signed to any major intangible asset class? ____  ____  ____
c. For goodwill:
(1) The total amount of goodwill and the amount that is expected
to be deductible for tax purposes? ____  ____  ____
(2) The amount of goodwill by reportable segment (if the com­
bined entity is required to disclose segment information in ac­
cordance with SFAS 131), unless not practicable. ____  ____  ____
[SFAS 141 par. 52]
3. If a series of individually immaterial business combinations com­
pleted during the period are material in the aggregate, is the follow­
ing disclosed:
a. The number of entities acquired and a brief description of those
entities? ____  ____  ____
b. The aggregate cost of the acquired entities, the number of equity 
interests, (such as common shares, preferred shares, or partner­
ship interests) issued or issuable, and the value assigned to those
interests? ____  ____  ____
c. The aggregate amount of any contingent payments, options, or 
commitments and the accounting treatment that will be followed 
should any contingency occur (if potentially significant in relation
to the aggregate cost of the acquired entities)? ------- ------- ------
d. The information described in question 2, if the aggregate amount
assigned to goodwill or to other intangible assets acquired is sig­
nificant in relation to the aggregate cost of the acquired entities? ------- ------- ------
[SFAS 141 par. 53]
4. If the combined entity is a public business enterprises, is the following 
supplemental information on a pro forma basis for the period in 
which a material business combinations occurs (or for the period in 
which a series of individually immaterial business combinations occur 
that are material in the aggregate) disclosed:
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a. Results of operations for the current period as though the busi­
ness combination or combinations had been completed at the be­
ginning of the period unless the acquisition was at or near the 
beginning of the period? ------
b. Results of operations for the comparable period as though the 
business combination or combinations had been completed at the 
beginning of that period if comparative financial statements are
presented? ------
[SFAS 141 par. 54]
5. Does the supplemental pro forma information display revenue, in­
come before extraordinary items and the cumulative effect of account­
ing changes, net income, and earnings per share at a minimum? ------
[SFAS 141 par. 55, as amended by SFAS 154]
Note: In determining the pro forma amounts, income taxes, interest ex­
pense, preferred share dividends, and depreciation and amortization of 
assets shall be adjusted to the accounting base recognized for each in re­
cording the combination. Pro forma information related to results of op­
erations of periods prior to the combination shall be limited to the results 
of operations for the immediately preceding period.
[SFAS 141 par. 55, as amended by SFAS 154]
6. Does the supplemental pro forma information disclose the nature and 
amount of material, nonrecurring items included in the reported pro
forma results of operations, if any? -------
[SFAS 141 par. 55, as amended by SFAS 154]
7. In the period in which an extraordinary gain is recognized related to
a business combination, do the notes to the financial statements dis­
close the information required by paragraph 11 of APB 30? ____
[SFAS 141 par. 56]
8. If a material business combination is completed after the balance sheet 
date but before the financial statements are issued, is the information
required by the preceding questions 1-2 disclosed if practicable? ____
[SFAS 141 par. 57]
Interim Financial Information
9. For summarized interim financial information of a public business en­
terprise is the following information disclosed if a material business 
combination is completed during the current year up to the date of 
the most recent interim statement of financial position presented:
a. The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired? ____
b. The primary reasons for the acquisition, including a brief descrip­
tion of the factors that contributed to a purchase price that results
in recognition of goodwill? ____
c. The period for which the results of operations of the acquired en­
tity are included in the income statement of the combined entity? ____
FSP §20,300.03
No N/A
Financial Statements and Notes Checklist 129
N/AYes No
d. The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred 
shares, or partnership interests) issued or issuable, the value as­
signed to those interests, and the basis for determining that value? ____  ___
e. Supplemental pro forma information that discloses the results of 
operations for the current interim period and the current year up 
to the date of the most recent interim statement of financial posi­
tion presented (and for the corresponding periods in the preced­
ing year) as though the business combination had been completed
as of the beginning of the period reported on? ____  ___
f. The nature and amount of any material, nonrecurring items in­
cluded in the reported pro forma results of operations? ____  ___
g. Do the pro forma information disclosures in e above display at a 
minimum, revenue, income before extraordinary items and the 
cumulative effect of accounting changes (including those on an
interim basis), net income and earnings per share? ____  ___
[SFAS 141 par. 58, as amended by SFAS 154]
Other Disclosures and Presentation Items
10. Is any portion of the valuation allowance for deferred tax assets for 
which subsequently recognized tax benefits will be allocated to re­
duce goodwill and other noncurrent intangible assets of an acquired 
entity or directly to contributed capital (paragraphs 30 and 36 of SFAS
109) disclosed? ____  ___
[SFAS 109 par. 48]
11. If a material liability is recognized by the combined institution for 
costs incurred to (1) exit and activity, (2) involuntarily terminate em­
ployees of an acquired institution, or (3) relocate employees of an ac­
quired entity, are disclosures made in accordance with EITF 95-3,
"Recognition of Liabilities In Connection with a Purchase Business
Combination?" ____  ___
[EITF 95-3]
12. Are the following disclosures made for business combinations be­
tween parties with a preexisting relationship:
a. The nature of the preexisting relationship? ------- -----
b. The measurement of the settlement amount of the preexisting re­
lationship, if any, and the valuation method used to determine
the settlement amount? ------- -----
c. The amount of any settlement gain or loss recognized and its clas­
sification in the statement of operations? ------- -----
[EITF 04-1 par. 8]
FSP §20,300.03
130 Life and Health Insurance Entities
Yes
13. Amounts previously recognized as goodwill should not be reclassi­
fied as an identifiable intangible asset, however, previously recog­
nized goodwill should be tested for impairment by applying the con­
sensuses in step 2 of a goodwill impairment test. As a result of the 
application of EITF 04-1, "Accounting for Preexisting Relationships 
between the Parties to a Business Combination," is any effect on a
goodwill impairment charge reported in operating income? ____
[EITF 04-1 par. 9]
U. Segment Information
Note: Public business enterprises are required to provide the disclosures 
described in SFAS 131 and nonpublic business enterprises are encouraged 
to do so.
1. Are the factors used to identify the reporting entity's reportable seg­
ments, including the basis of organization (for example, whether man­
agement has chosen to organize the reporting entity around differ­
ences in products and services, geographic areas, regulatory 
environments, or a combination of factors and whether operating seg­
ments have been aggregated) disclosed?
[SFAS 131 par. 26]
2. Are the types of products and services from which each reportable 
segment derives its revenues disclosed?
[SFAS 131 par. 26]
3. Has a measure of profit or loss and total assets been reported for each 
reportable segment?
[SFAS 131 par. 27, as amended by SFAS 135]
4. If the following specified amounts (a) are included in the measure of 
segment profit or loss reviewed by the chief operating decision maker 
or (b) are otherwise regularly provided to the chief operating decision 
maker, even if not included in that measure of segment profit or loss, 
are they disclosed for each reportable segment:
a. Revenues from external customers?
b. Revenues from transactions with other operating segments of the 
same enterprise?
c. Interest revenue?
d. Interest expense?
e. Depreciation, depletion, and amortization expense?
f. Unusual items as described in paragraph 26 of APB 30?
g. Equity in the net income of investees accounted for by the equity 
method?
h. Income tax expense or benefit?
i. Extraordinary items?
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j. Significant noncash items other than depreciation, depletion, and
amortization expense? ____  ____  ____
[SFAS 131 par. 27, as amended by SFAS 135]
5. If the following specified amounts are (a) included in the determina­
tion of segment assets reviewed by the chief operating decision maker 
or (b) are otherwise regularly provided to the chief operating decision 
maker, even if not included in that measure of segment assets, are 
they disclosed for each reportable segment:
a. The amount of investment in equity method investees? ____  ____  ____
b. Total expenditures for additions to long-lived assets other than
financial instruments, deferred policy acquisition costs, and de­
ferred tax assets? ____  ____  ____
[SFAS 131 par. 28, as amended by SFAS 135]
6. Is an explanation of the measurements of segment profit or loss and 
segment assets that discloses the following for each reportable seg­
ment provided:
a. The basis of accounting for any transactions between reportable
segments? ____  ____  ____
b. The nature of any differences between the reporting entities' con­
solidated income before taxes, extraordinary items, and discontin­
ued operations (if not apparent from the reconciliations required
by SFAS 131 par. 32)? ____  ____  ____
c. The nature of any differences between the measurements of the 
reportable segments' assets and the reporting entity's consoli­
dated assets (if not apparent from the reconciliations required by
SFAS 131 par. 32)? ____  ____  ____
d. The nature of any changes from prior periods in the measurement 
methods used to determine reported segment profit or loss and 
the effect, if any, of those changes on the measure of segment
profit or loss? ____  ____  ____
e. The nature and effect of any asymmetrical allocations to seg­
ments? ____  ____  ____
[SFAS 131 par. 31, as amended by SFAS 154]
7. Are reconciliations of the totals of the reportable segments' revenues, 
measures of profit or loss, assets, and every other significant item of 
information disclosed to corresponding consolidated amounts pre­
sented with all significant reconciling items separately identified and
described? ____  ____  ____
[SFAS 131 par. 32, as amended by SFAS 154]
8. If the reporting entity changes the structure of its internal organiza­
tion in a manner that changes the composition of its reportable seg­
ments, is the corresponding information for prior periods restated 
and is the fact that the corresponding items of segment information
for earlier periods have been restated disclosed? ------- ------- ------
[SFAS 131 par. 34]
FSP §20,300.03
132 Life and Health Insurance Entities
Yes No N/A
9. If the reporting entity changes the structure of its internal organiza­
tion in a manner that changes the composition of its reportable seg­
ments and the corresponding information for prior periods is not re­
stated, does disclosure in the year in which the change occurs include 
segment information for the current period under both the old basis
and the new basis? ____  ____  ____
[SFAS 131 par. 35]
10. For all reporting entities subject to SFAS 131, including those that 
have a single reportable segment, are the following enterprise-wide 
items disclosed:
a. Revenues from external customers for each product and service
or each group of similar products and services unless it is imprac­
ticable to do so? ____  ____  ____
[SFAS 131 par. 37]
b. The following geographic information unless it is impracticable to 
do so:
(1) Revenues from external customers (a) attributed to the report­
ing entity's country of domicile and (b) attributed to all for­
eign countries in total from which the reporting entity derives
revenue? ____  ____  ____
(2) Revenues from external customers attributed to an individual
foreign country, if material? ____  ____  ____
(3) The basis for attributing revenues from external customers to
individual countries? ____  ____  ____
(4) Long-lived assets other than financial instruments, deferred 
policy acquisition costs, and deferred tax assets (a) located in 
the reporting entity's country of domicile and (b) located in 
all foreign countries in total in which the reporting entity
holds assets? ____  ____  ____
(5) Long-lived assets as described above in an individual foreign
country, if material? ____  ____  ____
[SFAS 131 par. 38]
c. Information about the extent of the reporting entity's reliance on 
its major customers, including the following:
(1) If revenues from transactions with any single customer 
amount to 10 percent or more of the reporting entity's reve­
nues, that fact, the total amount of revenues from each such 
customer, and the identity of the segment or segments report­
ing the revenue? ____  ____  ____
[SFAS 131 par. 39]
11. If the information described in questions 10a-b has not been disclosed
because it is impracticable, is that fact disclosed? ____  ____  ____
[SFAS 131 par. 37-38]
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V. Postemployment Benefits
1. If an obligation for postemployment benefits (for example, salary con­
tinuation, supplemental unemployment benefits, severance benefits, 
disability related benefits, job training and counseling, and continua­
tion of health and insurance coverage) has not been accrued because 
the amount cannot be reasonably estimated, is that fact disclosed in
the financial statements? ____  ____  ____
[SFAS 112 par. 7]
W. Stock Compensation Plans
1. If the entity has one or more share-based payment arrangements, does 
it disclose information that enables users of the financial statements 
to understand:
a. The nature and terms of such arrangements that existed during 
the period and the potential effects of those arrangements on
shareholders? ____  ____  ____
b. The effect of compensation cost arising from share-based payment
arrangements on the income statement? ____  ____  ____
c. The method of estimating the fair value of the goods or services 
received, or the fair value of the equity instruments granted (or
offered to grant), during the period? ____  ____  ____
d. The cash flow effects resulting from share-based payment ar­
rangements? ____  ____  ____
[SFAS 123(R) par. 64]
Notes: Paragraphs A240-A241 of SFAS 123(R) indicate the minimum in­
formation needed to achieve those objectives and illustrate how the disclo­
sure requirements might be satisfied. In some circumstances, an entity 
may need to disclose information beyond that listed in paragraph A240 to 
achieve the disclosure objectives.
On October 20, 2006, FSP FAS 123 (R)-6, Technical Corrections of FASB State­
ment No. 123(R), which addresses certain technical corrections of SFAS 
123(R). Specifically, it amends paragraph A240(d)(1) to exempt nonpublic 
entities from disclosing the aggregate intrinsic value of outstanding fully 
vested share options (or share units), among other matters.
The provisions in FSP FAS 123(R)-6 are effective in the first reporting pe­
riod beginning after October 20, 2006. If in applying SFAS 123(R) an entity 
did so in a manner consistent with the provisions of this FSP, then that 
entity should continue to apply the provisions in this FSP to prior periods. 
However, if an entity did not apply SFAS 123(R) in a manner consistent 
with the provisions of this FSP, then that entity should retrospectively ap­
ply the provisions in this FSP to prior periods when those periods' finan­
cial statements are included for comparative purposes with current-period 
financial statements.
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2. If the entity acquires goods or services other than employee services 
in share-based payment transactions, does it provide disclosures sim­
ilar to those in question 1 required by paragraph 64 of SFAS 123(R) to 
the extent that those disclosures are important to an understanding of
the effects of those transactions on the financial statements? ____
[SFAS 123(R) par. 65]
3. If the entity has multiple share-based payment arrangements with 
employees, does it disclose information separately for different types 
of awards under those arrangements to the extent that differences in 
the characteristics of the awards make separate disclosure important 
to an understanding of the entity's use of share-based compensation?
(See paragraph A240 of SFAS 123(R).) ____
[SFAS 123(R) par. 65]
Notes: EITF 06-11 is effective for income tax benefits that result from div­
idends on equity-classified employee share-based payment awards that 
are declared in fiscal years beginning after December 15, 2007, and interim 
periods within those fiscal years. Early application is permitted as of the 
beginning of a fiscal year for which interim or annual financial statements 
have not yet been issued. Retrospective application to previously issued 
financial statements is prohibited.
This issue clarifies that a realized income tax benefit from dividends or 
dividend equivalents charged to retained earnings and that are paid to 
employees for equity classified nonvested equity shares, nonvested equity 
share units, and outstanding equity share options should be recognized as 
an increase to additional paid-in capital. The amount recognized in addi­
tional paid-in capital for the realized income tax benefit from dividends 
on those awards should be included in the pool of excess tax benefits 
available to absorb tax deficiencies on share-based payment awards (as 
described in paragraphs 62-63 of SFAS 123(R)).
4. If an entity awards its employees, as part of a share-based payment 
arrangement, with (a) dividends on equity-classified nonvested 
shares, (b) dividend equivalents on equity-classified nonvested share 
units, or (c) payments equal to the dividends paid on the underlying 
shares while an equity-classified share option is outstanding, and 
those dividends or dividend equivalents are charged to retained earn­
ings under SFAS 123(R) resulting in an income tax deduction for the 
employer, is the realized income tax benefit:
a. Recognized as an increase to additional paid-in capital?
b. Included in the pool of excess tax benefits available to absorb tax 
deficiencies on share-based payment awards (as described in par­
agraphs 62-63 of SFAS 123(R))?
c. That is reclassified from additional paid-in capital to the income 
statement when an entity's estimate of forfeitures increases (or ac­
tual forfeitures exceed the entity's estimates), limited to the en­
tity's pool of excess tax benefits available to absorb tax deficien­
cies on the date of the reclassification?
[EITF 06-11 par. 6; SFAS 123(R), fn. 61]
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X. Asset Retirement Obligations
1. Is the following information about its asset retirement obligations dis­
closed:
a. A general description of the asset retirement obligations and the
associated long-lived assets? ____  ____  ____
b. The fair value of assets that are legally restricted for purposes of
settling asset retirement obligations? ____  ____  ____
c. A reconciliation of the beginning and ending aggregate carrying 
amount of asset retirement obligations showing separately the 
changes attributable to (1) liabilities incurred in the current pe­
riod, (2) liabilities settled in the current period, (3) accretion ex­
pense, and (4) revisions in estimated cash flows, whenever there 
is a significant change in one or more of those four components
during the reporting period? ____  ____  ____
[SFAS 143 par. 22]
2. If the fair value of an asset retirement obligation cannot be reasonably
estimated is that fact and the reasons therefore disclosed? ____  ____  ____
[SFAS 143 par. 22]
3. In addition to the disclosures required by paragraphs 19 (c)-(d), and
21 of APB 20, is the liability for the asset retirement obligation com­
puted on a pro forma basis disclosed in the footnotes for the begin­
ning of the earliest year presented and at the end of all years pre­
sented as if SFAS 143 and FIN 47, Accounting for Conditional Asset 
Retirement Obligations—an interpretation of FASB Statement No. 143, had
been applied during all periods affected? ____  ____  ____
[SFAS 143 par. 27; FIN 47 par. 11]
Y. Demutualizations and Formations of Mutual Insurance Holding 
Companies
1. Are the nature and terms of a demutualization or formation of and
MIHC and the basis of presentation and terms of operation of the
closed block disclosed? ------- ------- ------
[SOP 00-3 par. 24 (ACC 10,810.24)]
2. Is a general description of the method of emergence of earnings from 
the closed block, presentation of assets and liabilities of the closed
block, and policyholder dividend obligation provided? ------- ------- ------
[SOP 00-3 par. 24 (ACC 10,810.24)]
3. If a closed block has formed, is the following disclosed (Note: Refer to 
appendix A, "Illustrative Guidance—Footnote Disclosure for the 
Closed Block," of SOP 00-3, Accounting by Insurance Enterprises for De­
mutualizations and Formations of Mutual Insurance Holding Companies 
and for Certain Long-Duration Participating Contracts (AICPA, Technical 
Practice Aids, ACC sec. 10,810) for an illustrative example):
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a. A general description of the closed block, including the purpose 
of the closed block, the types of insurance policies included, and 
the nature of the cash flows that increase and decrease the
amount of closed block liabilities? ____
[SOP 00-3 par. 25a (ACC 10,810.25a)]
b. An indication the continuing responsibility of the insurance enter­
prise to support the payment of contractual benefits and the na­
ture of expenses charged to the closed block operations? ____
[SOP 00-3 par. 25a (ACC 10,810.25a)]
4. Is summarized financial data of the closed block as of, or for periods 
ending on the date of, the financial statements presented, including at 
a minimum:
a. The carrying amounts for the major types of invested assets of the
closed block? ____
b. Future policy benefits and policyholders' account balances? ____
c. Policyholder dividend obligation? ____
d. Premiums? ____
e. Net investment income? ____
f. Realized investment gains and losses? ____
g. Policyholder benefits? ____
h. Policyholder dividends? ____
i. The amount of maximum future earnings remaining to inure to
the benefit of stockholders from the assets and liabilities of the 
closed block as well as an analysis of the changes in the policy­
holder dividend obligation? ____
[SOP 00-3 par. 25b (ACC 10,810.25b)]
Note: GAAP disclosures that typically would be required for the various 
specific elements included in the closed block need not be made separately 
for the closed block if the nature of the information for the closed block 
would not differ significantly from that already included for the reporting 
entity as a whole. For example, it is not necessary to show a separate 
schedule of contractual maturities of closed block fixed maturity securities 
if the relative composition of contractual maturities is similar to those of 
the reporting entity taken as a whole. However, if the relative maturities 
of the closed block fixed maturities securities differ from those of the re­
porting entity taken as a whole, separate disclosures should be made. 
[SOP 00-3 par. 25c (ACC 10,810.25c)]
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Z. Guarantees
1. Is the following information disclosed by a guarantor about each 
guarantee, or each group of similar guarantees, even if the likelihood 
of the guarantor's having to make any payments under the guarantee 
is remote (except as provided in paragraph 14 of FIN 45, Guarantor's 
Accounting and Disclosure Requirements for Guarantees, Including Indirect 
Guarantees of Indebtedness of Others—an interpretation of FASB State­
ments No. 5, 57, and 107 and rescission of FASB Interpretation No. 34, 
with respect to the disclosure specified in par.13(b)):
a. The nature of the guarantee, including the approximate term, 
how the guarantee arose, and the events or circumstances that
would require the guarantor to perform under the guarantee? ____  ____  ____
b. The maximum potential amount of future payments (undis­
counted) the guarantor could be required to make under the guar­
antee? ____  ____  ____
c. If the terms of the guarantee provide for no limitation to the max­
imum potential future payments under the guarantee, is that fact
disclosed? ____  ____  ____
d. If the guarantor is unable to develop an estimate of the maximum
potential amount of future payments under its guarantee, are the 
reasons why the maximum potential amount cannot be estimated 
disclosed (see paragraph 14 of FIN 45 for an exception to this re­
quirement)? ____  ____  ____
e. The current carrying amount of the liability, if any, for the guar­
antor's obligations under the guarantee, including the amount, if 
any, recognized under SFAS 5 paragraph 8, regardless of whether
the guarantee is freestanding or embedded in another contract? ____  ____  ____
f. The nature of
(1) any recourse provisions that would enable the guarantor to 
recover from third parties any of the amounts paid under the
guarantee? and ____  ____  ____
(2) any assets held either as collateral or by third parties that,
upon the occurrence of any triggering event or condition un­
der the guarantee, the guarantor can obtain and liquidate to 
recover all or a portion of the amounts paid under the guar­
antee? ------- ------- ------
g. If estimable, the approximate extent to which the proceeds from
liquidation of those assets would be expected to cover the maxi­
mum potential amount of future payments under the guarantee? ------- ------- ------
[FIN 45 par. 13]
2. For product warranties and other guarantee contracts that are ex­
cluded from the initial recognition and initial measurement require­
ments of FIN 45 pursuant to paragraph 7(b) of FIN 45 (collectively 
referred to as product warranties), is the following information dis­
closed:
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a. The guarantor's accounting policy and methodology used in de­
termining its liability for product warranties (including any liabil­
ity associated with extended warranties)?
b. A tabular reconciliation of the changes in the guarantor's aggre­
gate product warranty liability for the reporting period?
c. Does the tabular reconciliation present
(1) the beginning balance of the aggregate product warranty lia­
bility?
(2) the aggregate reductions in that liability for payments made 
(in cash or in kind) under the warranty?
(3) the aggregate changes in the liability for accruals to product 
warranties issued during the reporting period, and the aggre­
gate changes in the liability for accruals related to preexisting 
warranties, including adjustments related to changes in esti­
mates?
(4) the ending balance of the aggregate product warranty liabil­
ity?
[FIN 45 par. 14]
3. Are the disclosure requirements in paragraphs 13-14 of FIN 45 com­
plied with for intellectual property infringement indemnifications as 
described in FSP FIN 45-1?
[FSP FIN 45-1]
4. Are the disclosure requirements in paragraphs 13-16 of FIN 45 ap­
plied to all minimum revenue guarantees in financial statements of 
interim or annual periods ending after the beginning of the first fiscal 
quarter following November 10, 2005, the date that the final FSP was 
posted to the FASB Web site? Thus, the disclosure requirements in 
paragraphs 13-16 should be applied to any minimum revenue guar­
antees issued prior to the initial application of the FSP, regardless of 
whether those guarantees were recognized and measured under FIN 
45?
[FSP FIN 45-3, par. 7]
AA. Fair Value Measurements
Notes: In February 2007, FASB issued SFAS 159, which is effective for fi­
nancial statements issued for fiscal years beginning after November 15, 
2007. Early adoption is permitted as of the beginning of a fiscal year that 
begins on or before November 15, 2007, provided the organization also 
elects to apply the provisions of SFAS 157. The choice to adopt early 
should be made after issuance of this statement but within 120 days of the 
beginning of the fiscal year of adoption, provided the entity has not yet 
issued financial statements, including required notes to those financial 
statements, for any interim period of the fiscal year of adoption.
This statement applies to all entities. Most of the provisions of this state­
ment apply only to entities that elect the fair value option. However, the 
amendment to SFAS 115 applies to all entities with available-for-sale and
(continued)
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trading securities. Some requirements apply differently to entities that do 
not report net income.
The statement permits an organization to irrevocably elect fair value as the 
initial and subsequent measurement attribute for certain financial assets 
and financial liabilities on a contract-by-contract basis, with changes in fair 
value recognized in earnings (or another performance indicator if the busi­
ness entity does not report earnings) at each subsequent reporting date. 
The provisions of this statement need not be applied to immaterial items. 
If SFAS 159 is applicable to the financial statements (and related notes) of 
the entity, questions 9-15 should be answered.
In September 2006, FASB issued SFAS 157, Fair Value Measurements, which 
defines fair value, establishes a framework for measuring fair value in 
GAAP, and expands disclosures about fair value measurements. The state­
ment is effective for financial statements issued for fiscal years beginning 
after November 15, 2007, and interim periods within those fiscal years.
In February 2008, FASB issued FSP FAS 157-1, Application of FASB State­
ment No, 157 to FASB Statement No. 13 and Other Accounting Pronouncements 
That Address Fair Value Measurements for Purposes of Lease Classification or 
Measurement under Statement 13, which establishes that SFAS 157 does not 
apply under SFAS 13 and other accounting pronouncements that address 
fair value measurements for purposes of lease classification or measure­
ment under SFAS 13. This scope exception does not apply to assets ac­
quired and liabilities assumed in a business combination that are required 
to be measured at fair value under SFAS 141 or SFAS 141(R), regardless of 
whether those assets and liabilities are related to leases.
Also note, with the issuance of FSP FAS 157-2, Effective Date of FASB State­
ment No. 157, in February 2008, FASB has deferred the effective date of 
SFAS 157 to November 15, 2008, for nonfinancial assets and liabilities, ex­
cept for items that are recognized or disclosed at fair value in an entity's 
financial statements on a recurring basis (at least annually).
Additionally, on September 30, 2008, the SEC issued a press release titled 
"SEC Office of the Chief Accountant and FASB Staff Clarifications on Fair 
Value Accounting," which assisted preparers and auditors by providing 
immediate clarification on fair value accounting until FASB provided ad­
ditional interpretative guidance (see next paragraph on FSP FAS 157-3). 
This press release can be found on the SEC's Web site and users are en­
couraged to read the full release.
In October 2008, FASB issued FSP FAS 157-3, Determining the Fair Value of 
a Financial Asset When the Market for That Asset Is Not Active. This FSP clar­
ifies the application of SFAS 157 in a market that is not active and provides 
an example to illustrate key considerations in determining the fair value 
of a financial asset when the market for that financial asset is not active. 
This FSP was effective upon issuance. Users are encouraged to read the 
full FSP on the FASB Web site. Also note that the guidance in FSP FAS 
157-3 is consistent with and amplifies the guidance in the above referenced 
press release.
(continued)
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Yes
If SFAS 157 is applicable to the financial statements (and related notes) of 
the entity, and the entity is either not eligible for or has not elected to 
apply the deferral provisions of FSP FAS 157-2, questions 1-7 should be 
answered. For those entities that are eligible to apply the provisions of FSP 
FAS 157-2 (and have elected to do so), questions 1-7 should be answered 
only in the context of assets and liabilities outside the scope of the FSP, 
and question 8 should be answered also.
17 For derivative assets and liabilities, the reconciliation disclosure required by paragraph 32(c) may be presented net.
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1. For assets and liabilities that are measured at fair value on a recurring 
basis in periods subsequent to initial recognition (for example, trading 
securities), the reporting entity shall disclose information that enables 
users of its financial statements to assess the inputs used to develop 
those measurements and for recurring fair value measurements using 
significant unobservable inputs (level 3), the effect of the measure­
ments on earnings (or changes in net assets) for the period. To meet 
that objective, the reporting entity shall disclose the following infor­
mation for each interim and annual period (except as otherwise spec­
ified) separately for each major category of assets and liabilities:
a. The fair value measurements at the reporting date.
b. The level within the fair value hierarchy in which the fair value 
measurements in their entirety fall, segregating fair value meas­
urements using quoted prices in active markets for identical as­
sets or liabilities (level 1), significant other observable inputs 
(level 2), and significant unobservable inputs (level 3).
c. For fair value measurements using significant unobservable in­
puts (level 3), a reconciliation of the beginning and ending bal­
ances, separately presenting changes during the period attributa­
ble to the following:17
(1) Total gains or losses for the period (realized and unrealized), 
segregating those gains or losses included in earnings (or 
changes in net assets), and a description of where those gains 
or losses included in earnings (or changes in net assets) are 
reported in the statement of income (or activities).
(2) Purchases, sales, issuances, and settlements (net).
(3) Transfers in and/or out of level 3 (for example, transfers due 
to changes in the observability of significant inputs).
d. The amount of the total gains or losses for the period in subpara­
graph (c)(1) above included in earnings (or changes in net assets) 
that are attributable to the change in unrealized gains or losses 
relating to those assets and liabilities still held at the reporting 
date and a description of where those unrealized gains or losses 
are reported in the statement of income (or activities).
e. In annual periods only, the valuation technique(s) used to meas­
ure fair value and a discussion of changes in valuation tech­
niques, if any, during the period.
[SFAS 157 par. 32]
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2. For assets and liabilities that are measured at fair value on a nonre­
curring basis in periods subsequent to initial recognition (for example, 
impaired assets), the reporting entity shall disclose information that 
enables users of its financial statements to assess the inputs used to 
develop those measurements. To meet that objective, the reporting en­
tity shall disclose the following information for each interim and an­
nual period (except as otherwise specified) separately for each major 
category of assets and liabilities:
a. The fair value measurements recorded during the period and the
reasons for the measurements? ____  ____  ____
b. The level within the fair value hierarchy in which the fair value 
measurements in their entirety fall, segregating fair value meas­
urements using quoted prices in active markets for identical as­
sets or liabilities (level 1), significant other observable inputs
(level 2), and significant unobservable inputs (level 3)? ____  ____  ____
c. For fair value measurements using significant unobservable in­
puts (level 3), a description of the inputs and the information used
to develop the inputs? ____  ____  ____
d. In annual periods only, the valuation technique(s) used to meas­
ure fair value and a discussion of changes, if any, in the valuation 
technique(s) used to measure similar assets and/or liabilities in
prior periods? ____  ____  ____
[SFAS 157 par. 33]
3. Are the quantitative disclosures required in questions 1-2 above pre­
sented using a tabular format? (See appendix A of SFAS 157 for im­
plementation guidance and examples.) ____  ____  ____
[SFAS 157 par. 34]
4. Is the fair value information disclosed under SFAS 157 and the fair
value information disclosed under other accounting pronouncements 
(for example, SFAS 107) combined in the periods in which those dis­
closures are required, if practicable? (Encouraged, but not required.) ____  ____  ____
[SFAS 157 par. 35]
5. Is information about other similar measurements (for example, inven­
tories measured at market value under ARB 43 chapter 4) disclosed,
if practicable? (Encouraged, but not required.) ____  ____  ____
[SFAS 157 par. 35]
Transition Guidance
6. At the date that SFAS 157 is initially applied to the financial instru­
ments, is the difference between the carrying amounts and the fair 
values of those instruments recognized as a cumulative-effect adjust­
ment to the opening balance of retained earnings (or other appropri­
ate components of equity or net assets in the statement of financial
position) for that fiscal year, presented separately? ------- ------- ------
[SFAS 157 par. 38]
Note: The disclosure requirements of SFAS 154 for a change in accounting 
principle do not apply.
FSP §20,300.03
142 Life and Health Insurance Entities
7. Are the disclosure requirements of SFAS 157 (paragraphs 32-35), in­
cluding those disclosures that are required in annual periods only, 
applied in the first interim period of the fiscal year in which this state­
ment is initially applied?
[SFAS 157 par. 39]
8. For those entities that are eligible to apply the deferral provisions of 
FSP FAS 157-2 (and have elected to do so), has the entity disclosed the 
following:
a. The fact that the entity has only partially applied SFAS 157?
b. Each major category of assets and liabilities that are recognized or 
disclosed at fair value for which, in accordance with FSP FAS 157- 
2, the entity has not applied the provisions of SFAS 157?
[FSP FAS 157-2 par. 12]
Note: The disclosure requirements of SFAS 157, including those disclo­
sures that are required in annual periods only, shall be applied in the first 
interim period of the fiscal year in which this statement is initially applied. 
The disclosure requirements of this statement need not be applied for fi­
nancial statements for periods presented prior to initial application of this 
statement.
9. If the organization reports assets and liabilities at fair value pursuant 
to the fair value option in SFAS 159, has it either (a) presented the 
aggregate of fair value and non-fair-value amounts in the same line 
item in the statement of financial position and parenthetically dis­
closed the amount measured at fair value included in the aggregate 
amount or (b) presented two separate line items to display the fair 
value and non-fair-value carrying amounts of similar assets and lia­
bilities?
[SFAS 159 par. 15]
Note: The disclosures described in paragraphs 18-22 of SFAS 159 are re­
quired for items measured at fair value under the option in SFAS 159 and 
the option in paragraph 16 of SFAS 133 (as amended by SFAS 155). Those 
disclosures are not required for securities classified as trading securities 
under SFAS 115, life settlement contracts measured at fair value pursuant 
to FSP TB 85-4-1, Accounting for Life Settlement Contracts by Third-Party In­
vestors, or servicing rights measured at fair value pursuant to SFAS 156. 
Entities shall provide the disclosures required by paragraphs 18-22 of 
SFAS 159 in both interim and annual financial statements. Entities are en­
couraged but are not required to present the disclosures required by SFAS 
159 in combination with related fair value information required to be dis­
closed by other statements (for example, SFAS 107 and SFAS 157). Appen­
dix B of SFAS 159 provides illustrative fair value disclosures.
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10. As of each date for which a statement of financial position is pre­
sented, do the entities disclose the following information about items 
measured at fair value under the option in SFAS 159 or the option in 
paragraph 16 of SFAS 133:
a. Management's reasons for electing a fair value option for each el­
igible item or group of similar eligible items? ____  ___
b. The following information if the fair value option is elected for 
some but not all eligible items within a group of similar eligible 
items:
(1) A description of those similar items and the reasons for par­
tial election? ____  ___
(2) Information to enable users to understand how the group of 
similar items relates to individual line items on the statement
of financial position? ____  ___
c. The following information for each line item in the statement of 
financial position that includes an item or items for which the fair 
value option has been elected:
(1) Information to enable users to understand how each line item 
in the statement of financial position relates to major catego­
ries of assets and liabilities presented in accordance with
SFAS 157's fair value disclosure requirements? ____  ___
(2) The aggregate carrying amount of items included in each line 
item in the statement of financial position that are not eligible
for the fair value option, if any? ____  ___
d. The difference between the aggregate fair value and the aggregate 
unpaid principal balance of:
(1) Loans and long-term receivables (other than securities subject 
to SFAS 115) that have contractual principal amounts and for
which the fair value option has been elected? ------- -----
(2) Long-term debt instruments that have contractual principal
amounts and for which the fair value option has been elected? ____  ___
e. For loans held as assets for which the fair value option has been 
elected:
(1) The aggregate fair value of loans that are 90 days or more
past due? ------- -----
(2) If the entity's policy is to recognize interest income separately 
from other changes in fair value, the aggregate fair value of
loans in nonaccrual status? ------- ------
(3) The difference between the aggregate fair value and the ag­
gregate unpaid principal balance for loans that are 90 days or
more past due, in nonaccrual status, or both? ------- ------
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f. For investments that would have been accounted for under the 
equity method if the entity had not chosen to apply the fair value 
option, the information required by paragraph 20 of APB 18 (ex­
cluding the disclosures in paragraphs 20(a)(3), 20(b), and 20(e) of
that opinion)? ____  ___
[SFAS 159 par. 18]
11. As of each period for which an income statement is presented, has the 
organization disclosed the following information about items meas­
ured at fair value under the option in SFAS 159 or the option in par­
agraph 16 of SFAS 133:
a. For each line item in the statement of financial position, the 
amounts of gains and losses from fair value changes during the 
period included in earnings and in which line in the income state­
ment those gains and losses are reported? (An organization may 
meet this requirement by disclosing amounts of gains and losses 
that include amounts of gains and losses for other items measured
at fair value, such as items required to be measured at fair value.) ____  ___
b. A description of how interest and dividends are measured and
where they are reported in the income statement? ____  ___
c. For loans and other receivables held as assets:
(1) the estimated amount of gains or losses included in earnings
during the period attributable to changes in instrument-spe­
cific credit risk? ____  ___
(2) How the gains or losses attributable to changes in instrument-
specific credit risk were determined? ____  ____
d. For liabilities with fair values that have been significantly affected 
during the reporting period by changes in the instrument-specific 
credit risk:
(1) The estimated amount of gains and losses from fair value 
changes included in earnings that are attributable to changes
in the instrument-specific credit risk? ____  ____
(2) Qualitative information about the reasons for those changes? ____  ____
(3) How the gains and losses attributable to changes in instru­
ment-specific credit risk were determined? ____  ____
[SFAS 159 par. 19]
12. Has the organization disclosed the methods and significant assump­
tions used to estimate the fair value of items for which the fair value
option has been elected? ____  ____
[SFAS 159 par. 21]
13. If an organization elects the fair value option at a remeasurement 
event, has it disclosed the following for the period of the election:
a. Qualitative information about the nature of the event? ____  ____
b. Quantitative information by line item in the statement of financial 
position indicating which line items in the statement of activities 
include the effect of initially electing the fair value option for an
item? ____  ____
[SFAS 159 par. 22]
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Transition Guidance
Note: Retrospective application of SFAS 159 to fiscal years preceding the 
effective date, which would involve restatement of previously issued fi­
nancial statements, is not permitted because of the elective nature of the 
statement and the benefit of hindsight. Readers should refer to paragraph 
30 of SFAS 159 for specific requirements applicable to the early adoption 
of this statement.
14. At the date that SFAS 159 is initially applied to the financial state­
ments, is the effect of the adoption attributable to the election of the 
fair value option for selected financial assets and financial liabilities 
accounted for as a cumulative-effect adjustment to the opening bal­
ance of retained earnings (or other appropriate components of equity 
or net assets in the statement of financial position) as of the effective 
date, and not the beginning of the earliest year presented?
[SFAS 159 par. 25]
15. Has the organization electing the fair value option for items existing 
at the effective date provided the following in its annual and first- 
interim-period financial statements for the fiscal year that includes the 
effective date (or early adoption date):
a. A schedule that presents the following by line item in the state­
ment of financial position:
(1) The pretax portion of the cumulative-effect adjustment to re­
tained earnings (or appropriate class or classes of net assets) 
for items on that line?
(2) The fair value at the effective date (or early adoption date) of 
eligible items for which the fair value option is elected and 
the carrying amount of those same items immediately before 
electing the fair value option?
b. The net effect on the entity's deferred tax assets and liabilities of 
electing the fair value option?
c. Management's reasons for electing the fair value option for each 
existing eligible item or group of similar eligible items?
d. If the fair value option is elected for some but not all eligible items 
within a group of similar eligible items:
(1) A description of those similar items and the reasons for par­
tial election?
(2) Information to enable users to understand how the group of 
similar items relates to individual line items on the statement 
of financial position?
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e. The amount of valuation allowances that were removed from the 
statement of financial position because they related to items for
which the fair value option was elected? ------
[SFAS 159 par. 27]
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FSP Section 20,400 
Auditor’s Reports Checklist
This section of the checklist has been developed primarily to address the requirements most 
likely to be encountered when reporting on financial statements of commercial corporations in 
accordance with generally accepted auditing standards (GAAS) as issued by the Auditing Stan­
dards Board (ASB), a senior technical committee of the AICPA. Certain key differences in re­
porting requirements between audits conducted in accordance with GAAS and audits conducted 
in accordance with the rules and standards of the Public Company Accounting Oversight Board 
(PCAOB) are identified in bold text throughout this section of the checklist. However, the differ­
ences identified are not intended to be all inclusive, and readers should seek appropriate guidance 
for a comprehensive source of reporting requirements associated with audits conducted in 
accordance with the rules and standards of the PCAOB.
.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of 
the AICPA as a nonauthoritative practice aid.
.02 Explanation of References:
AR = Reference to section number in AICPA Professional Standards (vol. 2)
ASB = Auditing Standards Board
AU = Reference to section number in AICPA Professional Standards (vol. 1)
FASB = Financial Accounting Standards Board
PCAOB = Public Company Accounting Oversight Board
SAS = AICPA Statement on Auditing Standards
SSARS = AICPA Statement on Standards for Accounting and Review Services
.03 Checklist Questionnaire:
Yes No N/A
1. Is every financial statement audited specifically identified in the intro­
ductory paragraph of the auditor's report? ------- ------- ------
[AU 508.06]
2. Do the titles of the financial statements referred to in the introductory
paragraph of the auditor's report match the titles of the financial state­
ments presented? ------- ------- ------
[Generally Accepted]
3. Do the dates of the financial statements referred to in the introductory 
paragraph of the auditor's report match the dates of the financial
statements presented? ------- ------- ------
[Generally Accepted]
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4. Is the report appropriately addressed? ____  ____  ____
[AU 508.09]
Practice Tip
Auditing Interpretation No. 17, "Clarification in the Audit Report of the Extent of Testing of Internal Control 
Over Financial Reporting in Accordance With Generally Accepted Auditing Standards," of AU section 508, 
Reports on Audited Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 9508, par. .85-.88), pro­
vides language that may be added to the auditor's standard report on the financial statements of a nonissuer 
to clarify differences between a GAAS audit and an audit conducted in accordance with the standards of 
the PCAOB. Auditing Interpretation No. 18, "Reference to PCAOB Standards in an Audit Report on a Non­
issuer," of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508, par. .89-.92), explains how 
the auditor should report if engaged to also follow PCAOB Auditing Standards in the audit of a nonissuer.
5. Does the independent auditor's report include the following elements:
a. A title that includes the word independent?
[AU 508.08a]
b. A statement that the financial statements identified in the report 
were audited?
[AU 508.08b]
c. A statement that the financial statements are the responsibility of 
management and that the auditor's responsibility is to express an 
opinion on the financial statements based on his or her audit? 
[AU 508.08c]
d. (Audits of Nonissuers Only) For audits conducted in accordance 
with GAAS in the United States, a statement that the audit was 
conducted in accordance with GAAS and an identification of the 
country of origin of those standards (for example, auditing stan­
dards generally accepted in the United States of America or U.S. 
GAAS)?
[AU 508.08d]
e. (Audits of Issuers Only) A statement that the audit was con­
ducted in accordance with the standards of the PCAOB (United 
States)?
[AS 1.03]
f. A statement that these standards require that the auditor plan and 
perform the audit to obtain reasonable assurance about whether 
the financial statements are free of material misstatement?
[AU 508.08c]
g. A statement that an audit includes examining, on a test basis, ev­
idence supporting the amounts and disclosures in the financial 
statements; assessing the accounting principles used and signifi­
cant estimates made by management; and evaluating the overall 
financial statement presentation?
[AU 508.08f]
h. A statement that the auditor believes that his or her audit pro­
vides a reasonable basis for his or her opinion?
[AU 508.08g]
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i. When the auditor reports on financial statements presented in 
conformity with U.S. generally accepted accounting principles 
(GAAP), an opinion as to whether the financial statements pres­
ent fairly, in all material aspects, the financial position of the com­
pany as of the balance sheet date and the results of operations and 
its cash flows for the period then ended in conformity with GAAP 
and an identification of the country of origin of those accounting 
principles (for example, accounting principles generally accepted
in the United States of America or U.S. GAAP? ____  ____  ____
[AU 508.08h]
Notes: In May 2008, the ASB issued Auditing Interpretation No. 19, "Fi­
nancial Statements Prepared in Conformity With International Financial 
Reporting Standards as Issued by the International Accounting Standards 
Board" of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 
9508 par. .93-.97) which provides that, when the auditor of a nonissuer 
reports on financial statements prepared in conformity with International 
Financial Reporting Standards (IFRS), the auditor would refer, in the au­
ditor's report, to IFRS rather than U.S. GAAP.
When an auditor of a nonissuer reports on financial statements presented 
in conformity with both IFRS as issued by the International Accounting 
Standards Board and a jurisdictional variation of IFRS, the auditor would 
refer, in the auditor's report, to both IFRS and IFRS as endorsed by [insert 
name of endorsing country or economic union].
When an auditor of a nonissuer reports on financial statements presented 
in conformity with a jurisdictional variation of IFRS such that the entity's 
financial statements do not contain an explicit and unreserved statement 
of compliance with IFRS as issued by the International Accounting Stan­
dards Board, paragraphs .14-.15 of AU section 534, Reporting on Financial 
Statements Prepared for Use in Other Countries (AICPA, Professional Stan­
dards, vol. 1), and paragraphs .35-.60 of AU section 508 apply to financial 
statements prepared for more than limited distribution in the United 
States.
j. When the auditor reports on financial statements presented in 
conformity with IFRS, an opinion as to whether the financial 
statements present fairly, in all material respects, the financial po­
sition of the reporting entity as of the balance sheet date and the 
results of its operations and its cash flows for the period then 
ended in conformity with IFRS as issued by the International Ac­
counting Standards Board?
[AU 9508.93-.97]
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k. When the auditor reports on financial statements presented both
in conformity with IFRS and a jurisdictional variant of IFRS, an 
opinion as to whether the financial statements present fairly, in 
all material respects, the financial position of the reporting entity 
as of the balance sheet date and the results of its operations and 
its cash flows for the period then ended in conformity with IFRS 
as issued by the International Accounting Standards Board and 
with IFRS as endorsed by [insert name of endorsing country or eco­
nomic union]? ------- ------- ------
[AU 9508.93-.97]
l. When the auditor reports on financial statements presented in 
conformity with a jurisdictional variation of IFRS such that the 
entity's financial statements do not contain an explicit and unre­
served statement of compliance with IFRS as issued by the Inter­
national Accounting Standards Board, a variation of the standard 
report that reflects the guidance in paragraphs .14-.15 of AU sec­
tion 534 and paragraphs .35-60 of AU section 508 for financial 
statements prepared for more than limited distribution in the
United States? ------- ------- ------
[AU 9508.93-.97]
m. The manual or printed signature of the auditor's firm? ____  ____  ____
[AU 508.08l]
n. The date of the audit report? ____  ____  ____
[AU 508.08j]
Practice Tip
Paragraph .08 of AU section 508 illustrates the form of the auditor's standard report on financial statements 
covering a single year and on comparative financial statements.
Notes: In May 2008, the ASB issued Auditing Interpretation No. 14 (re­
vised 2008), "Reporting on Audits Conducted in Accordance With Audit­
ing Standards Generally Accepted in the United States of America and in 
Accordance With International Standards on Auditing" of AU section 508 
(AICPA, Professional Standards, vol. 1, AU sec. 9508 par. .56—.59) which pro­
vides that, when the audit of a nonissuer is conducted both in accordance 
with standards generally accepted in the United States of America and in 
accordance with the International Standards on Auditing (ISA), the audi­
tor may so indicate in the auditor's report.
To determine whether an audit was conducted in accordance with ISA, it 
is necessary to consider the text of ISA in their entirety, including the basic 
principles and essential procedures together with the related guidance in­
cluded in ISA.
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6. If the audit of financial statements to be used in the United States was 
conducted in accordance with ISA as issued by the International Au­
diting and Assurance Standards Board, in their entirety, has the au­
ditor considered indicating in the auditor's report that the audit was 
also conducted in accordance with ISA as allowed? (Note: Not re­
quired: Interpretation No. 14 of AU 508 provides an example report.)
[AU 9508.57-.59] ____  ____  ____
Notes: On May 24, 2007, the PCAOB adopted Auditing Standard No. 5, 
An Audit of Internal Control Over Financial Reporting That Is Integrated with 
An Audit of Financial Statements (AICPA, PCAOB Standards and Related 
Rules, Rules of the Board, "Standards"), that supersedes Auditing Stan­
dard No. 2. The PCAOB adopted Auditing Standard No. 5 with the pri­
mary objective of focusing the auditor on matters most important to inter­
nal control. Goals of this new standard are to eliminate unnecessary 
procedures, to simplify and shorten the standard by reducing detail and 
specificity, and to make the audit more scalable for smaller and less com­
plex companies.
Auditing Standard No. 5 is effective for audits of internal control over fi­
nancial reporting required by Section 404(b) of the Sarbanes-Oxley Act of 
2002 for fiscal years ending on or after November 15, 2007.
Among other significant guidance, Auditing Standard No. 5 states that an 
audit of internal control over financial reporting should be integrated with 
the audit of the financial statements. The auditor may choose to issue a 
combined report (that is, one report containing both an opinion on the 
financial statements and an opinion on internal control over financial re­
porting) or separate reports on the company's financial statements and on 
internal control over financial reporting. Paragraph 85 of Auditing Stan­
dard No. 5 lists the basic elements that an auditor's report on the audit of 
internal control over financial reporting must include. Readers can refer to 
the full text of the Auditing Standard at www.pcaob.org.
7. If a subsequent event disclosed in the financial statements occurs after 
the original date of the independent auditor's report but before the 
issuance of the related financial statements, has the auditor followed 
one of the following two methods available for dating the report:
a. Dual dating, in which the independent auditor's responsibility for 
events occurring subsequent to the original report date is limited 
to the specific event referred to in an explanatory note in the re­
port (or otherwise disclosed)?
b. Dating the report as of the later date, in which the independent 
auditor's responsibility for subsequent events extends to the date 
of the report?
[AU 530.03-.05]
8. (Audits of Issuers Only) If the auditor obtains knowledge about a 
subsequent event that:
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a. Materially and adversely affects the effectiveness of the com­
pany's internal control over financial reporting as of the date 
specified in the assessment, has the auditor either:
(1.) Issued an adverse opinion on internal control over financial 
reporting (and followed the direction in paragraph C2 of 
PCAOB Auditing Standard No. 5 if management's assessment 
states that internal control over financial reporting is effec­
tive)? ____
(2.) Disclaimed an opinion if the auditor is unable to determine 
the effect of the subsequent event on the effectiveness of the 
company's internal control over financial reporting? ____
b. Relates to conditions that did not exist at the date specified in the 
assessment but arose subsequent to that date and before issuance 
of the auditor's report, and the subsequent event has a material 
effect on the company's internal control over financial reporting, 
has the auditor included in his or her report an explanatory par­
agraph describing the event and its effects or directed the reader's 
attention to the event and its effects as disclosed in management's
report? ____
[AS 5.96-.97]
9. If the accountant is not independent, has he or she followed one of 
the two reporting alternatives available:
a. Disclaiming the opinion with respect to the financial statements
and specifically stating that he or she is not independent? ____
b. Issuing a compilation report in accordance with SSARS indicating
the lack of independence (nonpublic companies only)? ____
[AU 504.05 and .09-.10; AR 100A.21 and .48-.53]
10. If the opinion is based in part on the report of another auditor:
a. Does the introductory paragraph of the standard report disclose
the fact that the opinion is based, in part, on the report of other 
auditors? ____
b. Does the opinion paragraph include a reference to the report of
the other auditor? ____
[AU 508.11a and .12-.13]
11. If, to prevent the financial statements from being misleading because
of unusual circumstances, the financial statements contain a departure 
from an accounting principle promulgated by a body designated by 
the AICPA Council to establish such principles, does the report in­
clude, in a separate paragraph or paragraphs, the information re­
quired by the rule? ____
[AU 508.111b and .15]
12. If there is substantial doubt about the entity's ability to continue as a 
going concern for a reasonable period of time, not to exceed one year 
beyond the date of the financial statements being audited:
a. Does the report include an explanatory paragraph, following the
opinion paragraph, to reflect that conclusion? ____
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b. Is that conclusion expressed through the use of the phrase "sub­
stantial doubt about its (the entity's) ability to continue as a going 
concern" or similar wording that includes the terms substantial
doubt and going concern? ____  ____  ____
[AU 508.11c; AU 341.12]
Practice Tip
In evaluating whether there is substantial doubt about the entity's ability to continue as a going concern, the 
auditor's evaluation is based on his or her knowledge of relevant conditions that exist at or have occurred 
prior to the date of the auditor's report. If, after considering identified conditions and events and manage­
ment's plans, the auditor concludes that substantial doubt about the entity's ability to continue as a going 
concern for a reasonable period of time remains, the audit report should include an explanatory paragraph 
to reflect that conclusion.
In a going concern paragraph, the auditor should not use conditional language in expressing a conclusion 
concerning the existence of substantial doubt about the entity's ability to continue as a going concern. See 
AU section 341 paragraph .13 for an example.
13. (Audits of Nonissuers Only) Is the report dated no earlier than the 
date on which the auditor has obtained sufficient appropriate audit
evidence to support the auditor's opinion on the financial statements? ____  ____  ____
[AU 530.01]
14. (Audits of Issuers Only) Is the report dated no earlier than the date 
on which the auditor has obtained sufficient competent evidence to
support the auditor's opinion on the financial statements? ____  ____  ____
[AS 5.89]
15. (Audits of Issuers Only) When performing an integrated audit of fi­
nancial statements and internal control over financial reporting, are 
the auditor's reports on the company's financial statements and on
internal control over financial reporting dated the same? ____  ____  ____
[AS 5.89]
16. (Audits of Issuers Only) Prior to the report release date, among other 
matters, has the auditor obtained sufficient evidence to support the
representations in the auditor's reports? ____  ____  ____
[AS 3.15]
Notes: For audits of issuers, certain circumstances, though not affecting 
the auditor's unqualified opinion, may require that the auditor add ex­
planatory language to the standard report as described in paragraphs 
.11-.19 of AU section 508 (AICPA, PCAOB Standards and Related Rules, 
PCAOB Standards, As Amended).
Other circumstances may require a departure from an unqualified opin­
ion, either in the form of a qualified opinion, an adverse opinion, or a 
disclaimed opinion as described in paragraphs .20-63 of AU section 508 
(AICPA, PCAOB Standards and Related Rules, PCAOB Standards, As 
Amended).
For special reporting situations relating to the auditor's report on internal 
control over financial reporting, refer to appendix C, "Special Reporting 
Situations," of Auditing Standard No. 5.
(continued)
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In January, 2008, the PCAOB adopted Auditing Standard No. 6, Evaluating 
Consistency of Financial Statements, and an accompanying set of amend­
ments to the PCAOB's interim Auditing Standards. Among other signifi­
cant provisions, the new standard and related amendments update the au­
ditor's responsibilities to evaluate and report on the consistency of a 
company's financial statements and align the auditor's responsibilities 
with FASB Statement No. (SFAS) 154, Accounting Changes and Error Correc­
tions—a replacement of APB Opinion No. 20 and FASB Statement No. 3.
One significant difference in terminology between SFAS 154 and Auditing 
Standard No. 6 is the use of the term error in the SFAS compared with the 
use of the term misstatement in the PCAOB standard, which specifically 
states that the meaning is the same for purposes of the PCAOB Auditing 
Standards. Auditing Standard No. 6 also establishes that the auditor's re­
port should indicate whether an adjustment to previously issued financial 
statements results from a change in accounting principle or the correction 
of a misstatement.
Auditing Standard No. 6 contains numerous amendments to PCAOB AU 
section 508 and other interim PCAOB Auditing Standards. The Securities 
and Exchange Commission (SEC) approved Auditing Standard No. 6 in its 
Release No. 34-58555 dated September 16, 2008. The new standard and 
related amendments are effective November 15, 2008. If Auditing Stan­
dard No. 6 is applicable to issuers' financial statements, answer questions 
18-19; otherwise, skip questions 18-19. For more information and for the 
full text of the Auditing Standard, refer to the PCAOB Web site at 
www.pcaob.org. Also refer to the SEC Web site at www.sec.gov.
17. (Audits of Nonissuers Only) If there has been a material change be­
tween periods in accounting principles or in the method of their ap­
plication, including a change from an accounting principle that is not 
generally accepted to one that is generally accepted and a change in 
accounting principle that is inseparable from the effect of a change in 
estimate, that has a material effect on the comparability of the report­
ing entity's financial statements:
a. Does the report include an explanatory paragraph, following the 
opinion paragraph that refers to the change?
h. Does the explanatory paragraph identify the nature of the change 
and refer the reader to the note to the financial statements that 
discusses the change in detail?
[AU 508.05-.06 and .12-.13]
c. If the change in the accounting principle is a change in reporting 
entity that did not result from a transaction or an event, is an ex­
planatory paragraph included in the auditor's report? (Note: A 
change in the reporting entity resulting from a transaction or 
event, such as the creation, cessation, or complete or partial pur­
chase or disposition of a subsidiary or other business unit does 
not require that an explanatory paragraph about consistency be 
included in the auditor's report.)
[AU 420.08]
FSP §20,400.03
No N/A
Auditor's Reports Checklist 155
Yes No N/A
18. (Audits of Nonissuers Only) If there has been a change in accounting 
principle that has a material effect on the financial statements, includ­
ing a change in the method of applying an accounting principle, a 
change in estimate effected by a change in accounting principle, and 
a change in classification that represents a change in accounting prin­
ciple, and meets the four criteria established in paragraph 7 of PCAOB 
Auditing Standard No. 6:
a. Does the report include an explanatory paragraph, following the 
opinion paragraph, in the year of the change and in subsequent 
years until the new accounting principle is applied in all periods
presented? ____  _____ ____
b. Does the explanatory paragraph identify the nature of the change 
and include a reference to the note disclosure describing the
change? ____  ____ _ ____
c. If the change in the accounting principle is a change in reporting 
entity that did not result from a transaction or an event, is an ex­
planatory paragraph included in the auditor's report? (Note: A 
change in the reporting entity resulting from a transaction or 
event, such the creation, cessation, or complete or partial pur­
chase or disposition of a subsidiary or other business unit, does
not require recognition in the auditor's report.) ____  ____ _ ____
[AS 6.04-.08 and .11]
19. (Audits of Issuers Only) If there has been a correction of a material 
misstatement in previously issued financial statements, including a 
change from an accounting principle that is not generally accepted to 
one that is generally accepted and a change in classification that rep­
resents the correction of a material misstatement, does the auditor's 
report contain an explanatory paragraph, following the opinion par­
agraph, that includes:
a. A statement that the previously issued financial statements have 
been restated for the correction of a misstatement in the respective
period? ____  ____ _ ____
b. A reference to the company's disclosure of the correction of the
misstatement? ____  ____ _ ___
[AS 6.04-.08 and .11]
20. If in an updated report on the individual financial statements of one 
or more prior periods presented on a comparative basis with those of 
the current period the opinion is different from the opinion previ­
ously expressed on the financial statements of a prior period:
a. Does the report include an explanatory paragraph, preceding the 
opinion paragraph that discloses all of the substantive reasons for
the different opinion? ------- ------ - -----
b. Does the explanatory paragraph disclose:
(1) The date of the auditor's previous report? ------- ------ - -----
(2) The type of opinion previously expressed? ------- ------ - -----
(3) The circumstances or events that caused the auditor to ex­
press a different opinion? ------- -------- -----
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(4) That the auditor's updated opinion on the financial state­
ments of the prior period is different from his or her previous 
opinion on those statements?
[AU 508.11e and .69]
21. If financial statements of a prior period (presented for comparative 
purposes) have been audited by a predecessor auditor whose report 
is not presented:
a. Does the introductory paragraph of the successor's auditor report 
indicate:
(1) That the financial statements of the prior period were audited 
by another auditor?
(2) The date of the predecessor auditor's report?
(3) The type of report issued by the predecessor auditor?
(4) If the report was other than a standard report, the substantive 
reasons therefore including a description of the nature of and 
reasons for the explanatory paragraph added to the predeces­
sor's report or his or her opinion qualification?
b. If the financial statements have been restated, does the introduc­
tory paragraph indicate that the predecessor auditor reported on 
the financial statements of the prior period before restatement? 
[AU 508.11e and .74]
22. Is an explanatory paragraph (or other explanatory language) added 
to the standard auditor's report if:
a. The auditor wishes to clarify that an audit performed in accor­
dance with GAAS does not require the same level of testing and 
reporting on internal control over financial reporting as an audit 
of an issuer when Section 404(b) of the Sarbanes-Oxley Act is ap­
plicable? (Note: Not required: Interpretation No. 17 of AU section 
508 provides an example report.)
[AU 9508.85-.88]
b. The audit is conducted in accordance with both GAAS and the 
PCAOB's Auditing Standards? (Note: Not required: Interpreta­
tion No. 18 of AU 508 provides an example report.)
[AU 9508.89-.92]
23. Is an explanatory paragraph (or other explanatory language) added 
to the standard auditor's report if the prior period's financial state­
ments are audited by a predecessor auditor who had ceased opera­
tions?
[AU 9508.60-.75]
24. If selected quarterly financial data required by SEC Regulation S-K 
has been omitted or has not been reviewed, does the report include 
an additional paragraph stating that fact?
[AU 508.11/ AU 722.50]
25. If other information in a document containing audited financial state­
ments is materially inconsistent with information appearing in the fi­
nancial statements, has it been determined whether the financial state­
ments, the auditor's report, or both require revision?
[AU 508.11h; AU 550.04]
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26. If supplementary information required by GAAP has been omitted,
the presentation of such information departs materially from pre­
scribed guidelines, the auditor is unable to complete prescribed pro­
cedures with respect to such information, or the auditor is unable to 
remove substantial doubt about whether the supplementary informa­
tion conforms to prescribed guidelines, does the report include an ad­
ditional paragraph stating that fact? ____  ____  ____
[AU 508.11g; AU 558.08]
27. If the auditor decides to emphasize a matter regarding the financial 
statements in the report, is the matter being emphasized disclosed in 
the financial statements and is the explanatory information presented 
in a separate paragraph that avoids use of phrases such as “with the
foregoing (following) explanation?" ____  ____  ____
[AU 508.11 and .19; AU 9410.18; AU 9342.03]
28. If it has not been possible to conduct the audit in accordance with 
GAAS or to apply all of the procedures considered necessary in the 
circumstances, has consideration been given to the need to issue a
qualified opinion or to disclaim an opinion? ____  ____  ____
[AU 508.22]
29. If a qualified opinion is to be expressed because of a scope limitation:
a. Are all of the substantive reasons for the qualification disclosed in
one or more explanatory paragraphs preceding the opinion para­
graph? ____  ____  ____
b. Does the qualified opinion include the word except or exception in
a phrase such as except for or with the exception of? ____  ____  ____
c. Is the situation described and referred to in both the scope and
opinion paragraphs? ____  ____  ____
d. Does the wording in the opinion paragraph indicate that the qual­
ification pertains to the possible effects on the financial statements
and not the scope limitation itself? ____  ____  ____
[AU 508.21-.32; AU 318.76]
Practice Tip
Scope limitations can be imposed by the client or by circumstances such as the timing of the auditor's work, 
the inability to obtain sufficient appropriate audit evidence, or an inadequacy in the accounting records. 
Sufficient appropriate audit evidence includes, among other things, management having asserted responsi­
bility for the final financial statements. As provided in Technical Practice Aid (TPA) Technical Questions 
and Answers (TIS) section 9100.06, "Signing and Dating Reports" (AICPA, Technical Practice Aids), the au­
ditor will need to have the signed management representation letter in hand prior to releasing the auditor's 
report because management's refusal to furnish written representations constitutes a limitation on the scope 
of the audit sufficient to preclude an unqualified opinion.
In circumstances in which the auditor is unable to obtain sufficient appropriate audit evidence to support 
management's assertions about the nature of a matter involving an uncertainty and its presentation or dis­
closure in the financial statements, the auditor should consider the need to express a qualified opinion or to 
disclaim an opinion because of a scope limitation.
[AU 508.22 and .31]
(continued) 
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In circumstances in which the auditor is unable to audit the existence or measurement of interests in invest­
ments in securities and interests in trusts, the auditor should consider whether that scope limitation requires 
the auditor to either qualify his or her opinion or to disclaim an opinion, as discussed in paragraphs .22-.26 
of AU section 508; Interpretation No. 1, "Auditing Interests in Trusts Held by a Third-Party Trustee and 
Reported at Fair Value" of AU section 328, Auditing Fair Value Measurements and Disclosures (AICPA, Profes­
sional Standards, vol. 1, AU sec. 9238, paragraphs .01-.04); and Auditing Interpretation No. 1, "Auditing 
Investments in Securities Where a Readily Determinable Fair Value Does Not Exist" of AU section 332, 
Auditing Derivative Instruments, Hedging Activities, and Investments in Securities (AICPA, Professional Standards, 
vol. 1, AU sec. 9332, paragraphs .01-.04).
In circumstances in which the auditor is unable to audit the existence or measurement of interests in invest­
ments in securities and interests in trusts, the auditor should consider whether that scope limitation requires 
the auditor to either qualify his or her opinion or to disclaim an opinion, as discussed in paragraphs .22-26 
of AU section 508 (AICPA, Professional Standards, vol. 1), AU section 9328 paragraphs .01-.04, and AU section 
9332 paragraphs .01-.04
30. Is a qualified opinion or disclaimer of opinion expressed if the audi­
tor's understanding of internal control raises doubts about the audit- 
ability of an entity's financial statements, such as:
a. Concerns about the integrity of an entity's management cause the 
auditor to conclude that the risk of management misrepresenta­
tion in the financial statements is such that an audit cannot be 
conducted?
b. Concerns about the condition and reliability of an entity's records 
cause the auditor to conclude that it is unlikely that sufficient ap­
propriate audit evidence will be available to support an unquali­
fied opinion on the financial statements?
[AU 314.109]
31. If, in the auditor's judgment, the two-way communication between 
the auditor and those charged with governance as described in AU 
section 380 is not adequate and the situation cannot be resolved, 
thereby prohibiting the auditor from obtaining all the audit evidence 
required to form an opinion on the financial statements, has the au­
ditor considered the following:
a. Modifying the audit opinion on the basis of a scope limitation?
b. Obtaining legal advice about the consequences of different 
courses of action?
c. Communicating with an appropriate third party (for example, a 
regulator)?
d. Withdrawing from the engagement?
[AU 380.62-.63]
32. If, in the auditor's judgment, significant difficulties in dealing with 
management such as those described in AU section 380 have been 
encountered, has the auditor considered modifying the audit opinion 
on the basis of a scope limitation?
[AU 380.39]
33. If an opinion is disclaimed because of a scope limitation:
a. Are all of the substantive reasons for the disclaimer stated in a 
separate paragraph or paragraphs?
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b. Does the report state that the scope of the audit was not sufficient
to warrant the expression of an opinion? ____  ____  ____
c. Does the report avoid identifying procedures that were per­
formed? ____  ____  ____
d. Is the scope paragraph omitted? ____  ____  ____
e. If there are reservations about fair presentation of the financial 
statements in conformity with GAAP, are they described in the
report? ____  ____  ____
[AU 508.62-.63]
Note: Consult the Topical Index to the AICPA Professional Standards under 
"Scope of Audit—Limitations" for additional references to specific types 
of scope limitations that could result in either a qualified or disclaimer of 
opinion.
34. If the financial statements are materially affected by a departure from
GAAP (including, for example, inadequate disclosure, inappropriate 
accounting principles, and unreasonable accounting estimates), has 
the auditor issued a qualified opinion or an adverse opinion?
[AU 508.35]
35. If a qualified opinion is to be expressed because of a GAAP departure:
a. Are all of the substantive reasons that have led to the conclusion 
that there is a departure from GAAP disclosed in one or more 
separate explanatory paragraphs preceding the opinion para­
graph?
b. Does the qualified opinion include the word except or exception in 
a phrase such as except for or with the exception of and a reference 
to the explanatory paragraph?
c. Does the explanatory paragraph disclose the principle effects of 
the departure on financial position, results of operations, and cash 
flows, if practicable, or state that the effects are not reasonably 
determinable?
[AU 508. 21 and AU 508.37-.39]
36. If an adverse opinion is to be expressed because of a GAAP departure:
a. Are all of the substantive reasons for the adverse opinion dis­
closed in one or more separate explanatory paragraphs preceding 
the opinion paragraph?
b. Does the explanatory paragraph disclose the principle effects of 
the departure on financial position, results of operations, and cash 
flows, if practicable, or state that the effects are not reasonably 
determinable?
c. State that the financial statements do not present fairly the finan­
cial position, or results of operations or cash flows in conformity 
with GAAP?
[AU 508.58-.59]
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Notes: Consult the Topical Index to the AICPA Professional Standards un­
der "Departures From Standard Report" for additional information.
Readers may also wish to refer to TIS section 1400.31, "GAAP Departure 
for FIN No. 46(R)" (AICPA, Technical Practice Aids), for assistance in deter­
mining the implications on the auditor's report if the reporting entity does 
not consolidate a variable interest entity.
Practice Tip
Reporting on financial statements prepared in conformity with an other comprehensive basis of accounting 
(OCBOA) is addressed in AU section 623, Special Reports (AICPA, Professional Standards, vol. 1). For purposes 
of that section, a comprehensive basis of accounting other than GAAP is one of the following:
a. A basis of accounting that the reporting entity uses to comply with the requirements or financial 
reporting provisions of a governmental regulatory agency to whose jurisdiction the entity is subject. 
An example is a basis of accounting insurance companies use pursuant to the rules of a state insur­
ance commission.
b. A basis of accounting that the reporting entity uses or expects to use to file its income tax return for 
the period covered by the financial statements.
c. The cash receipts and disbursements basis of accounting, and modifications of the cash basis having 
substantial support, such as recording depreciation on fixed assets or accruing income taxes.
d. A definite set of criteria having substantial support that is applied to all material items appearing in 
financial statements, such as the price-level basis of accounting.
In considering whether the financial statements (including the accompanying notes) include all informative 
disclosures that are appropriate for the basis of accounting used, paragraph .09 of AU section 623 states that 
the auditor should apply essentially the same criteria to financial statements prepared on an OCBOA as he 
or she does to financial statements prepared in conformity with GAAP.
37. When reporting on financial statements prepared in conformity with 
a comprehensive basis of accounting other than GAAP, as defined in 
paragraph .04 of AU section 623, does the independent auditor's re­
port include the following elements (for audits prepared in conform­
ity with GAAS):
a. A title that includes the word independent?
[AU 623.05a]
b. A paragraph that states that:
(1) The financial statements identified in the report were au­
dited?
(2) The financial statements are the responsibility of the com­
pany's management and that the auditor is responsible for ex­
pressing an opinion on the financial statements based on the 
audit?
[AU 623.05b]
c. A paragraph that states that:
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(1) The audit was conducted in accordance with GAAS with spe­
cific identification of the United States of America as the
country of origin of those standards? ____  ____  ____
(2) Those standards require that the auditor plan and perform 
the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement? ____  ____  ____
(3) An audit includes examining, on a test basis, evidence sup­
porting the amounts and disclosures in the financial state­
ments; assessing the accounting principles used and signifi­
cant estimates made by management; and evaluating the
overall financial statement presentation? ____  ____  ____
(4) The auditor believes that his or her audit provides a reasona­
ble basis for the opinion? ____  ____  ____
[AU 623.05c]
d. A paragraph that states:
(1) The basis of presentation and refers to the note to the financial
statements that describes the basis? ____  ____  ____
(2) That the basis of presentation is a comprehensive basis of ac­
counting other than GAAP? ____  ____  ____
[AU 623.05d]
e. A paragraph that expresses the auditor's opinion (or disclaims an 
opinion) on whether the financial statements are presented fairly, 
in all material respects, in conformity with the basis of accounting
described? ____  ____  ____
[AU 623.05c]
f. If the financial statements are prepared in conformity with the re­
quirements or financial reporting provisions of a governmental 
regulatory agency, a separate paragraph at the end of the report 
stating that the report is intended solely for the information and 
use of those within the entity and the regulatory agencies to 
whose jurisdiction the entity is subject, and is not intended to be 
and should not be used by anyone other than these specified par­
ties? ____  ____  ____
[AU 623.05f]
g. The manual or printed signature of the auditor's firm? ____  ____  ____
[AU 623.05g]
h. The date of the audit report? ____  ____  ____
[AU 623.05h]
38. When the financial statements are prepared in conformity with the 
requirements or financial reporting provisions of a governmental reg­
ulatory agency and the financial statements and reports will be used 
by parties or distributed by the entity to parties other than the regu­
latory agencies to whose jurisdiction the entity is subject, has the stan­
dard form of report been modified as appropriate because of the de­
partures from GAAP and has an additional paragraph been added to 
express an opinion on whether the financial statements are presented 
in conformity with the regulatory basis of accounting? (Note: Audit­
ing Interpretation No. 15, "Auditor Reports on Regulatory Account
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ing or Presentation When the Regulated Entity Distributes the Finan­
cial Statements to Parties Other Than the Regulatory Agency Either 
Voluntarily or Upon Specific Request" of AU section 623 [AICPA, Pro­
fessional Standards, vol. 1, AU sec. 9623 par. .96-.98], provides an ex­
ample report.)
[AU 544.04; AU 9623.96-.98]
39. If certain other information, including supplementary information re­
quired by GAAP, contained in annual reports and other client-pre­
pared documents described in AU section 550 paragraph .02 that con­
tain audited financial statements has been subjected to auditing 
procedures applied in the audit of the basic financial statements, does 
the auditor express an opinion on whether the information is fairly 
stated in all material respects in relation to those financial statements 
taken as a whole in the auditor's report and does the report describe 
clearly the character of the auditor's work and the degree of respon­
sibility the auditor is taking?
[AU 550.07; AU 558.09]
40. If other information contained in annual reports and other client-pre­
pared documents described in AU section 550 paragraph .02 that in a 
document containing audited financial statements is materially incon­
sistent with information appearing in the financial statements, has it 
been determined whether the financial statements, the auditor's re­
port, or both require revision?
[AU 508.11h; AU 550.04]
41. If other information contained in annual reports and other client-pre­
pared documents described in AU section 550 paragraph .02 that con­
tain audited financial statements is materially inconsistent with infor­
mation appearing in the financial statements, and the auditor has 
determined that neither the financial statements nor the auditor's re­
port require revision, has the auditor either:
a. Requested that the client revise the other information to eliminate 
the material inconsistency?
b. Considered other actions such as revising the audit report to in­
clude an explanatory paragraph describing the material inconsis­
tency, withholding the use of the audit report in the document, 
and withdrawing from the engagement?
[AU 550.04]
42. If information accompanies the basic financial statements and audi­
tor's report in an auditor-submitted document, is it accompanied by a 
report that:
a. States that the audit was performed for the purpose of forming an 
opinion on the basic financial statements taken as a whole?
b. Specifically identifies the accompanying information?
c. States that the accompanying information is presented for pur­
poses of additional analysis and is not a required part of the basic 
financial statements?
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Yes No N/A
d. Includes either an opinion on whether the accompanying infor­
mation is fairly stated in all material respects in relation to the 
basic financial statements taken as a whole or a disclaimer of 
opinion (depending on whether the information was subjected to 
the auditing procedures applied in the audit of the basic financial
statements)? ____  ____  ____
[AU 551.05-.06]
43. If information accompanying the basic financial statements and audi­
tor's report in an auditor-submitted document is materially misstated 
in relation to the basic financial statements taken as a whole, has the 
auditor either:
a. Requested that the client revise the accompanying information to
eliminate the material misstatement? ____  ____  ____
b. Considered other actions such as modifying the audit report to
describe the misstatement or refusing to include the accompany­
ing information in the auditor-submitted document? ____  ____  ____
[AU 551.09]
44. When the basic financial statements are accompanied by supplemen­
tary information required by GAAP and such supplementary infor­
mation has not been audited as part of the basic financial statements, 
does the auditor's report exclude any language that refers to the sup­
plementary information or the limited procedures applied (except in
the circumstances described in AU section 558 paragraph .08)? ____  ____  ____
[AU 558.08]
45. When the basic financial statements are accompanied by supplemen­
tary information required by GAAP and such supplementary infor­
mation has been audited as part of the basic financial statements, has 
the audit report been expanded in accordance with AU section 550
paragraph .07? ____  ____  ____
[AU 558.09]
46. If supplementary information required by GAAP has been omitted,
the presentation of such information departs materially from pre­
scribed guidelines, the auditor is unable to complete prescribed pro­
cedures with respect to such information, or the auditor is unable to 
remove substantial doubt about whether the supplementary informa­
tion conforms to prescribed guidelines, does the report include an ad­
ditional paragraph stating that fact? ------- ------- ------
[AU 508.11g; AU 558.08]
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Supplemental Information for Life 
Insurance Companies That are 
Securities and Exchange 
Commission Registrants
.01 Footnote 3 to AU section 411, The Meaning of Present Fairly in Conformity With Generally Accepted 
Accounting Principles (AICPA, Professional Standards, vol. 1), states, in part, that for Securities and Exchange 
Commission (SEC) registrants, rules and releases of the SEC have an authority similar to other officially 
established accounting principles.
Regulation S-X is the primary source of requirements for financial statements and related footnotes required 
to be included in documents filed with the SEC. In addition to Regulation S-X, preparers and auditors of 
financial statements should be familiar with the SEC's Financial Reporting Releases (FRR) and Staff Account­
ing Bulletins (SAB). FRRs communicate the SEC's position on accounting and auditing principles and prac­
tices. SABs represent interpretations and practices followed by the Division of Corporation Finance and the 
Office of the Chief Accountant of the SEC. Insurance companies are subject to the requirements of Articles 
1-4, 7, 10, and 12 of Regulation S-X.
When determining compliance with SEC requirements, preparers and auditors should refer to the appropri­
ate SEC pronouncements to ensure compliance with SEC disclosure rules. In particular, the following doc­
uments should be consulted:
• Regulation S-X, Article 1, Application of Regulation S-X
• Regulation S-X, Article 2, Qualifications and Reports of Accountants
• Regulation S-X, Article 3, General Instructions as to Financial Statements
• Regulation S-X, Article 3A, Consolidated and Combined Financial Statements
• Regulation S-X, Article 4, Rules of General Application
• Regulation S-X, Article 7, Insurance Companies
• Regulation S-X, Article 10, Interim Financial Statements
• Regulation S-X, Article 12, Form and Content of Schedules
• SABs reflect the SEC staff's views regarding accounting-related disclosure practices. They represent 
interpretations and policies followed by the Division of Corporation Finance and the Office of the 
Chief Accountant in administering the disclosure requirements of the federal securities laws.
• FRRs adopt, change, or interpret requirements relating to accounting, auditing, and disclosure 
issues.
• The Sarbanes-Oxley Act of 2002
• Rules and standards of the Public Company Accounting Oversight Board
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Illustrative Financial Statements
.01 This section contains illustrative financial statements prepared in conformity with generally accepted 
accounting principles (GAAP). The financial statements are for illustrative purposes only, are not intended 
to be comprehensive and are not intended to establish preference among alternative principles acceptable 
under GAAP. Decisions about the application of the GAAP discussed in the accounting and financial re­
porting sections of the AICPA Audit and Accounting Guide Life and Health Insurance Entities (2008) should 
not be made by reference to the illustrative financial statements but by a careful reading to the specified 
authoritative literature. The illustrative financial statements reflect many of the minimum disclosure require­
ments for a life and health insurance entity but do not include all of the amounts or transactions discussed 
in other chapters of the guide or that might be found in practice. For example, the illustrative notes indicate 
the subject matter generally required to be disclosed, but they should be expanded, reduced, or otherwise 
modified to suit individual circumstances based on a careful reading of the specified authoritative literature.
.02 The illustrative financial statements do not include other transactions not unique to life and health 
insurance entities, such as disclosures about segments, employee benefit plans, certain risks and uncertain­
ties, or postemployment benefits other than pensions. Preparers and auditors should consult authoritative 
pronouncements for guidance on presenting such other information.
.03 The illustrative financial statements do not reflect rules and releases of the Securities and Exchange 
Commission (SEC) that, for SEC registrants, have an authority similar to other officially established account­
ing principles. SEC Regulation S-X, Article 7, Insurance Companies, should be referred to.
.04 Auditors of SEC-registrant financial statements are reminded that, in May 2007, the Public Company 
Accounting Oversight Board (PCAOB) adopted Auditing Standard No. 5, An Audit of Internal Control Over 
Financial Reporting That Is Integrated with An Audit of Financial Statements (AICPA, PCAOB Standards and 
Related Rules, Rules of the Board, "Standards"), which was later approved by the SEC on July 25, 2007. This 
standard replaces Auditing Standard No. 2, An Audit of Internal Control Over Financial Reporting Performed in 
Conjunction With an Audit of Financial Statements. Auditing Standard No. 5 is principles-based and presents 
a risk-based, top-down approach designed to increase the likelihood that material weaknesses will be found 
before resulting in a material misstatement of a company's financial statements, while eliminating unneces­
sary procedures. The standard was also designed to make audits more scaleable for smaller or less complex 
companies. This new standard is required for all audits of internal control for fiscal years ending on or after 
November 15, 2007. However, early adoption is permitted and encouraged. For more information, readers 
may refer to the AICPA Audit Risk Alert titled SEC and PCAOB Developments—2008 (product no. 022498kk).
.05 The illustrative financial statements also do not reflect the impact of laws and regulations of the 
insurance entity's state of domicile. The impact on the financial statements of such laws and regulations 
vary by state. Many states require conformity with the codification of statutory accounting practices in the 
National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures Manual to the 
extent it does not conflict with its own state laws and regulations. Refer to the NAIC Accounting Practices 
and Procedures Manual, NAIC Annual Statement Instructions, and specific state laws and regulations to deter­
mine the impact of codification and individual state laws and regulations.
.06 These illustrative financial statements are not intended to include items that should be accounted for 
under the requirements of Financial Accounting Standards Board (FASB) Statement of Financial Accounting 
Standards No. (SFAS) 133, Accounting for Derivative Instruments and Hedging Activities, and, therefore, do not 
reflect the requirements of SFAS 133 or its amendments. Practitioners should refer to SFAS 133 and related 
amendments for guidance on reporting derivative instruments and hedging activities.
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.07 Life and health insurance entities generally present unclassified balance sheets.
.08 Also, preparers and auditors of SEC-registrant financial statements are reminded that as discussed 
in Staff Accounting Bulletin No. 74, Topic 11M, Disclosure of the Impact that Recently Issued Accounting Stan­
dards will have on the Financial Statements of the Registrant when Adopted in a Future Period, and Interpretation 
No. 3, "The Impact on an Auditor's Report of an FASB Statement Prior to the Statement's Effective Date" of 
AU section 410, Adherence to Generally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1, 
AU sec. 9410, paragraphs .13-18), filings with the SEC that include financial statements for a period ending 
after the issuance of an accounting standard but before the required date of adoption of that accounting 
standard should include disclosure of the impact that the recently issued accounting standard will have on 
the financial position and results of operations of the registrant when such standard is adopted in a future 
period. The following disclosures should be considered by registrants:
• A brief description of the new standard, the date that adoption is required and the date that the 
registrant plans to adopt, if earlier.
• A discussion of the methods of adoption allowed by the standard and the method expected to be 
utilized by the registrant, if determined.
• A discussion of the impact that adoption of the standard is expected to have on the financial state­
ments of the registrant, unless unknown or not reasonably estimable. In that case, a statement to 
that effect may be made.
• Disclosure of the potential impact of other significant matters that the registrant believes might re­
sult from the adoption of the new standard (such as technical violations of debt covenant agree­
ments and planned or intended changes in business practices).
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.09
ABC LIFE INSURANCE COMPANY 
Balance Sheet
December 31, 20X2 and 20X1 
(Amounts in Thousands)
20X2 20X1
Assets
Investments:
Debt and equity securities:
Fixed maturities, held to maturity, at amortized cost
(estimated fair value: $47,830 in 20X2 and $45,255 in 20X1) $ 44,864 $ 46,310
Fixed maturities, available for sale, at estimated fair value
(amortized cost: $247,525 in 20X2 and $219,565 in 20X1) 255,893 214,563
Trading account securities, at estimated fair value
(cost: $4,220 in 20X2 and $4,419 in 20X1) 3,950 4,190
Mortgage loans 79,258 106,692
Real estate 6,410 6,147
Policy loans 43,549 51,013
Short-term investments 7,515 6,321
Total investments 441,439 435,236
Cash and cash equivalents 5,285 3,343
Accrued investment income 6,660 8,026
Premiums due and other receivables,1 net of allowance
of $4,500 and $2,100 for doubtful accounts 1,647 1,092
Reinsurance receivable on paid and unpaid losses 596 407
Reinsurance receivable related to contract holder liabilities 5,714 3,048
Deferred policy acquisition costs 38,936 36,429
Property and equipment, net of accumulated depreciation 501 420
Other assets 152 158
Separate account assets 732 525
Total assets $501,662 $488,684
Liabilities
Future policy benefits $345,887 $341,207
Guaranteed interest contracts 21,342 23,555
Policyholders funds on deposit 49,408 46,202
Unpaid claims 5,418 4,737
Policyholders dividends 2,335 3,450
Amounts held in escrow and accrued expenses 4,977 4,562
Deferred federal income taxes 1,412 1,027
Other liabilities 253 4,465
Separate account liabilities 732 525
Total liabilities 431,764 429,730
1 Statement of Position (SOP) 01-6, Accounting by Certain Entities (Including Entities With Trade Receivables) That Lend to or Finance the 
Activities of Others (AICPA, Technical Practice Aids, ACC sec. 10,850), requires, among other things, that the summary of significant 
accounting policies include the basis for accounting for trade receivables, and the classification and method of accounting for other 
receivables. SOP 01-6 requires that a description of the accounting policies and methodology the entity used to estimate its allowance for 
doubtful accounts be included in the notes to the financial statements. Such a description should identify the factors that influenced 
management's judgment and may also include discussion of risk elements relevant to particular categories of financial instruments. In 
addition, SOP 01-6 requires that the summary of significant accounting policies include the policy for charging off uncollectible trade 
receivables.
SOP 01-6 contains other presentation and disclosure requirements that may apply to the financial statements of insurance entities. 
Readers should refer to the full text of SOP 01-6.
Commitments and contingencies (Note 12)
(continued)
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See accompanying notes to financial statements.
20X2 20X1
Shareholders' Equity
Capital stock: authorized—5,000,000 shares of $2 par value; 
3,341,624 shares issued and outstanding 6,683 6,683
Retained earnings 57,776 55,522
Accumulated other comprehensive income 5,439 (3,251)
Total shareholders' equity 69,898 58,954
Total liabilities and shareholders' equity $501,662 $488,684
FSP §20,600.09
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.10
ABC LIFE INSURANCE COMPANY 
Statements of Income 
Years Ended December 31, 20X2 and 20X1 
(Amounts in Thousands)
See accompanying notes to financial statements.
20X2 20X1
Premiums and Other Revenues
Premiums:
Life and annuity premiums $24,833 $24,783
Accident and health premiums 10,141 9,153
Other premiums 20 43
Contract holder fees 1,961 1,844
Net investment income 32,998 35,141
Net realized gains (losses) on investments and 
other 4,222 (2,670)
Total premiums and other revenues 74,175 68,294
Benefits and Other Expenses
Policyholder benefits 39,158 30,815
Interest credited to policyholder accounts 4,363 4,156
General expenses 4,288 4,984
Amortization of deferred policy acquisition costs 1,276 1,305
Underwriting, acquisition, and insurance expenses 18,029 17,266
Policyholders' dividends 4,665 6,898
Total benefits and expenses 71,779 65,424
Income before income taxes 2,396 2,870
Income taxes:
Current 1,547 601
Deferred (1,405) 540
Total income taxes 142 1,141
Net income 2,254 1,729
Net income per common share .67 .52
Dividends per common share — .98
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ABC LIFE INSURANCE COMPANY 
Statements of Comprehensive Income (Loss) 
Years Ended December 31, 20X2 and 20X1 
(Amounts in Thousands)
20X2 20X1
Net income $ 2,254 $ 1,729
Other comprehensive income (loss) 8,690 (1,730)
Total comprehensive income (loss) $10,944 $ (1)
See Note 5 to the financial statements for information about other comprehensive income (loss).
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ABC LIFE INSURANCE COMPANY 
Statement of Changes in Shareholders' Equity 
Years Ended December 31, 20X2 and 20X1 
(Amounts in Thousands)
See accompanying notes to financial statements.
Balance at January 1, 20X1
Capital
Stock
$6,683
Retained
Earnings
$57,068
Accumulated
Other
Comprehensive 
Income (Loss) 
$(1,521)
Total
Shareholders'
Equity
$62,230
Net income for 20X1 — 1,729 — 1,729
Shareholders' dividends — (3,275) — (3,275)
Other comprehensive income (loss) — — (1,730) (1,730)
Balance at December 31, 20X1 6,683 55,522 (3,251) 58,954
Net income for 20X2 — 2,254 — 2,254
Other comprehensive income — — 8,690 8,690
Balance at December 31, 20X2 $6,683 $57,776 $ 5,439 $69,898
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ABC LIFE INSURANCE COMPANY 
Statements of Cash Flows 
Years Ended December 31, 20X2 and 20X1 
(Amounts in Thousands)
See accompanying notes to financial statements.
20X2 20X1
Cash flows from operating activities:
Net income $ 2,254 $ 1,729
Adjustments to reconcile net income to net 
cash provided by operating activities:
Interest credited to universal life policies 7,927 10,445
Accrual of discount on investments, net (976) (1,328)
Net realized (gains) losses on investments (4,222) 2,670
Depreciation and amortization 3,041 3,534
Amortization of deferred policy acquisition costs 1,276 1,305
Deferred federal income taxes (2,538) 540
Change in operating assets and liabilities:
Accrued investment income 1,366 880
Capitalization of deferred policy acquisition costs (3,783) (6,645)
Policy liabilities (3,440) (16,234)
Other items, net (644) 3,269
Net cash provided by operating activities 261 165
Cash flows from investing activities:
Cost of investments purchased:
Fixed maturities and equity securities (228,053) (122,495)
Mortgage loans and real estate (921) —
Proceeds from investments sold, redeemed, or matured:
Fixed maturities and equity securities 206,051 95,177
Mortgage loans and real estate 27,970 18,621
Policy loans, net 2,320 6,468
Short-term investments, net 409 15,446
Net cash provided by investing activities 7,776 13,217
Cash flows from financing activities:
Dividends to shareholders — (3,275)
Receipts from universal life policies credited to contract
holder account balances 7,918 8,365
Return of contract holder account balances on universal
life policies (4,165) (3,718)
Withdrawals from interest-sensitive contracts (9,848) (13,046)
Cash used in financing activities (6,095) (11,674)
Net increase in cash and cash equivalents 1,942 1,708
Cash and cash equivalents, beginning of year 3,343 1,635
Cash and cash equivalents, end of year $ 5,285 $ 3,343
Supplemental cash flow information:
Income taxes paid $ 1,205 $ 785
FSP §20,600.13
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ABC LIFE INSURANCE COMPANY 
Notes to Financial Statements
Years Ended December 31, 20X2 and 20X1
Note 1: Organization and Significant Accounting Policies
Organization. ABC Life Insurance Company (ABC or the company) is a stock life insurance com­
pany incorporated in the state of ABC that offers individual life, disability income, long-term care, 
annuity, and investment products. ABC does business in the continental United States, with a 
concentration in New York, New Jersey, and Connecticut.
Basis of presentation. The significant accounting policies followed by ABC that materially affect 
financial reporting are summarized as follows. The accompanying financial statements have been 
prepared in accordance with generally accepted accounting principles (GAAP) that differ from 
statutory accounting practices (SAP) used for regulatory authorities. The preparation of the finan­
cial statements in conformity with GAAP requires management to make estimates and assump­
tions that affect the reported amounts of assets and liabilities and disclosure of contingent assets 
and liabilities at the date of the financial statements and the reported amounts of revenues and 
expenses during the reporting period. Actual results could differ from those estimates.
Investments. Fixed maturity securities available for sale consist of bonds, notes, and redeemable 
and nonredeemable preferred stock not classified as either trading or held to maturity, and are 
reported at estimated fair value. Unrealized holding gains and losses, net of tax, on available-for- 
sale securities are reported as a net amount in other comprehensive income. Deferred policy ac­
quisition cost offsets for universal life type contracts and amounts attributable to certain partici­
pating contracts are recorded as a separate component of accumulated other comprehensive 
income. Fixed maturity securities held to maturity consist of bonds, notes, redeemable and non­
redeemable preferred stock which the insurance company has the intent and ability to hold to 
maturity, and are reported at amortized cost and adjusted for amortization of premium or dis­
count. Declines in fair value of individual held-to-maturity and available-for-sale securities below 
their cost that are other then temporary have resulted in write-downs of the individual securities 
to their fair value. The related write-downs have been included in earnings as realized losses. 
Trading account securities consist of bonds, notes, and redeemable and nonredeemable preferred 
stock, and common stock held principally for resale in the near term, and are recorded at their 
estimated fair values. Realized and unrealized gains and losses on trading account securities are 
included in other income.
Mortgage loans on real estate are carried at unpaid balances and are adjusted for amortization of 
premium or discount, less allowance for losses. Real estate held for sale is carried at the lower of 
depreciated cost or fair value less estimated selling costs. Real estate classified as held-for-sale is 
no longer depreciated. Real estate, including real estate acquired in satisfaction of debt, is carried 
at depreciated cost. Impaired real estate is written down to fair value with the impairment loss 
being included in net realized gains (losses) on investments and other. Upon foreclosure (includ­
ing in-substance foreclosure), the carrying value of the property is recorded at the lower of cost 
or fair value (less selling costs if to be sold), which becomes its new cost basis. The estimated fair 
value for real estate is determined based upon independent appraisals and other available infor­
mation about the property, which may take into consideration a number of factors, including (i) 
discounted cash flows, (ii) sales of comparable properties, (iii) geographic location of property 
and related market conditions, and (iv) disposition costs.
Foreclosed properties are actively managed by the company in order to maximize their value. 
Subsequent to foreclosure, the carrying value of the property is periodically evaluated and a val­
uation allowance is established, if necessary, to reflect any additional amounts considered unre­
coverable upon sale. At the time of the sale, the difference between the sales price and the carry­
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ing value is recorded as a realized gain or loss. Policy loans are carried at unpaid balances.
Short-term investments are stated at amortized cost, which approximates fair value.•
Provisions for impairments of securities classified as held to maturity are included in net realized 
gains (losses) on investments and other. Realized gains and losses are determined by specific 
identification.
Cash and cash equivalents. Cash equivalents are carried at cost, which approximates fair value. 
Cash equivalents are highly liquid financial instruments with an original maturity of three 
months or less.
Deferred policy acquisition costs. Commissions and other costs of acquiring traditional life insur­
ance, universal life insurance and investment products, and accident and health insurance, that 
vary with and are primarily related to the production of new and renewal business, have been 
deferred. Traditional life insurance and accident and health insurance acquisition costs are being 
amortized over the premium-paying period of the related policies using assumptions consistent 
with those used in computing future policy benefit liabilities. For universal life-type contracts and 
investment contracts that include significant surrender charges or that yield significant revenues 
from sources other than the investment of contract holders' funds, the deferred contract acquisi­
tion cost amortization is matched to the recognition of gross profit.
Otherwise, deferred policy acquisition costs on investment contracts are amortized using an ac­
counting method that recognizes acquisition costs as expenses at a constant rate applied to net 
policy liabilities. The effect on the deferred acquisition costs (DAC) asset that would result from 
realization of unrealized gains (losses) is recognized with an offset to accumulated other compre­
hensive income in consolidated shareholders' equity as of the balance sheet date.
Effective January 1, 2007, the company adopted Statement of Position (SOP) 05-1, Accounting by 
Insurance Enterprises for Deferred Acquisition Costs in Connection With Modifications or Exchanges of 
Insurance Contracts (AICPA, Technical Practice Aids, ACC sec. 10,920), which provides guidance on 
accounting by insurance enterprises for DAC on internal replacements of insurance and invest­
ment contracts other than those specifically described in Financial Accounting Standards Board 
(FASB) Statement of Financial Accounting Standards No. (SFAS) 97, Accounting and Reporting by 
Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and Losses from the 
Sale of Investments. SOP 05-1 defines an internal replacement and is effective for internal replace­
ments occurring in fiscal years beginning after December 15, 2006. In addition, in February 2007, 
the AICPA issued related Technical Practice Aids (TPAs) to provide further clarification of SOP 
05-1. The TPAs became effective concurrently with the adoption of SOP 05-1. As a result of the 
adoption of SOP 05-1 and the related TPAs, if an internal replacement modification substantially 
changes a contract, then the DAC is written off immediately through income and any new defer­
rable costs associated with the new replacement are deferred. If a contract modification does not 
substantially change the contract, the DAC amortization on the original contract will continue 
and any acquisition costs associated with the related modification are immediately expensed.
The adoption of SOP 05-1 and the related TPAs resulted in a reduction to DAC and value of 
business acquired on January 1, 2007, and an acceleration of the amortization period relating 
primarily to the company's group life and health insurance contracts that contain certain rate 
reset provisions. Prior to the adoption of SOP 05-1, DAC on such contracts was amortized over 
the expected renewable life of the contract. Upon adoption of SOP 05-1, DAC on such contracts 
is to be amortized over the rate reset period. The impact as of January 1, 2007, was a cumulative 
effect adjustment of $XXX, net of income tax of $XXX, which was recorded as a reduction to 
retained earnings.
Deferred sales inducements. Costs related to sales inducements offered on sales to new customers, 
principally on investment contracts and primarily in the form of additional credits to the cus­
tomer's account value or enhancements to interest credited for a specified period, which are be­
yond amounts currently being credited to existing contracts, are deferred and recorded as other 
assets. All other sales inducements are expensed as incurred and included in interest credited to 
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contract holders' funds. Deferred sales inducements are amortized to income using the same 
methodology and assumptions as DAC, and are included in interest credited to contract holders' 
funds. Deferred sales inducements are periodically reviewed for recoverability and written down 
when necessary.
Property and equipment. Property and equipment are reported at cost, net of accumulated depre­
ciation of $1,915,000 and $1,721,000 in 20X2 and 20X1, respectively. Property and equipment are 
depreciated using the straight-line method over their estimated useful lives.
Future policy benefits and expenses. The liabilities for traditional life insurance and accident and 
health insurance contract benefits and expenses are computed using a net level premium method 
including assumptions about investment yields, mortality, withdrawals, and other assumptions 
based on ABC's experience modified as necessary to reflect anticipated trends and to include 
provisions for possible unfavorable deviations. Liability interest assumptions are graded and 
range from 3 percent to 10 percent. Benefit liabilities for traditional life insurance contracts in­
clude certain deferred profits on limited-payment policies that are being recognized in income 
over the contract term. Contract benefit claims are charged to expense in the period that the 
claims are incurred.
The accrued account balance for nontraditional life insurance and investment contracts is com­
puted as deposits net of withdrawals made by the contract holder, plus amounts credited based 
on contract specifications, less contract fees and charges assessed, plus any additional interest. 
Interest crediting rates for universal life and investment products range from 5.50 percent to 9.25 
percent.
Included in contract holders' account balances is a provision for contract holder dividends. Ben­
efit liabilities for contract holders' account balances are computed under a retrospective deposit 
method and represent contract account balances before applicable surrender charges. Contract 
benefits and claims that are charged to expense include benefit claims incurred in the period in 
excess of related contract account balances. Interest crediting rates for universal life and invest­
ment products range from 5.50 percent to 9.25 percent. Benefits and expenses are charged against 
the account balance to recognize costs as incurred over the estimated lives of the contracts. Ex­
penses include interest credited to contract account balances and benefits paid in excess of con­
tract account balances.
Minimum guarantees. The company issues variable annuity contracts through separate accounts 
where the company contractually guarantees to the contract holder total deposits made to the 
contract less any partial withdrawals plus a minimum return. This guarantee includes benefits 
that are payable in the event of death, annuitization, or at specified dates during the accumulation 
period.
Accounting policy for health liabilities. Unpaid claims on accident and health policies represent the 
estimated liability for benefit expenses both reported but not paid and incurred but not reported 
to ABC through December 31. ABC does not discount its liabilities for unpaid claims. Liabilities 
for unpaid claims are estimated using individual case-basis valuations and statistical analyses. 
Those estimates are subject to the effects of trends in claim severity and frequency. Although 
considerable variability is inherent in such estimates, management believes that the liabilities for 
unpaid claims are adequate. The estimates are continually reviewed and adjusted as necessary as 
experience develops or new information becomes known; such adjustments are included in cur­
rent operations.
Income taxes. Federal income taxes are charged or credited to operations based upon amounts 
estimated to be payable or recoverable as a result of taxable operations for the current year. De­
ferred income taxes have been provided for temporary differences between the tax basis of assets 
and liabilities calculated using the criteria of SFAS 109, Accounting for Income Taxes, as amended 
by FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes—an interpretation of 
FASB Statement No. 109, and their reported amounts in the financial statements using enacted 
income tax rates and laws. The company recognizes interest and penalties accrued on any unre-
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cognized tax benefits as a component of income tax expense. The company did not have any 
accrued and recognized interest or penalties associated with unrecognized tax benefits for the 
years ending December 31, 20X2 and 20X1.1
1 Because these standards are not insurance industry specific, transition and adoption specifics are excluded.
Reinsurance. In the normal course of business, the company seeks to limit its exposure to loss on 
any single insured and to recover a portion of benefits paid by ceding reinsurance to other insur­
ance entities or reinsurers under excess coverage and coinsurance contracts. The company retains 
a maximum of $400,000 of coverage per individual life. Amounts paid or deemed to have been 
paid for reinsurance contracts are recorded as reinsurance receivable.
Insurance premium revenues. Traditional life premiums, which include those products with fixed 
and guaranteed premiums and benefits and consist principally of whole life insurance contracts, 
limited-payment life insurance contracts, and certain annuities with life contingencies, are gener­
ally recognized as revenue when due. Revenues on universal life and investment-type contracts 
consist of contract charges against contract holders' funds for the cost of insurance, administra­
tion, surrender charges, actuarial margin, and other fees. Accident and health insurance premi­
ums are recognized as revenue pro rata over the terms of the contracts.
Separate accounts. Separate account assets and liabilities generally represent funds maintained in 
accounts to meet specific investment objectives of contract holders who bear the investment risk. 
Investment income and investment gains and losses accrue directly to such contract holders. The 
assets supporting the variable portion of both traditional variable annuities and variable contracts 
with guarantees are carried at fair value and reported as summary total separate account assets 
with an equivalent summary total reported for liabilities. Amounts assessed against the contract 
holders for mortality, administrative, and other services are included in revenue and changes in 
liabilities for minimum guarantees are included in policyholder benefits in the statement of op­
erations. Separate account net investment income, net investment gains and losses, and the re­
lated liability changes are offset within the same line item in the statement of operations.
Business risks and uncertainties. The development of liabilities for future policy benefits for the 
company's products requires management to make estimates and assumptions regarding mortal­
ity, morbidity, lapse, expense, and investment experience. Such estimates are primarily based on 
historical experience and future expectations of mortality, morbidity, expense, persistency, and 
investment assumptions. Actual results could differ materially from those estimates. Management 
monitors actual experience and, if circumstances warrant, revises its assumptions and the related 
future policy benefit estimates.
The company's investments are primarily comprised of fixed maturity securities, equity securi­
ties, real estate, and mortgage loans. Significant changes in prevailing interest rates and geo­
graphic conditions may adversely affect the timing and amount of cash flows on such invest­
ments and their related values. In addition, the value of these investments is often derived from 
an appraisal, an estimate or opinion of value. A significant decline in the fair value of these in­
vestments could have an adverse effect on the company's balance sheet.
The company regularly invests in mortgaged backed securities (MBS) and other securities subject 
to prepayment and call risk. Significant changes in prevailing interest rates may adversely affect 
the timing and amount of cash flows on such securities. In addition, the amortization of market 
premium and accretion of market discount for MBS is based on historical experience and esti­
mates of future payment speeds on the underlying mortgage loans. Actual prepayment speeds 
will differ from original estimates and may result in material adjustments to amortization or ac­
cretion recorded in future periods.
Codification. The National Association of Insurance Commissioners (NAIC) revised the Accounting 
Practices and Procedures Manual in a process referred to as codification. Codification became effec­
tive on January 1, 2001. The company's state of domicile has adopted the provisions of the revised
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manual effective January 1, 2001. The revised manual has changed to some extent, prescribed 
SAP, and has resulted in changes to the company's statutory-basis financial statements. The cu­
mulative effect of changes in accounting principles adopted to conform to the revised Accounting 
Practices and Procedures Manual of $______has been reported as an adjustment to increase (de­
crease) surplus in the company's statutory-basis financial statements as of January 1, 2001.
Guaranty funds. Guaranty fund (and other) assessments are accrued at the time the events occur 
on which assessments are expected to be based.
Note 2: Earnings Per Common Share
Basic and diluted earnings per common share are as follows.
(Thousands, except per 
common share data)
Income
(Numerator)
Shares
(Denominator)
Per Common 
Share Amount
20X2
Net income 2,254
Income applicable to common ownership 2,254 3,342 .67
20X1
Net income 1,729
Income applicable to common ownership 1,729 3,342 .52
Note 3: Investments
In reporting disclosures about investments in securities, entities should comply primarily with 
the requirements of paragraphs 6, 17, and 19-22 of SFAS 115, Accounting for Certain Investments in 
Debt and Equity Securities (as amended); paragraphs 17-18 of FSP FAS 115-1 and 124-1, The Mean­
ing of Other-Than-Temporary Impairment and Its Application to Certain Investments; paragraphs 
47-48 of SFAS 60, Accounting and Reporting by Insurance Enterprises (as amended); paragraphs 
22-23 and 28 of SFAS 91, Accounting for Nonrefundable Fees and Costs Associated with Originating or 
Acquiring Loans and Initial Direct Costs of Leases—an amendment of FASB Statements No. 13, 60, and 
65 and a rescission of FASB Statement No. 17 (as amended); and appendix C of the Audit and 
Accounting Guide Life and Health Insurance Entities. Other disclosure requirements may also be 
applicable.
Note 4: Fair Value of Financial Instruments
The following methods and assumptions were used to estimate the fair value of each class of 
financial instruments for which it is practicable to estimate that value in conformity with SFAS 
157, Fair Value Measurements, and SFAS 159, The Fair Value Option for Financial Assets and Financial 
Liabilities—Including an amendment of FASB Statement No. 115.
Short-term investments. For those short-term instruments amortized cost is a reasonable estimate 
of fair value.
Investment securities and trading account assets. For securities held for trading purposes and mar­
ketable equity securities held for investment purposes, fair values are based on quoted market 
prices or dealer quotes. For other securities held as investments, fair value equals quoted market 
price, if available. If a quoted market price is not available, fair value is estimated using quoted 
market prices for similar securities.
Mortgage loans on real estate and policy loans. The fair value of mortgage loans on real estate is 
estimated using discounted cash flows. The fair value of policy loans is estimated by discounting 
the future cash flows using reasonable assumptions for mortality and repayments and using the 
current rates at which similar loans would be made to contract holders with similar credit ratings 
and the same remaining maturities.
The estimated fair values of ABC's mortgage loans on real estate and policy loans are as follows.
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20X2 20X1
Mortgage loans on real estate 
Policy loans
Carrying
Amount
$79,258
43,549
(Amounts in thousands)
Fair Carrying Fair
Value Amount Value
$83,506 $106,692 $112,027
60,000 51,013 59,000
Note 5: Accumulated Other Comprehensive Income
Accumulated other comprehensive income (loss) represents cumulative gains and losses on items 
that are not reflected in earnings. The balances and activity for the years 20X2 and 20X1 are as 
follows.
20X2 20X1
(Amounts in thousands)
Changes in net unrealized gains (losses) on investment securities:
Net unrealized gains (losses) arising during the period $13,324 $(1,873)
Reclassification adjustment for gains (losses) included
in net earnings 46 (300)
Changes in net unrealized gains (losses) on investment securities 13,370 (2,173)
Adjustments for:
Policyholder liabilities, deferred acquisition costs and deferred 
federal income taxes (4,680) 443
Changes in net unrealized gains (losses) net of adjustments 8,690 (1,730)
Total other comprehensive income (loss) $ 8,690 $(1,730)
Note 6: Income Taxes
Significant components for income tax expense attributable to continuing operations are as follows.
20X2 20X1
(Amounts in thousands)
Current income tax expense $ 1,547 $ 601
Deferred income tax (benefit) expense (1,405) 540
Total income tax expense $ 142 $1,141
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts 
of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. 
Significant components of the company's deferred tax liabilities and assets are as follows.
December 31, December 31,
20X2 20X1
(Amounts in thousands)
Deferred tax liabilities:
Deferred policy acquisition costs $13,131 $12,297
Future policy benefits — 512
Accrual of discount on bonds 924 1,982
Other 3,641 1,024
Total deferred tax liabilities 17,696 15,815
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December 31, 
20X2
December 31,
20X1
(Amounts in thousands)
Deferred tax assets:
Policyholder dividends 8,067 8,224
Future policy benefits 851 —
Deferred policy acquisition costs 2,078 1,561
Investment valuation allowance 1,087 1,651
Retirement plan accruals 1,917 497
Tax credits and loss carryforwards 1,820 1,945
Investment income differences 574 556
Other 406 354
Total deferred tax assets 16,800 14,788
Valuation allowance for deferred tax assets (516) —
Net deferred tax assets 16,284 14,788
Net deferred tax liabilities $ 1,412 $ 1,027
A valuation allowance has been established due to the uncertainty of realized certain tax credits 
and loss carryforwards, and a portion of other deferred tax assets.
A reconciliation of federal income tax expense as presented in the financial statements and in­
come taxes calculated using the statutory corporate tax rate follows.
20X2 20X1
(Amounts in thousands)
Income from operations $2,396 $2,870
Application of income tax rate 838 1,005
Small company deduction for life insurance companies (556) (496)
Policyholders' share of income (loss) in excess of (less than)
dividends paid (264) 752
Dividend received deduction (3) (50)
Other 127 (70)
Total tax expense $ 142 $1,141
Reconciliation of Unrecognized Tax Benefits
20X2 20X1
(Amounts in thousands)
Beginning Balance $XXX $XXX
Prior period position increases XXX XXX
Prior period position decreases (XXX) (XXX)
Current period position increases XXX XXX
Current period position decreases (XXX) (XXX)
Decreases relating to settlements with taxing authorities (XXX) (XXX)
Reductions due to a lapse of applicable statue of limitations (XXX) (XXX)
Ending balance XXX XXX
None of the aforementioned unrecognized tax benefits, if recognized, would affect the effective 
tax rate. Additionally, no tax positions exist for which it is reasonably possible that the total 
amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of 
December 31, 20X2. No interest or penalties were recognized in the statement of operations or the
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statement of financial position for the years ending December 31, 20X2 and 20X1. Tax years that 
remain subject to examination by major tax jurisdictions include the years ending December 31, 
19X9-20X2.
Note 7: Financial Instruments With Off-Balance Sheet Risk and Concentration of Credit Risk
At December 31, 20X2, ABC held unrated or less-than-investment grade corporate debt securities 
of $8,000,000, net of allowance for losses, with an aggregate market value of $7,500,000. Those 
holdings amounted to 4 percent of ABC's corporate debt securities investments and less than 2 
percent of total assets. The holdings of less-than-investment grade securities are widely diversi­
fied and of satisfactory quality based on ABC's investment policies and credit standards. ABC 
also invests in mortgage loans principally involving commercial real estate. At December 31, 
20X2, 3 percent of such mortgages ($2,000,000) involved properties located in California and Ar­
izona. Such investments consist of first mortgage liens on completed income-producing proper­
ties, and mortgages on individual properties do not exceed $300,000.
Note 8: Liability for Unpaid Claims
The liability for unpaid claims and claim adjustment expenses is based on the estimated amount 
payable on claims reported prior to the balance sheet date that have not yet been settled, claims 
reported subsequent to the balance sheet date that have been incurred during the period then 
ended, and an estimate (based on prior experience) of incurred but unreported claims relating to 
such period.
Activity in the liability for unpaid claims and claim adjustment expenses for the company's health 
and disability coverages is summarized as follows.
20X2 20X1
(Amounts in thousands)
Balance, beginning of year $ 4,737 $ 7,669
Less: reinsurance recoverables 296 1,018
Net balance, beginning of year 4,441 6,651
Amount incurred, related to
prior years $ (297) $ 313
Current year 26,197 25,671
Total 25,900 25,984
Amount paid, related to
prior years 6,923 8,937
Current year 18,303 19,257
Total 25,226 28,194
Net balance, end of year 5,115 4,441
Plus: reinsurance recoverables 303 296
Balance, end of year $ 5,418 $ 4,737
As a result of changes in estimates of insured events in prior years, the provision of claims and 
claim adjustment expenses (net of reinsurance recoveries of $(7,000) and $722,000 in 20X2 and 
20X1, respectively) decreased by $297,000 in 20X2 reflecting lower-than-anticipated losses on
___________ , and increased by $313,000 in 20X1 reflecting higher-than-anticipated losses and
related expenses for claims for____________
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Note 9: Minimum Guarantees
The following summarizes the liabilities for guarantees on variable contracts reflected in the general 
account.
Balance at January 1
Minimum 
guaranteed Death 
Benefit (MGDB)
$X,XXX,XXX
Guaranteed 
Minimum 
Accumulation 
Benefit (GMAB) 
$X,XXX,XXX
Guaranteed 
Minimum Income 
Benefit (GMIB)
$X,XXX,XXX
Totals
$X,XXX,XXX
Incurred guarantee 
benefits1 X,XXX,XXX X,XXX,XXX X,XXX,XXX X,XXX,XXX
Paid guarantee 
benefits X,XXX,XXX X,XXX,XXX X,XXX,XXX X,XXX,XXX
Balance at
December 31, 20XX1 2 $X,XXX,XXX $X,XXX,XXX $X,XXX,XXX $X,XXX,XXX
1 For guaranteed minimum accumulation benefits, incurred guarantee benefits incorporates all changes in fair value other than 
amounts resulting from paid guarantee benefits.
2 Included in the total reserve balance are reserves for variable annuity death benefits of $---------, variable annuity income benefits of
$_____ and other guarantees of $______
The minimum guaranteed death benefit (MGDB) liability is established equal to a benefit ratio 
multiplied by the cumulative contract charges earned, plus accrued interest less contract benefit 
payments. The benefit ratio is calculated as the estimated present value of all expected contract 
benefits divided by the present value of all expected contract charges. The company regularly 
evaluates estimates used and adjusts the additional liability balance, with a related charge or 
credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions 
should be revised.
The following assumptions and methodology were used to determine the MGDB liability at De­
cember 31, 20XX:
• Data used was 1,000 stochastically generated investment performance scenarios.
• Mean investment performance assumption was XX.
• Volatility assumption was XX.
• Mortality was assumed to be 90 percent of the Annuity 2000 table.
• Lapse rates vary by contract type and duration and range from 1 percent to 20 percent, 
with an average of 3 percent.
• Discount rate was XX percent.
Guaranteed minimum accumulation benefits are considered to be derivatives under SFAS 133, 
Accounting for Derivative Instruments and Hedging Activities, as amended, and are recognized at fair 
value through earnings.
The guaranteed minimum income benefit (GMIB) liability is established equal to a benefit ratio 
multiplied by the cumulative contract charges earned, plus accrued interest less contract benefit 
payments. The benefit ratio is calculated as the estimated present value of all expected contract 
benefits divided by the present value of all expected contract charges. The company regularly 
evaluates estimates used and adjusts the additional liability balance, with a related charge or 
credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions 
should be revised. The assumptions used for calculating the GMIB liability at December 31, 20XX, 
are consistent with those used for calculating the MGDB liability. Underlying assumptions for the 
liability related to income benefits include assumed future annuitization elections based on fac­
tors such as the extent of benefit to the potential annuitant, eligibility conditions and the annui­
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tant's attained age. In addition, the calculation of the GMIB liability assumes X percent of the 
potential annuitizations that would be beneficial to the contract holder will be elected.
Note 10: Reinsurance
The company utilizes indemnity reinsurance agreements to reduce its exposure to large losses in 
all aspects of its insurance business. Such reinsurance permits recovery of a portion of losses from 
reinsurers, although it does not discharge the primary liability of the company as direct insurer 
of the risks reinsured. The company evaluates the financial strength of potential reinsurers and 
continually monitors the financial condition of reinsurers. The following tables include premium 
amounts ceded or assumed to or from other companies.
Direct 
Amount
Ceded to
Other Companies
Assumed from 
Other Companies
Net 
Amount
20X2
(Amounts in thousands)
Premiums:
Life insurance $2,090 $ 560 $3,330 $4,860
Accident and health 1,440 1,290 — 150
Annuities 3,130 — 70 3,200
Total earned premiums $6,660 $1,850 $3,400 $8,210
20X1
Premiums:
Life insurance $2,080 $ 520 $3,680 $5,240
Accident and health 1,510 1,370 — 140
Annuities 1,840 — 30 1,870
Total earned premiums $5,430 $1,890 $3,710 $7,250
Note 11: Separate Accounts
At December 31, 20X1 and 20X2, the company had the following variable contracts with guaran­
tees. The company's variable annuity contracts may offer more than one type of guarantee in 
each contract; therefore, the sum of amounts listed exceeds the total account balances of variable
annuity contracts' separate accounts with guarantees.
Return of net deposits plus a minimum return:
In the event of death
Account value $XXX $XXX
Net amount at risk1 $XXX $XXX
1 Defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.
2 Defined as the present value of the minimum guaranteed annuity payments determined in accordance with the terms of the contract 
in excess of the current account balance.
Average attained age of contract holders XX XX
Range of guaranteed minimum return rates X-X% X-X%
At annuitization
Account value $XXX $XXX
Net amount at risk1 2 $XXX $XXX
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Weighted average period remaining until expected annuitization XX XX
Range of guaranteed minimum return rates X-X% X-X%
Accumulation at specified date
Account value $XXX $XXX
Net amount at risk3 $XXX $XXX
3 Defined as the present value of the guaranteed minimum accumulation balance in excess of the current account balance.
4 The insurance enterprise may want to consider disclosing mutual funds by investment objective or other meaningful groupings that 
are useful in understanding the nature of the guarantee risk.
Range of guaranteed minimum return rates X-X% X-X%
Account balances of contracts with guarantees were invested in variable separate accounts as 
follows:
Asset Type December 31, 20X1
U.S. Treasury securities and obligations of $
U.S. government corporations and agencies
Obligations of states of the United States and 
political subdivisions of the states
Corporate debt securities:
—Investment grade 
—Noninvestment grade
Foreign debt securities
Mortgage-backed securities
Equity securities (including mutual funds)4
Real estate
Mortgage loans
Derivative financial instruments
Cash and cash equivalents ___________
Total $X,XXX,XXX
December 31, 20X2
$
$X,XXX,XXX
Assets transferred from the general account to the separate accounts are recognized at fair value 
to the extent of third-party contract holders' proportionate interest in separate accounts when the 
arrangement meets applicable criteria (paragraph 11 of SOP 03-1, Accounting and Reporting by 
Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts 
[AICPA, Technical Practice Aids, ACC sec. 10,870]). The gains recognized assets transferred to the 
separate accounts during 20X2 and 20X1 were XX,XXX and XX,XXX, respectively.
Note 12: Guaranty Fund Assessments
At December 31, 20X2 and 20X1, ABC has recorded $45,000 and $67,000, respectively, in liabilities 
related to guaranty fund (and other) assessments which are included in other liabilities in the 
balance sheet. At December 31, 20X2 and 20X1, the carried liability was reduced by recoverables 
for related premium tax offsets and policy surcharges in the amount of $25,000 and $35,000, re­
spectively. The period over which the assessments are expected to be paid and the recorded pre­
mium tax offsets and policy surcharges are expected to be realized is up to five and four years, 
respectively.
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Note 13: Statutory Financial Information
Under the law of ABC state, the state of incorporation, the maximum dividend that may be paid 
(without prior approval of the ABC state insurance department), in any 12 month period is the 
greater of (a) net investment income for the preceding calendar year or (b) 10 percent of contract 
holders' surplus at the end of the preceding calendar year. In general, net investment income for 
dividend purposes is interpreted by the insurance department to be the statutory pretax net in­
vestment income including net realized capital losses but excluding net realized capital gains. 
The maximum permissible amount of dividends for 20X3, based on statutory net investment in­
come for 20X2, is $20,000.
The company, which is domiciled in ABC state, prepares its statutory financial statements in 
accordance with accounting principles and practices prescribed or permitted by the ABC state 
insurance department, which (state of domicile) recognizes for determining solvency under the 
(state of domicile) insurance law. The commissioner of the state of domicile insurance department 
has the right to permit other practices that may deviate from prescribed practices. Prescribed SAP 
are those practices that are incorporated directly or by reference in state laws, regulations, and 
general administrative rules applicable to all insurance enterprises domiciled in (state of domi­
cile). Permitted SAP encompass all accounting practices that are not prescribed; such practices 
differ from state to state, may differ from company to company within a state, and may change 
in the future.
Note: Although the following reconciliation to statutory financial information is not required to 
be disclosed in financial statements prepared in conformity with GAAP, insurance entities some­
times include such disclosures to facilitate use of those financial statements for purposes of filing 
with state regulatory authorities. The second disclosure on variances from NAIC SAP (defined as 
follows) and permitted accounting practices is required under SOP 94-5, Disclosures of Certain 
Matters in the Financial Statements of Insurance Enterprises (AICPA, Technical Practice Aids, ACC sec. 
10,630), as amended by SOP 01-5, Amendments to Specific AICPA Pronouncements for Changes Re­
lated to the NAIC Codification (AICPA, Technical Practice Aids, ACC sec. 10,840).
The following reconciles ABC's statutory net income and statutory surplus and capital stock de­
termined in accordance with accounting practices prescribed or permitted by the insurance de­
partment of Connecticut with net earnings (loss) and equity on a GAAP basis.
20X2 20X1
(Amount in thousands)
Statutory net income $ 3,572 $ 2,719
Adjustments:
Future policy benefits and policyholders' account balances 572 894
Deferred policy acquisition costs 60 40
Deferred federal income tax (expense) benefit (1,405) 540
Valuation of investments 115 270
Postretirement benefits 272 354
Other, net (932) (3,088)
GAAP net income $ 2,254 $ 1,729
Statutory surplus and capital stock $65,388 $54,505
Asset valuation reserves (1,054) (1,972)
Statutory surplus, capital stock and asset valuation reserves (875) (967)
Adjustments:
Fixed income securities (29,472) (27,905)
Future policy benefits and policyholders' account balances 115 270
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20X2 20X1
(Amount in thousands)
Deferred federal income taxes (1,412) (1,027)
Valuation of investments 772 891
Deferred policy acquisition costs 38,936 36,429
Postretirement benefits (2,272) (2,354)
Other, net (228) 1,084
GAAP equity $69,898 $58,954
The company's statutory financial statements are presented on the basis of accounting practices 
prescribed or permitted by the [state of domicile] insurance department. [State of domicile] has 
adopted the NAIC Accounting Practices and Procedures Manual as the basis of its SAP, except that 
it has retained the prescribed practice of writing off goodwill immediately to statutory surplus in 
the year of acquisition.
In addition, the commissioner of [state of domicile] insurance department has the right to permit 
other specific practices that may deviate from prescribed practices. The commissioner has per­
mitted the company to record its home office property at estimated fair value instead of at depre­
ciated cost, as required by NAIC SAP. This accounting practice increased statutory capital and 
surplus by $X million and $X million at December 31, 20X2 and 20X1, respectively, over what it 
would have been had the permitted practice not been allowed. The company's statutory capital 
and surplus, including the effects of the permitted practice, was $X million and $X million at 
December 31, 20X2 and 20X1, respectively.
Had the company amortized its goodwill over ten years and recorded its home office property at 
depreciated cost, in accordance with NAIC SAP, the company's capital and surplus would have 
been $X million and $X million at December 31, 20X2 and 20X1, respectively.
Note 14: Commitments and Contingencies
Future minimum rental payments, principally for administrative offices, under noncancellable 
operating leases at December 31, 20X2, are as follows: 20X3, $1,113,000; 20X4, $1,064,000; 20X5, 
$1,011,000; 20X6, $976,000; 20X7, $976,000; and $3,906,000 thereafter. Rental expense was 
$1,164,000 in 20X2 and $1,184,000 in 20X1.
ABC is named as defendant in a number of legal actions arising primarily from claims made 
under insurance contracts or in connection with previous reinsurance agreements. These actions 
have been considered in establishing its contract benefit liability. Management and its legal coun­
sel are of the opinion that the settlement of these actions will not have a material effect on ABC's 
financial position or results of operations.
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